Quarterlytics / Financial Services / Asset Management - Leveraged / Iress Ltd

Iress Ltd

ire · ASX Financial Services
Claim this profile
Ticker ire
Exchange ASX
Sector Financial Services
Industry Asset Management - Leveraged
Employees 1001-5000
← All annual reports
FY2021 Annual Report · Iress Ltd
Sign in to download
Loading PDF…
2021  
Annual Report

Technology to 
perform better 
every day.

We provide 
technology to power 
financial services. 

What’s our purpose?

We believe technology should help 
people perform better every day.

What are we trying to do?

Make it easy for people to love 
financial services. 

If we get there, what 
will we become?

The essential partner for 
forward‑thinking financial 
services businesses.

Our values

We make things happen. 
We do things the right way. 
There’s got to be a better way. 
Clients, clients, clients.

Annual General Meeting (AGM) details
The AGM will be a hybrid event, with 
the option to attend online or in 
person (subject to local government 
restrictions) on:
Thursday 5 May 2022, 11.30am AEST
King & Wood Mallesons 
Level 27, Collins Arch, 
447 Collins St,  
Melbourne VIC 3000, Australia

4,400

client sites & services 
moved to the Iress Cloud 
Platform (ICP) to date

02

2021 highlights

04

Business overview

06

12

From our leadership

Our approach to ESG

Contents

2021 highlights 

Business overview 

Chair & CEO’s letter 

2

4

6

Operating & Financial Review 

Directors’ Report 

Auditor’s independence declaration  

Our vision & strategy 

10

Financial statements  

Environmental, Social & Governance  
& Iress Foundation  

Iress Leadership team 

Board of Directors 

Material business risks 

Directors’ declaration  

Independent Auditor’s Report  

Shareholder information  

Corporate directory 

12

18

20

22

24

28

59

60

107

108

112

113

1

Annual Report 20212021 highlights

Reported NPAT up 25%. 
Strategy execution underway, 
2025 targets reaffirmed.

Financial

Operating revenue AUD (m)

$595.9m

+11%  on a constant currency basis
+10%  on 2020

2019

2020

2021

$595.9m

$542.6m

$508.9m

Shareholder

Sustainable return for shareholders

Reported Segment Profit AUD (m)

152.1

152.9

37.9 

32.4 

Earnings per share AUD (cents)

Net Profit After Tax AUD (m)

65.1

Dividend per share AUD (cents)

46

59.2

46

2019

2020

2021

2

$166.2m

38.8c

$73.8m

46.0c

Iress LimitedOperational

Cloud adoption

4,400

client sites & services moved to the 
Iress Cloud Platform (ICP) to date

Sales & service effectiveness

3,000+hrs

of sales and service training  
completed by our people to improve  
high quality client service

ESG

Renewable energy in Sydney
& Melbourne offices

(representing 95% of our 
Australian footprint)

95%

renewable energy

Iress Community

16,000+

active users to date

Supporting refugee 
employment 

Employment of two software engineers from 
Syria and Iraq to support refugee employment 
through Talent Beyond Boundaries

The Iress Foundation was established in 2017 to 
focus our effort and support towards an already 
strong and engaged community. The guiding 
principles established then still remain relevant 
today: facilitate, support, and promote people 
engagement; make a visible, reliable, and meaningful 
contribution to partner charities.

+$231k

donated to charitable 
causes

615

volunteering hours

36

charities supported

Business overview

Iress is a leading technology company, 
designing and developing software and services 
for the financial services industry. Iress operates 
across Asia Pacific, the United Kingdom & 
Europe, Africa, and North America.

Our people & locations  
across the globe

2,224

Globally

1,200

Asia Pacific

725

UK & Europe

55

North America

244

Africa

Where our people focus

54%
Product & technology

4

26%
Commercial

10%
Client
solutions 

10%
Corporate

Iress LimitedSoftware & clients

Integrations

Clients

Users

Our clients range from small retail to large institutional 
businesses across the financial services industry. Our 
technology sits at the centre of our clients’ businesses, 
supporting their core operations with essential 
infrastructure and functionality, helping them to deliver 
to their clients, members and customers. 

550+

10k+

500k+

Financial advice

Trading & 
market data

Software

Integrated financial advice 
software including:
•  client management
•  business automation
•  portfolio data
•  research

•  financial planning tools
•  scaled advice journeys
•  digital client solutions
•  data‑driven compliance and analytics
•  regulatory obligations management 

Global market data and trading  
software including:
•  market data
•  trading interfaces
•  order and execution management
•  smart order routing
•  FIX services
•  portfolio management

•  securities lending
•  analytical tools
•  algorithmic trading
•  market making
•  CFD clearing
•  post trade solutions
•  trading and market data APIs

Clients

Institutional and 
independent advisory.

Institutional sell-side 
brokers, retail brokers, 
and online brokers. 

Investment 
management

Global investment management
and trading software including:
•  portfolio management
•  order and execution management 

services
•  FIX services
•  analytical tools
•  connectivity

Integration solutions including:
•  market data
•  order management
•  portfolio management
•  client relationship management
•  wealth management

Investment managers, 
investment platforms, fund 
managers, private client 
advisers and managers, 
wealth managers, 
custodians, and retail 
platforms.

Funds administration services including:
•  fund registry
•  retail platform licensing and technology

Fund data distribution via Iress 
Blockchain 

Superannuation

Superannuation administration 
software including:
•  fund registry
•  digital member portal

•  digital advice solutions
•  fund administration services

Superannuation funds.

Mortgages

Multi-channel mortgage sales and 
origination software including:
•  automated workflow
•  application processing
•  connectivity

Mortgage intermediary 
software including:
•  mortgage comparison
•  mortgage advice
•  lender connectivity

Mortgage lenders and 
intermediaries.

Life &  
pensions 

Insurance and pension sourcing  
software including:

•  quoting
•  comparison
•  application processing

Institutional and 
independent advisory, and 
insurance intermediaries.

5

Annual Report 2021Chair & CEO’s letter

As we entered the second year of the global pandemic, 
2021 proved in many ways just as turbulent as the year 
it followed. Despite these challenges, Iress continued to 
make strong progress towards our goal of becoming the 
essential partner for forward-thinking financial services 
businesses, with technology and transformation 
remaining core to our clients’ ability to adapt to change.

Our demonstrated adaptability, agility and 
innovation over the past year, has placed us in a 
strong position to achieve our goals.

We are pleased to report strong results for 2021. 
Return on invested capital (ROIC) was up 130 basis 
points to 10.5% with earnings per share (EPS) up 
20% on 2020 on a reported basis.

With a refreshed Board, new members of the 
management team leading product and sales, and 
a continued client-focus from our people, Iress is 
making good progress on our mission: 

to make it easy for people to 
love financial services and to 
become the essential partner 
for forward-thinking financial 
services businesses.

In 2021, Iress Management remained committed to 
two core priorities for guiding our ongoing response 
to COVID-19: uninterrupted service delivery to 
clients, and the health and wellbeing of our people.

Lockdowns continued to be a feature of how we 
lived and worked in 2021. Pleasingly, Iress has been 
able to operate remotely for extended periods of 
time as required without any negative impact on 
operations or productivity. The health and safety of 
our people has remained paramount. We continue 
to take a cautious approach to reopening offices 
in line with local conditions, while supporting our 
people to manage their mental and physical health 
and wellbeing.

The Board and Management are proud of how our 
people have continued to demonstrate resilience 
and adaptability in responding to the pandemic—
including being focused on supporting our clients, 
users and each other. 

From January 2021, we commenced the integration 
of OneVue and its people into the Iress business. 
This program has met all milestones, with a 
commercial launch of an integrated Iress and 
OneVue offering on track for delivery in 2022.

In May 2021, we welcomed our new Board Chair, 
Roger Sharp. The period following this appointment 
was eventful. 

Following consultation with major shareholders, 
in February we instigated an extensive internal 
review of Iress’ product and technology profile, 
geographical focus, and financial returns.

The resulting strategy update was announced to the 
market on 29 July, and included measures aimed at 
accelerating growth and returns for shareholders 
with a new medium target to more than double net 
profit after tax and earnings per share by 2025. 

A key component of this strategy is the delivery of 
a single product and technology platform, driving 
intellectual property and experience into multiple 
offerings, accelerating product development and 
delivery, and creating a seamless technology 
experience for clients and users.

The execution of our strategies to leverage our 
technology, add more value to our clients, and build 
scale across our geographic markets will deliver 
profitable growth and improved returns. 

Also in July, Iress received the first of a number of 
confidential, unsolicited, non-binding offers from 
EQT Fund Management S.à r.l. (EQT) to acquire all 
of Iress’ shares. Following careful consideration, 
the Iress Board decided it was important to engage 
with EQT to determine whether value could be 
maximised for shareholders through these offers. 
The Board has a clear idea of the value of the 
company, and held firm on its price expectations. 

In September, it was announced that discussions 
between Iress and EQT concluded with the parties 
unable to agree a transaction. 

Iress has continued with plans to accelerate growth 
and returns to shareholders. The transition to 
this platform has continued at pace. In 2021, we 
appointed a Global Head of Technology Platform 
to lead this work, and our cloud transition and 
optimisation is progressing well. 

In October, we announced the departure of two 
executives. Michael Blomfield, Chief Commercial 
Officer, left Iress immediately for health reasons and 
Coran Lill, Chief Communications and Marketing 
Officer, resigned and left Iress in December.

In December, it was announced that Simon 
New, previously Chief Client Solutions Officer, 
would become Iress’ Chief Commercial Officer. 
Additionally Kelly Fisk, previously Head of 
Communications & Marketing (APAC & South 
Africa), was announced as Chief Communications 
and Marketing Officer.

6

Iress LimitedStrategic priorities

Environmental, Social & Governance (ESG)

Iress has made significant progress on our 
ESG approach. 

In 2021 we were recognised by the Australian 
Council of Superannuation Investors (ACSI) in 
their assessment of ESG reporting by ASX200 
companies. Iress was one of only 34 ASX200 
companies to achieve a ‘Detailed’ rating—
recognising our commitment to continuous 
improvement. 

In 2021, we also appointed Amarjot Bagga as 
Head of Social Impact and Iress Foundation to 
engage the business and stakeholders on ESG 
and continue building our impact. This involved 
the development of a 2025 environmental and 
social impact strategy following a process of 
comprehensive stakeholder interviews, analysis 
of our own ESG processes and a review of external 
ESG best practice and methodologies, globally.

In 2022, we look forward to continuing our 
ESG journey through our commitment to set 
science-based targets for emissions reduction 
and have meaningful impact through Iress 
Foundation initiatives.

Capital management

The company is focused on 
improving earnings per share 
and achieving improved returns 
on capital deployed.

During 2021 we announced and launched an 
on-market share buyback for up to $100m. We 
completed 48% of the $100m on-market buyback 
in 2021, with the balance to be completed in 2022. 
Our potential sale of UK mortgages business is 
progressing, with indicative offers being received in 
the first quarter of calendar 2022.

Under the leadership of Iress’ Chief Product Officer, 
Joydip Das, Iress has established global product 
design, enabling us to focus on applying consistent 
and scaled best practice principles to our software 
and services. Building on our collaboration with 
the Australian financial services industry in 
2020, in 2021 we launched two market-leading 
industry services to support the industry to meet 
their compliance obligations in Australia. Iress’ 
Advice Fee Consent (AFC) solution and Design 
and Distribution Obligations (DDO) solution are 
industry-wide technology-based solutions that 
leverage blockchain technology to help clients meet 
their compliance obligations in an efficient, secure, 
and cost-effective manner. 

We have undergone an extensive program of 
work to uplift our ways of working across Iress, 
embracing a new sales and service methodology 
throughout our commercial teams. In 2021, the 
Iress-wide sales training rollout made significant 
inroads towards the uplift of our sales and services 
capabilities. Representatives from all parts of Iress 
were included in over 3,000 hours of training, and 
93% of our commercial team are now certified 
to improve our high-quality client service. This 
supports our objective of building and sustaining 
strategic relationships with our clients, driven by 
excellence in every interaction. 

Attracting and retaining the best people remains 
core to Iress’ success. Like many organisations, 
we have not been immune to the talent mobility 
challenges brought about by the pandemic. Our 
approach of leveraging a diverse range of channels 
for attracting talent continues, including through 
partners such as Talent Beyond Boundaries. The 
announcement of ‘The Long Weekend’ at Iress—a 
new way of working that entitles all employees 
up to six long weekends every year—was warmly 
welcomed and will reinforce Iress as an innovative 
and desirable place to work.

Overall, we see Iress as well-placed to grow. 
The Iress Board and Management continue to 
be proud of our peoples’ unwavering focus on 
building market-leading software and services 
and cultivating strong client relationships. Our 
plans to accelerate growth build upon the strong, 
successful, and leading technology business we 
are today.

7

Annual Report 2021Chair & CEO’s letter

Remuneration structure

The strategy update launched on 29 July 2021 
targets a more than doubling of earnings per share 
(EPS) and significantly improving returns on capital 
deployed over a five-year period to 2025.

Central to this plan is to build and launch a single 
product and technology platform and operating 
model, integrating Iress’ key product features. 

The current remuneration structure does not 
align with these goals, and this year we plan to 
implement a new equity plan that aligns directly to 
these goals and to shareholder outcomes of these 
goals. The key characteristics of the plan are that it 
will align awards with performance not only in share 
price but in EPS, return on invested capital and 
delivery of platform goals.

In the most competitive market for technology talent 
that the Iress Board has seen, this equity plan is a 
vital tool to retain, attract and motivate the team.

Board structure

The Iress Board has been going through a renewal 
process, with the retirement of Chair Tony D’Aloisio 
and two Non-Executive Directors John Hayes and 
Geoff Tomlinson in 2021. 

In 2022 John Cameron will retire from the board. A 
search is underway to replace John, whom we thank 
for his insights and commitment over many years. 

Financial results

Our reported segment profit for the year was 
$166.2m, up 9% from 2020, while NPAT grew 25% to 
$73.8m. Reported ROIC increased 130 basis points 
to 10.5% while reported EPS grew 20% to 38.8 cents 
per share in 2021.

Recurring revenue, which underpins our group, 
increased by 12%, making up around 90% of total 
revenue. We have strong revenue growth, up 11% 
versus 2020 in constant currency. This has largely 
been driven by the full period impact of the OneVue 
acquisition, growth in Australia, mortgages, and 
North America.

We continue to make good progress in executing 
our growth strategies, including providing 
Australian superannuation funds with a highly 
efficient, outsourced administration solution. 
GuildSuper went live in 2021, delivering superior 
member experience, lowering risk, and providing 
cost certainty to the fund. Our UK margins have 
increased by 1% versus 2020, and two mortgage 
clients went live in 2021. In North America, revenue 
in local currency increased by 14% in 2021, 
reflecting the go-live of a retail trading system 
to a Tier 1 bank in 2020, and additional project 
work to meet new regulatory requirements. Our 
OneVue integration is meeting milestones, with the 
commercial launch of pilot integration in the second 
half of 2021. Funds registry FUM is $869bn, up 11% 
(1 Jan 2021 to 31 Dec 2021).

The recovery from the impact of COVID-19 varies 
from location to location. Overall, projects are 
progressing well and our pipelines remain strong.

We have a positive outlook for 2022. Our growth 
strategies in the UK, superannuation, and investment 
infrastructure are well placed to capitalise on in 
2022 with major contracts already won.

Your dividend

The final dividend is 30 cents per share franked 
to 15%, bringing the full year 2021 dividend to 
46.0 cents per share, franked to 38% at a 30% 
corporate tax rate. Iress continues to maintain a 
conservative balance sheet at a leverage ratio1 of 
1.4x segment profit.

Annual General Meeting (AGM)

Subject to any government restrictions relating 
to the pandemic, it is the Board’s intention to 
have a hybrid AGM via video conferencing and in 
person. The meeting is scheduled for 11.30am on 
Thursday 5 May 2022 at King & Wood Mallesons 
in Melbourne.

1.  Net debt (borrowings plus net derivatives less cash and cash equivalents) divided by last twelve months Segment Profit.

8

Iress LimitedThank you

Thank you to our shareholders, our 
clients and users, and to Iress’ 2,224 
people. As we move through 2022, 
we are excited by the opportunities 
ahead of us to accelerate growth and 
transform the industry we serve.

Roger Sharp
Chair

Andrew Walsh
Managing Director & CEO

1.  Net debt (borrowings plus net derivatives less cash and cash equivalents) divided by last twelve months Segment Profit.

9

Annual Report 2021Our vision & strategy

Our vision

Target future state

Simpler, faster  
with higher returns

In July 2021, Iress outlined to the 
market our strategy goals aimed at 
accelerating growth and scale to 
double NPAT by 2025. 

Our plans to accelerate growth build 
upon Iress’ unique foundations in 
the financial technology market 
today, leveraging our capability 
and assets. We believe these will 
translate to benefits for clients and 
users, our people, and returns for 
our shareholders. These plans have 
been in development since late 
2020, when we began a strategic 
review with a view to accelerating 
returns and increasing pace. 

Simpler

Faster

Higher 
returns

Underpinning our vision of a simpler and faster Iress is 
a single product and technology platform—a natural 
evolution of the rich set of capabilities we already have 
in our leading software applications today. It will enable 
us to unlock scale and markedly greater returns. The 
transition to this platform has been underway since the 
initiation of our cloud program in 2018.

The IP & functionality in each 
product can be easily leveraged by 
Iress & accessed by clients across 
multiple offers.

Simple sign‑ups, 
implementation 
partnerships, 
continued streamlined 
implementation 
of large clients.

The capabilities are 
available as a single 
experience through 
commercialised, 
productised & unified 
APIs.

Single product
& technology
platform

All clients receive 
automatic & 
ongoing upgrades.

Built‑in capability for 
data‑rich insights, 
monitoring & security.

2025 NPAT target

Double 2020 NPAT to

~$120m

A single product and technology platform that drives:

•  Iress’ strong intellectual property into multiple offerings

•  faster product development and delivery

•  seamless technology experience including onboarding and upgrades

•  decoupling of cost growth from revenue growth

•  improved returns.

Growth priorities

We are building scale in large addressable 
markets with a focus on the United Kingdom, 
superannuation and investment infrastructure.

Our five areas to win

As shared in July, we see benefits being 
realised at a greater rate with the opportunity 
for acceleration in key areas.

Areas to win

Opportunity

Progress

Additional focus

Single product & 
technology platform

Operational leverage, 
speed & response.

Building & delivering cloud native 
business capabilities.

Movement of remainder of 
Iress applications to cloud.

Investment 
infrastructure

Disrupting status quo through 
industry‑wide infrastructure.

Pilot of Xplan‑OneVue 
integration underway.

Addressable revenue pool is  
$3bn+.(1)

First phase of single 
technology platform will be 
investment infrastructure.

United Kingdom

Revenue pool addressable by 
Iress’ wealth solutions in the UK is 
in excess of £400m (~$700m).

Strong private wealth 
implementations, growing 
sell‑side trading, continued 
momentum in Xplan sales.

Acceleration of sales using 
strong client case studies.

Superannuation

Transforming superannuation 
through automation. 
TAM of $1.4bn+.

Go live of automated 
superannuation solution. 
Superannuation gateway 
& clearing house launched 
and delivered.

Continued rollouts, cloud 
migration & sales.

Data  
solutions

International data vendor. 
Critical part of infrastructure 
and software, especially with 
digitalisation. Market data  
TAM of US$33bn.(2)

Strong international market 
data capabilities. Advice 
compliance solution.

Existing and new capabilities 
to cloud.

1.   All statements in relation to addressable revenue pool and addressable markets in this table are based on Iress management estimates and in A$, 

unless otherwise stated.

2.  Source: Burton-Taylor, April 2021.

11

Annual Report 2021Environmental, Social & Governance  
& Iress Foundation
Continuing our commitment to a sustainable 
future. Iress has made significant progress on our 
ESG approach. 2021 marked the beginning of an 
exciting new direction Iress is adopting when it 
comes to environmental and social impact.

The Iress Foundation, established in 2017, also now 
has a more structured framework that focuses 
on three causes aligned to Iress’ business areas 
and communities as well as the UN Sustainable 
Development Goals. Some of the Iress Foundation 
highlights include partnering with Talent Beyond 
Boundaries to support skilled refugees in finding 
pathways to great jobs and new lives, Two Good Co 
to support women escaping domestic violence, 
the Healing World creche in South Africa, and many 
more globally.

For more information on our ESG approach, 
please refer to our 2021 ESG Report.

Social
•  Introduced the ‘Long Weekend’—enabling all 

permanent employees and fixed‑term contractors 
to take a Friday or Monday off work for up to six 
days per calendar year.

•  Employed two software engineers from Syria 

and Iraq to support refugee employment through 
Talent Beyond Boundaries. 

•  3,000+ hours of sales and service training for  

our people.

•  Implemented new supplier management system 

that utilises real‑time monitoring of supplier 
and supply chain risks, using specialist market 
data vendors to identify human rights and 
environment risks.

•  Committed to ‘40:40 vision’ initiative aimed 

at improving gender diversity in executive roles 
by 2030.

95%

Switched to renewable 
energy in Sydney & 
Melbourne offices 
(representing 95% of 
Australian footprint)

40:40

Committed to improve 
gender diversity in 
executive roles by 2030

$231k+

Donated to 
charitable causes

Our overall ethos with respect to ESG is substance 
over form—meaning we want to go beyond simply 
doing the right thing by ensuring we use data and 
insights to determine the strategic benefits, risks 
and impact of everything we do. We are committed 
to observing internationally-recognised risks, such 
as climate change and modern slavery, and acting 
on these as part of our ESG roadmap.

2021 Highlights

Environment
•  Switched to renewable energy in Sydney 

and Melbourne offices (representing 95% of 
Australian footprint).

•  Implemented a new environmental management 
system to measure consumption and emissions.

•  Upgraded new offices in the UK with low voltage 

LED lighting to minimise power usage.

•  Transitioned 2000+ services to the cloud.

•  Signed science‑based targets commitment.

•  Established e‑waste partnerships, addressing 

digital inequalities in remote communities 
(Sustainable Development Goals): 

Foundation
•  615 volunteering hours.

•  $231,811 donated to charitable causes.

•  36 charities supported.

Governance
•  Inclusion of ESG matters in the Audit & Risk 

Committee charter to formalise Board oversight.

•  Continuous improvement in disclosures and 
reporting with ACSI assessing Iress’ 2020 
ESG report with a ‘Detailed’ rating.

12

Iress Limited 
   
Social

Prospering community
Supporting aligned causes

• Quality education
• Decent work
• Enabling charitable services

People wellbeing
Great place to work

• Diversity & inclusion
• Human rights

Healthy environment
Sustainable consumption

• Emissions management 
  & climate change
• E-waste

Environmental &
social impact at Iress

Responsible business
Strong foundations

• Corporate governance
• Risk management

G

o

v

e

r

n

a

n

c

e

ental

m
n
viro

n
E

Environmental & social impact roadmap 

Through stakeholder consultation, we developed 
a comprehensive 2025 environment and social 
impact strategy that takes a structured approach 
aimed at creating genuine outcomes. The Iress 
Foundation framework focuses on causes aligned 
with Iress’ business and communities.

We recognise our key impacts as:

•  energy consumption through operations and 

suppliers

•  e-waste management

•  diversity and inclusion 

•  human rights including modern slavery.

Social

•  Create an Australian Indigenous inclusion 

program to assess areas aligned with Iress’ 
business and communities, including a consistent 
practice of the Acknowledgement of Country at 
public events.

•  Develop a calendar of events (regional and global) 

to create a culture of inclusion and belonging.

•  Identify the scope for affinity groups (as part of 

the broader diversity strategy), led by members of 
the Iress Leadership team.

•  Identify opportunities for sustainable suppliers to 
be included in the procurement selection process.

To address these key impacts, our environmental 
and social impact strategy:

Foundation

•  aligns stakeholder expectations, commitment and 

builds trust

•  establishes structured, consistent implementation

•  quantifies and tracks impact.

Key initiatives include:

Environment

•  Measure emissions and set science-based 

targets for reduction.

•  Create an e-waste partnership in every region.

•  Start a conversation around how Iress can 

understand, model, and adopt sustainability 
principles in software engineering and design.

•  Establish three areas of focus for the Iress 

Foundation: quality IT education, decent work and 
the provision of services to charities.

•  Seek partnerships in countries of operation that 
support underrepresented communities with 
digital upskilling.

•  Find decent work opportunities for refugee 

employment.

Governance

•  Reporting on the Task Force on Climate-Related 

Financial Disclosures (TCFD) in 2022.

13

Annual Report 2021 
Environmental, Social & Governance & Iress Foundation

Environment 

With the known impacts of climate change, and 
greater visibility of environmental considerations 
across the supply chain, taking action on 
environmental issues is critical. 

In 2021, we made significant progress in our 
approach to understanding our impact on the 
environment, and will continue to reduce our impact 
by implementing an environmental management 
system to measure Scope 1, 2 & 3 emissions. 

As a technology company, energy consumption 
is one of our key impacts. It is consumed through 
operations and suppliers (data centres) and 
contributes to greenhouse gas emissions. Via 
an environmental management system and the 
inclusion of emissions reduction in our strategic 
priorities, we capture and measure emissions 
across the business and create awareness.

Once measured, the ambition is to set science-based 
targets for an emissions-reduction pathway.

Science-based targets
The Intergovernmental Panel on Climate 
Change warns that global warming must not 
exceed 1.5 degrees celsius (above pre-industrial 
temperatures) to avoid the most catastrophic 
impacts to the environment. Businesses have 
a vital role to play in driving down greenhouse 
gas (GHG) emissions and building a resilient, 
zero-emissions economy grounded in science. 

Science-based targets show companies the 
actual reductions in GHG required to meet their 
own targets, they prevent the worst impact of 
climate change, and provide a path towards 
decarbonisation. 

Committed to 
set near-term
company-wide 
emission reductions
in line with the 
Science Based 
Targets initiative.

14

Iress Limited

Environmental data
Environmental data is calculated using an 
environmental management system, Worldfavor. 
Worldfavor uses the GHG protocol as a standard 
with both location and market based factors. We do 
activity-based calculations across the three scopes.

CO2

HFCs, PFCs

CH4, N2O, 
NF3, SF6

SCOPE 1

Refrigerants from air 
conditioning gases & 
company cars

SCOPE 2

SCOPE 3

Electricity consumption 
in offices

Waste, water, travel 
& data centres

Scope 2 

Energy use & emissions 

Usage (kWh ‘000)

CO2 emissions (tonnes)

2019

2020

2021

2019

2020

2021

^
^
8
8
1
1
9
9

8
8
0
0
8
8

^
^
2
2
8
8
6
6

0
0
0
0
6
6

9
9
4
4
5
5

3
3
8
8
4
4

7
7
3
3
9
9

4
4
4
4
8
8

7
7
8
8
5
5

9
9
2
2
5
5

9
9
1
1
4
4

7
7
7
7
3
3

4
4
6
6
3
3
,
,
1
1

*
*
*
*
*
*
8
8
8
8
9
9

2
2
8
8
8
8

0
0
9
9
2
2

7
7
8
8
1
1

6
6
0
0
2
2

*
*
7
7
6
6
1
1

*
*
0
0
4
4
1
1

1
1
3
3
1
1

2
2
1
1

0
0
1
1

6
6
5
5

0
0
4
4

9
9

*
*
*
*

*
*
*
*

3
3

2
2

*
*
*
*

*
*
*
*

*
*
*
*

9
9
*8 0
*8 0
*
*

.
.

8
8
1
1

2
2
7 6 2 1
7 6 2 1

5
5

4
4
* 2
* 2
*
*

*
*
*
*

4
4
1
1

2
2
1
1

7
7

Australia****
Australia****

Canada
Canada

France
France

New Zealand
New Zealand

Singapore
Singapore

South Africa
South Africa

Tunisia
Tunisia

UK
UK

Note: Due to current limitations in reporting, the data may not reflect 100% capture across the 
business. Our ambition for 2022 is to increase measurement and reporting.

2019 and 2020 emissions have been recalculated in the new environmental management system to create a baseline. 

Sydney and Melbourne data only. Data was not collected for other Australian office locations. 

^ 
*  Correction in data from previous report.
**  Data was unavailable during reporting period. 
*** 
****  Australia also consumed 369,092.4 kWh certified renewable electricity in Sydney and Melbourne offices.

Includes natural gas consumption with an emission factor of 0.20297 (Department for Environment, Food and Rural Affairs 2021).

15

Annual Report 2021 
 
 
 
 
Environmental, Social & Governance & Iress Foundation 

The Iress Foundation was established in 
2017 to focus effort & support towards an 
already strong & engaged community.

Guiding principles established still remain 
relevant today: facilitate, support, and promote 
people engagement; make a visible, reliable, 
and meaningful contribution to partner charities.

Iress Foundation focus areas

Talent Beyond Boundaries
We walked, ran, cycled, swam and rode 
100,000kms around the world globally to 
raise $20,000 for Talent Beyond Boundaries’ 
Afghanistan program.

$20,000

Talent Beyond Boundaries’ 
Afghanistan program

Quality IT 
education

Decent 
work

Charitable services 
through skilled 
volunteering

Caring for 
communities 
& people

125 hours at Hamper 
Scamper, a local 
charity initiative, 
coordinating presents 
and food donations. 

125hrs

At Hamper Scamper

Our impact

Two Good Co

$231k

Donated to charitable 
causes (including 
employee giving)

615

Volunteering hours

990

Meals donated

75

Employment hours 
for vulnerable women

36

Charities supported

Story Factory

Helped over 60 young writers in two 
under‑resourced communities in Western 
Sydney to build their confidence and 
connection to their education by celebrating 
their creative and important voice.

60

Young writers helped

16

Iress LimitediSchool Africa

11

Online education 
sessions per week

10

Subjects covered through 
online sessions including 
coding & robotics

5

Sphero robots deployed 

Foodbank Victoria

82

Volunteer hours

50

Number of charities helped

70

Students provided with 
access to smart tablets 
& headphones

40%

60%

Grade improvement for 
beneficiary students 
in mathematics

Grade improvement for 
beneficiary students in 
physical sciences

24,505kg

Amount of food packed

49,010

Total meals

17

Annual Report 2021Iress Leadership team

Our greatest asset at Iress is our people. 
Supporting them is a leadership team 
committed to achieving Iress’ mission of making 
it easy for people to love financial services. 

Peter Ferguson
Chief Legal Officer & 
Company Secretary 

John Harris
Chief Financial 
Officer

Kelly Fisk
Chief Communications 
& Marketing Officer

Andrew Walsh
Chief Executive 
Officer

18

Iress LimitedSimon New
Chief Commercial 
Officer

Andrew Todd
Chief Technology 
Officer

Julia McNeill
Chief People 
Officer 

Joydip Das
Chief Product 
Officer

19

Annual Report 2021Board of Directors

Roger Sharp
Independent Non-Executive Director 
(since February 2021) & Chair 
(since May 2021)

Andrew Walsh
Managing Director & 
Chief Executive Officer
(since October 2009)

Roger has more than 30 years’ global 
experience in markets, technology, and 
governance. During his career he has 
built, chaired, and advised a number of 
technology companies. He currently chairs 
Webjet Limited (ASX: WEB) (since July 2017) 
and is a Non-Executive Director and 
former chair of Geo Limited (NZX: GEO) 
(since June 2016). He is also Chair of the 
Lotteries Commission of New Zealand. 

Roger is also the founder of boutique 
technology investment bank, North Ridge 
Partners. Past executive roles included 
Global Head of Technology and CEO of Asia 
Pacific Securities for ABN AMRO Bank. 

After a career as an actuarial consultant, 
Andrew co-founded and spearheaded the 
development of market-leading financial 
planning software Xplan and joined Iress 
when it acquired Xplan Technology in 
2003. Andrew became Iress’ CEO in 2009 
and has since led the growth of the group. 
Since Andrew became CEO, Iress has 
expanded organically and made several 
local and international acquisitions, with 
a focus on designing, developing and 
delivering software solutions for the 
financial services industry in Asia-Pacific, 
UK & Europe, Africa, and North America.

Julie Fahey
Independent Non-Executive Director
(since October 2017) & Chair of the 
People and Performance Committee 
(since February 2020)

Julie has over 35 years’ experience in 
technology through an executive career 
spanning IT consulting, IT software 
and services businesses, and as an IT 
executive, leading strategy development 
and operational delivery of IT services. 
Julie was also a management consulting 
partner in the IT advisory practice with 
KPMG for over 10 years, and was a member 
of KPMG’s National Executive Committee, 
as the Managing Partner Markets for four 
years before retiring in 2014.

Julie is a Non-Executive Director of 
Seek Limited (appointed July 2014) 
and Australian Foundation Investment 
Company Limited (appointed April 2021) 
and was a Non-Executive Director of Vocus 
Group Ltd (February 2018–July 2021). 
Julie also has a portfolio of Directorships 
of private companies in the technology 
and telecommunications industry, and 
the government sector. 

Company Secretary

Peter Ferguson
(since June 2011)

Peter has a bachelor of law from Sydney 
University (1987) and has many years’ 
experience in international legal and 
commercial appointments in the financial 
technology sector, with prior international 
and domestic appointments including 
seven years with Nasdaq OMX, located in 
Stockholm and later in Sydney. In addition 
to his role as Group General Counsel & 
Company Secretary, Peter is responsible 
for management of Iress’ compliance and 
risk functions. He also carries oversight of 
Iress’ environment, social, and governance 
(ESG) strategy. Peter has been a Board 
member of the Schizophrenia Fellowship 
of NSW (trading as One Door) since 2012.

John Cameron
Independent Non-Executive Director 
(since March 2010)

John is one of the pioneers of electronic 
trading. He was a key member of the team 
that first automated the trading floor of 
the Australian Securities Exchange—one 
of the first in the world. He has designed 
and developed information systems for 
major financial institutions in the United 
Kingdom, France, the United States and 
Australia. In 1997 John created what was 
to become the world’s leading FIX solution, 
CameronFIX. It was acquired by Orc 
Software in 2006 where John served as 
CTO until 2009. In 2007 John created the 
Cameron Foundation. John co-founded 
the global refugee initiative Talent Beyond 
Boundaries and now works pro bono for 
them and serves as Vice Chair of its board.

20

Iress LimitedTrudy Vonhoff
Independent Non-Executive Director 
(since February 2020) & Chair of the 
Audit & Risk Committee 
(since May 2021)

Trudy has over 25 years’ experience 
in retail banking, financial markets, 
and investment. She is currently a 
director of Credit Corp Group (appointed 
September 2019), Cuscal Limited and 
Australian Cane Farms Limited. Previous 
directorships include Ruralco Holdings 
Limited (September 2014–September 
2019), AMP Bank Limited and Tennis NSW. 
For 13 years Trudy held senior executive 
roles at Westpac and AMP across retail 
banking, finance, risk, technology and 
operations, and agribusiness.

Michael Dwyer AM
Independent Non-Executive Director 
(since February 2020) 

Michael has over 35 years’ experience in 
superannuation and investment, including 
14 years as CEO of First State Super (now 
Aware Super). After serving as a director 
from 1 June 2019, on 31 August 2020 
Michael was appointed as the Chair 
of TCorp (New South Wales Treasury 
Corporation). On 1 December 2020 
Michael was appointed as a director of 
Bennelong Funds Management Group and 
appointed as Chair on 1 July 2021.

He is a director of the Global Advisory 
Council of Tobacco Free Portfolios, 
appointed in 2016, and the Sydney 
Financial Forum from 1 January 2009. 
Since 1 July 2000 Michael has also 
been a director and subsequently from 
25 June 2018 appointed as Chair of 
Australia for UNHCR, the private sector 
partner of the UN Refugee Agency. He is 
a life member of ASFA (The Association of 
Superannuation Funds of Australia) and 
a Life Member of FEAL (Fund Executive 
Association Limited).

Niki Beattie
Independent Non-Executive Director 
(since February 2015)

Niki has more than 30 years’ experience 
in financial technology and capital 
markets. She currently runs Market 
Structure Partners, a strategic consulting 
firm and previously spent more than 
a decade in senior positions at Merrill 
Lynch International. She is currently 
Non-Executive Chair of privately owned 
XTX Markets (since October 2017), a 
quantitative-driven, electronic global 
market-maker. She is also a Non-Executive 
Director of Kepler Cheuvreux UK Ltd (since 
July 2011), a French brokerage firm and 
of FMSB, Fixed Income, Currencies and 
Commodities Standards Board (since 
June 2020), a standard setting body for 
wholesale markets. She was previously 
Non-Executive Chair of UK listed entity 
Aquis Exchange Plc (January 2013–
December 2021), which operates a 
pan-European stock exchange and 
technology business, and also on the 
board of MOEX (June 2012–April 2016), the 
Moscow Exchange and of Borsa Istanbul 
(April 2016–October 2019), the Turkish 
Exchange. She also spent 12 years on the 
Secondary Markets Advisory Committee 
(2008–2020) to the European Securities 
Markets Authority and six years on 
the Regulatory Decisions Committee 
of the UK Financial Conduct Authority 
(March 2012–December 2018).

21

Annual Report 2021Material business risks

The material business risks that have the 
potential to impact Iress’ financial prospects 
& future performance are outlined together 
with mitigating actions undertaken to 
minimise these risks.

22

Iress Limited

Risk

Nature of risk

Mitigating actions

Information 
security, including 
cyberattacks or 
failure of critical 
systems

Iress may be impacted significantly 
by the failure of critical systems, 
whether caused by error or 
malicious attack. Our information 
security risks are heightened by 
the growing sophistication of cyber 
terrorists, the increased reliance on 
our technology and services by our 
customers, and our employees and 
clients working remotely during the 
COVID‑19 pandemic.

Iress continues to invest in a wide range of information security 
protection and preventative measures in response to the increasing 
threats presented by cyberattacks and cyber terrorists. 

Our information security risks are closely monitored through 
our dedicated global information security function. At the same 
time, material information security risks and issues are escalated 
to the Board Audit & Risk Committee for oversight and action, 
while Executive‑level oversight is provided via the Executive Risk 
Committee and Chief Information Security Officer. 

Iress’ Global Information Security Management System 
(ISMS) is certified by independent audit to meet the global 
ISO 27001 standard.

Economic climate

Economic conditions, domestically 
and internationally, may 
negatively impact client expenditure 
on, and demand for, Iress’ systems 
and services.

Iress’ diverse geographic presence, and diverse product and 
financial services portfolio both serve to mitigate the impacts of 
adverse economic conditions on our business.

The ongoing impact of COVID‑19 is mitigated by the recurring 
revenue base and cash generative nature of the Group.

Foreign exchange

Due to its international operations, 
Iress may be exposed to foreign 
exchange movements, which may 
affect the value of profits repatriated 
to Australia.

Legal or regulatory 
change

Technology 
change or failure

Iress’ business could be adversely 
affected by changes to the law, 
regulation, policy, or regulatory 
expectations. Over time, these types 
of changes may result in market 
consolidation or fragmentation, both 
of which may negatively impact 
Iress’ business, prospects, and 
financial performance. 

Responding to regulatory change 
may also result in Iress incurring 
substantial cost, as significant 
management attention and 
resources may be required to modify 
existing, or implement new, processes 
to comply with such changes.

A pronounced shift in technology, 
or in the way market segments 
organise themselves and make use 
of Iress’ technology, may adversely 
impact our business.

At the same time, a critical 
technology system or process 
failure, or the release of personal 
data, whether by error or mischief, 
may have adverse impacts for Iress.

Iress mitigates foreign exchange risk associated with its 
international operations by funding these investments in the 
local currency. Foreign currency transaction risks are hedged, 
where appropriate. Iress does not hedge translation risk on 
foreign currency earnings. However, Iress reports the financial 
performance of its offshore operations in both local currency and 
in AUD, to enable investors to better understand the performance 
of the underlying business.

As a licensed financial services business, Iress has increased 
its investment in compliance, and the management and 
implementation of regulatory change through the establishment 
of a dedicated compliance team and the recruitment of senior 
compliance professionals. 

We continue to closely monitor regulatory developments globally 
and remain proactively engaged with relevant regulatory bodies 
and policy makers across the jurisdictions in which we operate.

Iress seeks to maintain a highly‑skilled team of technology 
professionals, who constantly consider and test the potential 
utilisation or impact of emerging technologies. In the same way, 
Iress endeavours to manage market change by maintaining a 
high degree of engagement with its customers. In that regard, 
Iress is fortunate that its customer base, being distributed 
geographically and being comprised of highly sophisticated 
industry representatives, is likely to be at the forefront of industry 
change and evolution.

Mitigation of technology risk lies at the heart of Iress’ information 
security function and software development practices. The latter 
includes rigour in architecture, code development and testing. 

23

Annual Report 2021Operating & Financial Review

Operating revenue

Segment profit

Segment profit after share-based payments
EBITDA

Reported NPAT

Reported
Constant currency basis (1)
Reported
Constant currency basis (1)

2020
$m

542.6
542.6
152.9
152.9
131.9
125.5

59.2

2021
$m

595.9
600.2
166.2
166.4
148.8
148.9

73.8

2021 vs 
2020

10%
11%
9%
9%
13%
19%

25%

(1)  Constant currency basis assumes the 2021 financial results are converted at the same average foreign exchange rates used to convert the 2020 

financial results.

2020
Cents per
 share

2021
Cents per
 share

2021 vs 
2020

32.4

46.0

38.8

46.0

20%

0%

Operating revenue

Direct contribution

2020
$m

289.8
154.6
26.9
42.9
28.4

542.6

2021
$m

335.3
156.2
29.5
43.4
31.5

595.9

2021 vs 
2020

16%
1%
9%
1%
11%

10%

2020
$m

204.0
94.4
18.1
33.9
11.0

361.4

(128.4)
(42.6)
(37.4)

152.9

2021
$m

239.1
98.0
21.1
33.8
14.5

406.5

(135.1)
(60.0)
(45.2)

166.2

2021 vs 
2020

17%
4%
17%
0%
32%

12%

5%
41%
21%

9%

Earnings and dividends per share
Basic earnings per share

Dividends per share

APAC
UK & Europe
Mortgages
South Africa
North America

Total group

Product & Technology
Operations
Corporate

Segment profit

Operating revenue

On a reported basis, operating revenue from ordinary activities grew 10% from $542.6m in 2020 to $595.9m in 2021, and 11% in 
constant currency primarily driven by the full year impact from acquiring OneVue and O&M in 2020. Excluding OneVue and O&M, 
operating revenue for the group grew 2% primarily driven by growth in APAC Trading & Market Data, Mortgages and Canada.

Segment Profit (1)

On a reported basis, Segment Profit increased 9% from $152.9m in 2020 to $166.2m in 2021. In constant currency, Segment Profit 
grew 9% partly due to the full year benefit of acquiring OneVue and O&M in 2020. Excluding the full year benefit of acquisitions, 
Segment Profit in constant currency grew 8% reflecting revenue growth and strong cost discipline across the group.

(1)  Iress uses Segment Profit as a measure of underlying earnings to aid inter-period comparability of results. Refer to reconciliation of Segment Profit to Net 

Profit after Tax (NPAT) on page 66.

24

Operating & Financial ReviewFor the year ended 31 December 2021Iress LimitedMortgages
On a reported basis, revenue increased 9% from $26.9m in 2020 
to $29.5m in 2021. In local currency, revenue was up 10% over 
the same period.

This revenue increase was largely driven by the full period impact 
of two clients that went live in 2020 and two additional clients 
that went live in 2021. As a result, the business continued to grow 
recurring subscription licence revenue which contributed 59% 
of total revenue in 2021, up from 46% in 2020.

On a reported basis, direct contribution increased 17% from 2020 
to 2021. In local currency, direct contribution increased 17% 
from 2020 to 2021 which reflects revenue growth and ongoing 
cost discipline.

During 2021, as a result of a strategic review, Iress informed the 
market that it was considering a sale of the Mortgages business. 
The sale process commenced during 2H21. Potential acquirers 
have been given access to a data room to complete due diligence. 
The pipeline of emerging client opportunities for the business 
is very strong and therefore the divestment process is being 
managed to ensure that pipeline opportunities are appropriately 
reflected in value.

South Africa
On a reported basis, revenue increased 1% from $42.9m in 2020 
to $43.4m in 2021, while in local currency, revenue marginally 
declined from 2020.

Revenue was impacted by weak economic conditions in South 
Africa during 2021 which has been exacerbated further by the 
impact of COVID-19 in that country. This was offset by successful 
deployment of a broad solution to a Tier 1 financial services firm 
and two large client contract renewals.

On a reported basis, direct contribution remained flat from 
2020 to 2021 reflecting flat revenue growth and ongoing 
cost discipline.

North America 
On a reported basis, revenue increased 11% from $28.4m in 
2020 to $31.5m in 2021. In local currency, revenue increased 
14% reflecting strong growth in Canada mainly attributable to 
additional project work driven by regulatory change and higher 
recurring revenue from the launch of a retail trading system for 
a Tier 1 bank.

On a reported basis, direct contribution increased 32% from 2020 
to 2021. In local currency, direct contribution increased 35% 
which reflects revenue growth and ongoing cost discipline.

APAC
On a reported basis, APAC revenue grew 16% from $289.8m in 
2020 to $335.3m in 2021 with the result benefitting from the 
full year impact of the OneVue acquisition. Excluding OneVue, 
APAC revenue grew 2%.

Trading & Market Data revenue grew 7% in Australia reflecting 
successful project deliveries and new customer wins, and 10% in 
Asia reflecting the full year revenue impact of successful client 
implementations in 2020.

Financial Advice revenue for 2021 was largely in line with 
2020. The ongoing reshaping of the financial advice industry 
in Australia has seen a shift in users from large institutions to 
independent firms. Xplan user numbers have remained relatively 
stable during this transition.

Superannuation revenue increased 17% from 2020 to 2021 with 
the full year impact of the OneVue acquisition in November 2020. 
Excluding OneVue Superannuation, revenue decreased 12% 
primarily due to timing of delivery of projects in 2021 against a 
backdrop of elevated non recurring project revenues in 2020. 
However, recurring Superannuation revenue grew by 7% as a 
result of clients going live.

Investment Infrastructure revenue increased as a result of the full 
year impact of the acquisition in November 2020. On a full year 
equivalent basis, Investment Infrastructure revenue increased 
4% from 2020 to 2021. 2021 revenue benefitted from new client 
wins in Managed Fund Administration. The pilot program of Xplan 
integration with OneVue was successfully launched in 2021 with 
live managed funds and equity trades successfully executed. 

On a reported basis, direct contribution increased 17% from 
2020 to 2021. In constant currency, excluding the acquisitions 
of OneVue and adjusting for internal staff transfers, direct 
contribution was in line with 2020.

UK & Europe
On a reported basis, UK & Europe revenue grew 1% from $154.6m 
in 2020 to $156.2m in 2021.

In local currency, revenue increased 3% from 2020 to 2021 
which reflects the full year contribution from subscription licence 
revenue following the successful go-live of key clients in 2020, 
integration of the 2020 acquisition of O&M, as well as new and 
ongoing client projects. Project work at large existing Private 
Wealth clients continued, as did the migration of Adviser Office 
users to Xplan.

During 2021, the UK business achieved a number of important 
milestones including:

•  Successful go-live of Commpay at an enterprise Retail 

Wealth client. 

•  First market making clients progressing with a strong pipeline 

of prospects.

•  Work commenced on a Retail Wealth solution following a new 

Tier 1 Bank client win.

On a reported basis, direct contribution increased 4% from 2020 
to 2021. In local currency, direct contribution was up 5% which 
reflects revenue growth and ongoing cost discipline. 

25

Annual Report 2021Product & Technology
Investment in product and technology is at the heart of Iress’ success and market position, supporting client retention and future 
recurring revenue growth. Product and Technology cost is primarily made up of people costs and reflects Iress’ ongoing investment in 
existing and new technology.

On a reported basis, costs increased 5% from $128.4m in 2020 to $135.1m in 2021. In constant currency, excluding the acquisitions 
of OneVue and O&M and adjusting for internal staff transfers, Product and Technology costs decreased by 2% reflecting strong 
cost discipline.

Operations
Operational costs include core business infrastructure and people, such as internal and external communications technology, 
information security, operating hardware and software and client help desks.

On a reported basis, Operations costs increased 41% from $42.6m in 2020 to $60m in 2021. In constant currency, excluding the 
acquisitions of OneVue and O&M and adjusting for internal staff transfers, Operations costs increased by 1% reflecting new information 
security initiatives, offset by savings in general administrative expenses.

Corporate
Corporate costs include Iress’ central business functions including human resources, finance, communications & marketing, legal and 
other general corporate costs.

On a reported basis, costs increased 21% from $37.4m in 2020 to $45.2m in 2021. In constant currency, excluding the acquisitions of 
OneVue and O&M and adjusting for staff transfers, Corporate costs increased by 7% as a result of the hurdles for the global profit share 
scheme being achieved as well as increases in insurance costs and compliance related staff costs. This was partly offset by reduced 
spend in discretionary costs such as travel due to COVID-19.

Net Profit after Tax (NPAT)

Segment profit
Share-based payment expense

Segment profit after share-based payments
Other non-operating expenses

Profit before depreciation and amortisation, interest and income tax expense
Depreciation and amortisation expense

Profit before interest and income tax expense
Net interest and financing costs
Income tax expense

Net profit after income tax expense

2020
$m

152.9
(21.0)

131.9
(6.4)

125.5
(39.1)

86.3
(8.0)
(19.1)

59.2

2021
$m

166.2
(17.4)

148.8
0.1

148.9
(47.0)

101.9
(9.0)
(19.1)

73.8

2021 vs 
2020

9%
17%

13%
large

19%
(20%)

18%
(13%)
0%

25%

26

Operating & Financial ReviewFor the year ended 31 December 2021Iress LimitedNet profit after tax (NPAT)

Dividends

Iress’ reported NPAT increased 25% from $59.2m in 2020 to 
$73.8m in 2021. The increase in NPAT largely reflects the net 
provision release associated with the finalisation of QuantHouse 
and BC Gateways earnout arrangements which have been 
reported as part of other non-operating expenses below.

Iress’ dividend policy is to maintain a payout ratio of not less than 
80% of underlying earnings (2) on an annualised basis, subject 
to accounting limitations. Dividends continue to be franked to 
the greatest extent possible, while reflecting the geographical 
context of the business and timing of tax payments.

Share-based payments decreased 17% from $21.0m in 2020 to 
$17.4m in 2021 as a result of a large number of forfeitures in 2021 
due to employees leaving the business.

Other non-operating expenses are one-off costs primarily in 
relation to:

•  early finalisation of Quanthouse earnout resulting in recognition 

of a gain of $14.2m from the provision release

•  early finalisation of the BC Gateways earnout resulting in a gain 
of $8.1m from the provision release offset by integration costs 
($6.1m) in relation to the acquisition of OneVue

In respect of 2021 earnings, the Directors determined to pay 
a final dividend of 30.0 cents per share franked to 15% at a 
30% corporate tax rate bringing the full year 2021 dividend to 
46.0 cents per share, franked to 38% at a 30% corporate tax rate.

Statement of Financial Position

Net debt (measured as borrowings excluding capitalised 
borrowing costs, net of derivatives, and less cash and cash 
equivalents) increased by $108.6m mainly due to the following 
capital management and investing activities:

•  defence advisory costs ($4.0m) incurred in relation to the offer 

•  Commencement of an on market share buy-back in 

received from EQT Fund Management

•  lease right-of-use asset impairment ($3.9m) and other expenses 

($2.1m) recognised in relation to decisions taken during the 
year to vacate leased office space no longer required in the UK 
and Australia

•  team restructuring expenses ($3.1m)

•  other non-recurring expenses primarily incurred in relation 

to projects to integrate acquired businesses, upgrade 
infrastructure and retire legacy products and services.

Depreciation and Amortisation (D&A) increased 20% from $39.1m 
in 2020 to $47m in 2021. Lease right-of-use assets, leasehold 
improvement, office equipment and furniture and fitting D&A 
expense increased as a result of new UK and Sydney leases and 
associated office equipment and furniture as well as the full year 
impact of OneVue depreciation (twelve months in 2021 versus 
two months in 2020).

Net interest and financing costs increased 13% from $8m in 
2020 to $9m in 2021 which reflects higher average net debt 
balances in 2021. Net debt balances in 2H 20 were abnormally 
low following the equity raise in June 2020. Since the completion 
of the OneVue acquisition in November 2020, the payment of the 
final FY20 dividend in March 2021 and the commencement of the 
on market share buyback in September 2021, drawn debt levels 
have increased and as a result interest expense has risen.

The Group’s effective tax rate of 21% in 2021 is a function of the 
tax rates in the jurisdictions in which the business operates and 
the impact of the gains recognised on the release of earnout 
provisions ($22.3m in total) which are not subject to income 
tax. If the impact from the earnout provision release is removed, 
the effective tax rate would have been 27%.

September 2021 with $47.8m of shares purchased by the end  
of the year.

•  On market purchase of shares ($20.4m) to deliver shares for 

employee share schemes.

•  Payment of deferred contingent consideration of $10.4m in 

relation to the acquisition of QuantHouse.

As a result, the leverage ratio (defined in these financial 
statements as the ratio of net debt over the last twelve months 
Segment Profit) increased to 1.41x (2020: 0.82x) at the end of the 
year. Iress continues to maintain a conservative level of gearing 
and to actively manage cash holdings to reduce interest costs.

Provisions (current and non-current) reduced by a net $31.1m 
primarily due to the finalisation of the earnout arrangements in 
relation to the QuantHouse and BC Gateways acquisitions. Total 
provisions on the balance sheet at 31 December 2020 in relation 
to these potential liabilities were $37.8m with $4.4m remaining 
on the balance sheet at 31 December 2021 representing the final 
BC Gateways settlement which was made in January 2022. Of 
the net deferred contingent consideration provision movement of 
$33.4m, $10.4m was paid to the previous owners of QuantHouse 
during the year, $22.3m was released to profit and loss during the 
year as a result of the finalisation of the earn out amounts and 
the remainder related to currency movements.

Lease liabilities (both current and non-current) increased in total 
by $8.3m primarily due to the commencement of new office 
leases in the UK and Australia.

Intangible assets increased by $12.4m primarily due to the 
impact of currency revaluation ($18m) on goodwill denominated in 
currencies other than AUD with GBP being the primary contributor.

Issued capital decreased by $64.5m primarily due to the 
buyback of $47.8m of shares through the on market buyback 
which commenced in September 2021 and $20.4m of shares 
purchased on market to deliver to employees in relation to 
employee share schemes. Refer to Note 3.2 to the Financial 
Statements for more details. 

(2)  Segment Profit less operating depreciation and tax at 30%.

27

Annual Report 2021The Directors of Iress Limited and its subsidiaries (“the Group”) submit the annual financial report for the year ended 31 December 2021.

Directors’ Meetings

The following table sets out the number of meetings of the Group’s Board of Directors and of each Board Committee held during 
the year ended 31 December 2021, and the number of meetings attended by each Director as a member of the Board or relevant 
Board Committee. 

Directors who are not members of a particular Board Committee are entitled to attend meetings in a non-voting capacity and are given 
access to all Board Committee papers and minutes. 

Director

Eligible

Attended

Eligible

Attended

Eligible

Attended

Eligible

Attended

Board Meetings

Audit & Risk

People & Performance

Special Committee

A D’Aloisio (2)
R Sharp (1)
A Walsh
N Beattie
J Cameron
M Dwyer
J Fahey
J Hayes (2)
G Tomlinson (2)

T Vonhoff

6
19
20
20
20
20
20
6
6

20

6
18
20
20
20
20
20
5
5

20

*
*
*
*
*
6
6
3
3

6

*
*
*
*
*
6
6
3
3

6

*
*
*
9
9
9
9
*
*

9

*
*
*
9
9
9
9
*
*

9

*
9
9
*
*
9
9
*
*

9

*
9
9
*
*
9
9
*
*

9

*   Not a member of this committee.

(1)  Appointed as Independent Non-Executive Director on 18 February 2021 and Chair on 6 May 2021.

(2)  Retired on 6 May 2021.

Events subsequent to the Statement of Financial Position date

On 16 February 2022 the Directors declared a final dividend of 30.0 cents per share franked to 15% totalling $58.0 million.

Other than the declaration of the final dividend and the items noted above, there has been no other matter nor circumstance which 
has arisen since the end of the financial year which has significantly affected, or may significantly affect, the operations of the Group, 
the results of those operations, or the state of affairs of the Group in subsequent years.

Changes in operations during the year

During the year, the operations of the Group were not modified in any material way.

Changes in state of affairs

On 29 July 2021, Iress announced the launch of an on-market buyback of up to $100m of ordinary fully-paid shares which will be 
funded from Iress’ existing cash and committed debt facilities. As at 31 December 2021, Iress had repurchased 4,048,2966 shares at 
an average price of $11.8016 for a total amount of $47.8m. Refer to Note 3.2 of the Financial Statements for further details.

On 10 August 2021 Iress received a confidential, non-binding and indicative proposal from funds represented by EQT Fund 
Management S.à r.l. (EQT) to acquire all of Iress’ shares via a scheme of arrangement. On 17 September 2021 the discussion between 
Iress and EQT concluded and the parties confirmed that they had not been unable to agree a transaction and the incorporating 
exclusivity terms between Iress and EQT were terminated.

On 19 November 2021, Iress executed an extension of the expiry date of its unsecured bank facilities from April 2024 to October 2025. 
The amount of the unsecured bank facilities was reduced from $405m to $400m. The covenant requirements remained unchanged.

Other than the above, there was no significant change in the state of affairs of the Group during the financial year.

28

Directors’ ReportFor the year ended 31 December 2021Iress LimitedIndemnification of Officers & Auditors

During the year, the Company paid a premium in respect of a contract insuring each of the Directors of the Company (as named 
above), the Company Secretary and each of the Executive Officers of the Company and any related body corporate against a liability 
or expense incurred in their capacity as a Director, Secretary or Executive Officer to the extent permitted by the Corporations Act 2001. 
Further details have not been disclosed due to confidentiality provisions in the insurance contract.

In addition, the Company has entered into a Deed of Indemnity which ensures that a Director or an officer of the Company will generally 
incur no monetary loss as a result of defending actions taken against them as a Director or an officer. Certain actions are specifically 
excluded, for example, penalties and fines which may be imposed in respect of breaches of the law.

The Company has not otherwise, during or since the end of the financial year, except to the extent permitted by the law, indemnified or 
agreed to indemnify an officer or auditor of the Company or of any related body corporate against a liability incurred in their capacity 
as an officer or auditor.

Non‑audit services

Details of the amounts paid or payable to the auditor for audit services provided during the year are outlined in Note 1.6(b) to the 
financial statements. During the year, the Company’s auditor performed certain other services in addition to its audit responsibilities. 
The Board is satisfied that the provision of non-audit services during the year by the auditor is compatible with, and did not compromise 
the auditor independence requirements of the Corporations Act 2001 for the following reasons:

•  All non-audit services were subject to the corporate governance procedures adopted by the Company to ensure that they do not 

impact the integrity and objectivity of the auditor.

•  The non-audit services provided did not undermine the general principles relating to auditor independence as set out in APES 

110 Code of Ethics for Professional Accountants as they did not involve reviewing or auditing the auditor’s own work, acting in a 
management or decision making capacity of the Company, acting as an advocate of the Company or jointly sharing risks or rewards.

Auditor’s independence declaration

A copy of the auditor’s independence declaration as required under section 307C of the Corporations Act 2001 (Cth), is set out on 
page 59.

Rounding of amounts

The amounts shown in this report and in the financial statements have been rounded off, except where otherwise stated, to the 
nearest thousand dollars, the Company being in a class specified in the ASIC Corporations (Rounding in Financial/Directors’ Reports) 
Instrument 2016/191, issued by the Australian Securities and Investments Commission.

Corporate governance

The corporate governance statement is located on the Iress website.

https://www.iress.com/trust/corporate-governance/corporate-governance-statement/

29

Annual Report 2021Letter from Julie Fahey, Chair of the People and Performance Committee

Dear shareholders,

On behalf of the People & Performance Committee (PPC), I am pleased to present Iress’ Remuneration Report for the financial 
year ended 31 December 2021. This letter summarises the remuneration outcomes for 2021 and key changes to the executive 
remuneration framework for 2022 to align to our 2025 strategy outcomes.

Iress’ performance and remuneration outcomes in 2021
The 2021 year was again a challenging one, as the health, social and economic consequences of COVID-19 presented ongoing 
uncertainty for our clients, our people and society at large.

Throughout this extraordinary period, we continued to effectively support our clients whilst also prioritising the safety, wellbeing 
and retention of our people. Consistent with 2020, Iress did not participate in any COVID-19-related government payment programs.

On a reported basis, Iress’ operating revenue grew 10% to $595.9m and Net Profit After Tax (NPAT) increased 25% to $73.8m. We have 
continued to meet product and platform delivery milestones and the pipeline of new business into 2022 is building.

There were no remuneration increases provided to executives or to Non-executive Directors in 2021.

Under Iress’ 2021 executive remuneration framework share price performance directly impacts the amount and value of equity vested. 
A significant proportion of remuneration is delivered in Equity Rights and Performance Rights, thereby aligning executive interests 
with shareholders.

There was partial vesting of the three Performance Rights awards based on Relative Total Shareholder Return (RTSR) performance at 
the time of the 30 June 2021 re-test:

•  52nd percentile RTSR resulting in 54.0% vesting of CEO’s 2017 four-year award (1 Jan 2017 – 30 Jun 2021)

•  60th percentile RTSR resulting in 69.8% vesting of CEO’s 2017 three-year award (1 Jan 2018 – 30 Jun 2021)

•  60th percentile RTSR resulting in 69.8% vesting of executive 2018 three-year award (1 Jan 2018 – 30 Jun 2021).

Changes to the executive remuneration framework in 2022
In July 2021, reflecting work commencing in February 2021, we announced plans to accelerate growth and returns for shareholders 
with a new 2025 target to more than double NPAT, EPS, and Return on Invested Capital (ROIC) compared to 2020 outcomes. We also 
committed to re-assess the alignment of our current executive remuneration framework to our revised strategy and therefore have 
worked through a review of the framework, metrics, targets, and quantum, resulting in changes to our approach for 2022.

The Board is confident that the framework elements (Base Salary, Equity Rights and Performance Rights) remain appropriate for our 
business. As originally intended when implemented in 2019, the Equity Rights and Performance Rights continue to provide significant 
share price exposure and long-term performance focus. In addition, the framework supports the attraction and retention of talent 
within the highly competitive global technology sector where we compete with both start-ups and established businesses for talent. 
We consider the framework critical to support our team to deliver on our 2025 strategy and to directly align executive remuneration to 
the 2025 strategic objectives of doubling EPS, ROIC, and the delivery of the technology platform.

Following consultation with shareholders, the Company will implement changes to the executive remuneration framework in 2022 to 
better align executives with its revised target outcomes. The following changes will therefore be in effect for 2022:

•  Performance Rights will vest against three equal hurdles of EPS growth, growth in ROIC, and delivery of our strategic product and 
technology platform: As flagged with our shareholders in July, the Board has specifically aligned performance hurdles and metrics 
to the 2025 strategy. The performance hurdles are directly aligned with the intent to double EPS and ROIC from 2020 by 2025. 
The platform measure is the fundamental measure underpinning the July strategy acceleration.

•  Performance Rights vesting will be subject to an ATSR gate: The new 10% Absolute Total Shareholder Return (ATSR) vesting gate has 
been set at the maximum vesting level under the 2021 Performance Rights plan. The approach means Executives will be rewarded 
with Performance Rights vesting where significant additional value is delivered for shareholders over the period to 2025.

•  The quantum of the Performance Rights opportunity will increase: The 2022 Performance Rights hurdles represent an uplift on 
current and historic expectations. Executives will have the opportunity to earn up to 1.8 times the quantum available under the 
2021 Total Remuneration framework across the period 2022–2025, provided each of the ATSR gateway, EPS, ROIC, and strategic 
product and technology platform hurdles are met in full. The challenging performance hurdles mean executives will earn less over the 
2022–2025 period, versus the 2021 approach, if ATSR is not at least 10% p.a., and there is not at least threshold vesting on the new 
EPS, ROIC and platform measures.

30

Remuneration ReportFor the year ended 31 December 2021Iress Limited•  The 2022 Performance Rights grants will be delivered over a longer time period than the current plan, directly aligned to the 2025 

strategic plan timeframe:

•  2022 Performance Rights will vest in three years with a new one-year holding lock.

•  The 2023 Performance Rights allocation will be brought forward and granted in 2022 to again align with the 2025 strategic 

objectives. This portion will vest in four years, also with a one-year holding lock.

•  As a result, there will be no allocation of Performance Rights in 2023.

•  Performance Rights allocation will extend beyond executives: To support the delivery of our strategy and to attract and retain key 

talent, Performance Rights will be extended beyond executives on a discretionary basis subject to the same performance hurdles as 
executives, vesting in four years.

•  Fixed Remuneration comprises Base Salary and Equity Rights: To provide clarity in response to internal and external stakeholders, 

these elements will be considered Fixed Remuneration. There is no change to the quantum of Base Salary or Equity Rights for 
executives for 2022 or the terms of the Equity Rights.

Achievement of maximum performance under the 2022 plan would result in Executive KMP receiving approximately 2% of the total 
shareholder value created. Over the four year life of the scheme, the additional accounting cost of this grant of Performance Rights to 
Executive KMP is on average approximately $1.1m per annum.

We recognise that we have significantly increased the total remuneration opportunity for executives. The increase is all delivered 
through Performance Rights which are wholly contingent on strategy outcomes.

In essence, we are asking our executives to deliver significant value for shareholders, including achieving an ATSR gate for 
Performance Rights equal to the top end of the 2021 plan, before we consider the achievement of the three separate performance 
measures, which have been set in line with the strategy.

The Board is confident that the changes to the executive remuneration framework in 2022 will focus our team on delivering 
substantially higher returns to shareholders over the next four years.

Further detail on changes is included in Section 3.

I invite you to provide feedback on our remuneration framework and look forward to your continued support at our AGM.

Julie Fahey 
Chair of the People & Performance Committee

31

Annual Report 2021Contents

KMP

SECTION 1  EXECUTIVE REMUNERATION FRAMEWORK IN 2021

SECTION 2  PERFORMANCE AND REMUNERATION OUTCOMES IN 2021

SECTION 3  CHANGES TO EXECUTIVE REMUNERATION IN 2022

SECTION 4  REMUNERATION GOVERNANCE

SECTION 5  NON-EXECUTIVE DIRECTOR FEES

SECTION 6  ADDITIONAL REQUIRED DISCLOSURES

32

33

38

45

48

50

52

This remuneration report provides details of Iress’ remuneration policy and practice for Key Management Personnel (KMP) for the 2021 
financial year (FY21). The KMP are identified in the below table and comprise the Non-executive Directors (NEDs), Executive Director, 
and Executives. For the purposes of this report: ‘Executive KMP’ refers to the Executive Director and Executives; ‘executives’ refers to 
those noted below and the broader executive leadership team at Iress who are not considered to be KMP.

The information presented in this report has been audited as required under section 308(3C) of the Corporations Act 2001 and forms 
part of the Director’s report.

KMP

For the year ended 31 December 2021, the KMP were:

KMP

Position

Term as KMP

Non-executive Directors (NED)

A D’Aloisio (a)

R Sharp (b)

N Beattie

J Cameron

M Dwyer

J Fahey

J Hayes (a)

G Tomlinson (a)

T Vonhoff
Executive Director 
A Walsh
Executive
M Blomfield (c)

J Das

P Ferguson

K Fisk (d)

J Harris

C Lill (c)

J McNeill

S New (e)

A Todd

Non-executive Chairman

Non-executive Chairman

Non-executive Director

Non-executive Director

Non-executive Director

Non-executive Director

Non-executive Director

Non-executive Director

Non-executive Director

Partial year

Partial year

Full year

Full year

Full year

Full year

Partial year

Partial year

Full year

Managing Director and Chief Executive Officer (CEO) 

Full year

Chief Commercial Officer

Chief Product Officer

Chief Legal Officer

Chief Communications & Marketing Officer

Chief Financial Officer 

Chief Communications & Marketing Officer

Chief People Officer

Chief Commercial Officer

Chief Technology Officer

Partial year

Full year

Full year

Partial year

Full year

Partial year

Full year

Full year

Full year

(a) A D’Aloisio, J Hayes and G Tomlinson ceased to be a KMP on 6 May 2021.
(b) R Sharp commenced 18 February 2021.
(c) M Blomfield and C Lill ceased to be KMP on 25 October 2021.
(d) K Fisk was appointed Chief Communications & Marketing Officer on 8 December 2021 after acting in that role from 25 October 2021.
(e) S New, previously Chief Client Solutions Officer was appointed Chief Commercial Officer on 25 October 2021.

The numbers reported reflect the period for which executives are KMP.

There have been no changes to KMP since the end of 2021 up to the date of signing the Directors’ Report.

32

Remuneration ReportFor the year ended 31 December 2021Iress LimitedSECTION 1  EXECUTIVE REMUNERATION FRAMEWORK IN 2021

1.1  Overview of the 2021 executive remuneration framework

Iress’ 2021 executive remuneration framework applies to executives and is summarised below.

Our goal

To be the most innovative, reliable, & respected technology partner,  
regarded by our clients as essential & desirable.

Our goal is supported by our remuneration principles & performance framework

Remuneration 
principles & 
performance

Alignment with 
strategy

Alignment with 
shareholder 
interests

Support attraction, 
motivation, & 
retention

Simple to 
understand & 
transparent

Support robust 
performance 
management

Annual 
performance 
management

Remuneration 
components

Long-term 
performance 
measurement

Long-term deferred 
awards with vesting 
linked to key 
business success 
measures.

Significant 
exposure to share 
price through 
equity-based awards 
and Performance 
Rights vesting 
subject to substantial 
Total Shareholder 
Return outcomes.

Competitive 
opportunity aligned 
to global market 
practice. Long-term 
equity awards 
support retention 
and allow executives 
to share in the value 
they create.

Total Remuneration 
structured clearly 
and easy to value 
unvested equity.

Long-term view of 
performance to 
avoid short-term 
gains for long-term 
loss. Strong 
performance 
and pay linking 
mechanisms.

Robust performance management incorporating the ‘what’ and the ‘how’

Base Salary

Equity Rights

Performance Rights

Market-based reward 
for role.

Equity to align with 
shareholder returns 
and retain talent.

Equity to reward exceptional shareholder returns.

Minimum shareholding requirement

A 225% – 400% of base salary minimum shareholding requirement  
(for the executives and CEO respectively) to be met within five years

Individual  
performance

Share price  
movement

Absolute total shareholder 
return (ATSR)

Shareholder wealth

Any increases in base 
salary will consider the 
market and individual 
contribution and 
experience.

Over the four-year 
aggregate Equity 
Rights holding period, 
executives will be directly 
exposed to the same 
share price movements 
as shareholders.

ATSR over a three-year 
period relative to a 
predetermined benchmark 
determines vesting for 
Performance Rights 
awards granted from 2019.

Over time, executives 
will see a direct increase 
(or decrease) in their 
wealth in the same way 
shareholders do.

The Board also considered non-financial factors centred around:

•  Clients & users.

•  Product & technology.

•  Company & people.

33

Annual Report 2021 
1.2  Our 2021 remuneration framework

The executive remuneration structure is as follows and comprises Base Salary, Equity Rights, Performance Rights, and Minimum 
Shareholding Requirement.

Base Salary

Base Salary reflects a market-related reward for performing a leadership role at Iress, plus superannuation and benefits.

Equity Rights

Equity Rights are an upfront award of rights, subject to service requirements. Participants are eligible for dividend equivalents during the 
service period (in the form of additional Equity Rights on vesting), and dividends (or cash dividend equivalents for some jurisdictions) during 
the restriction period. 

Purpose

To facilitate immediate, collective alignment of executives with shareholders. To reward shareholder returns and 
facilitate retention. 

Opportunity

Executives

Equity Rights as a percentage of 
Total Remuneration

CEO

Other executives

33%

25%

The number of Equity Rights granted to each executive is calculated using face value, divided by the twenty-trading-day 
volume weighted average share price (VWAP) to 31 December of the year prior to when the grant is made. 

Performance 
measurement

Performance is reflected in share price movements and dividends earned which collectively impact the value of 
Equity Rights. executives will share in the same price movements and dividends as shareholders over the entire 
vesting and holding period.

Board discretion:

The Board retains ultimate discretion to adjust the award or vesting quantum of Equity Rights, subject to their 
assessment of individual and company performance.

Vesting

Vesting after two years is subject to continued service. A further two-year restriction period applies, supporting 
retention and sustainable value creation over a total of four years.

Depending on the tax rules in the relevant jurisdiction, the restriction will either be in the form of a holding lock 
(preventing the share received on exercise from being sold) or an exercise restriction (preventing the right from 
being converted to a share). Australian tax residents have the option of choosing an additional six-month voluntary 
holding lock period.

If employment ceases due to resignation, termination for cause, or gross misconduct, then unvested equity lapses. 
If employment ceases for other reasons, Equity Rights will continue to be held subject to original terms (subject to 
Board discretion). 

Board discretion also applies to a change in control. The Board will consider time elapsed and performance achieved 
when exercising this discretion.

Significant underperformance or misconduct can lead to reduced vesting at the Board's discretion or clawback of 
awards in the holding lock. In addition, the Board may decline to make future grants in such cases.

Termination of 
employment

Change of control

Malus & clawback

34

Remuneration ReportFor the year ended 31 December 2021Iress LimitedPerformance Rights 

A Performance Right is a right to receive one Iress share (or cash of equivalent value) upon vesting and exercise of that right at no cost, 
subject to adjustment for certain capital actions. Performance Rights do not carry any dividend entitlements or voting rights. Shares 
allocated upon exercise carry the same rights as any other Iress share.

Purpose

To reward exceptional shareholders returns.

Opportunity

Executives

Performance Rights as a percentage of 
Total Remuneration

CEO

Other executives

35%

25%

The number of Performance Rights granted to each executive is calculated using face value, divided by the 
twenty-trading-day VWAP to 31 December of the year prior to when the grant is made. 

Performance 
measurement

A grant of Performance Rights will vest subject to Iress’ ATSR performance over three financial years and 
ongoing service.

•  TSR is aligned to Iress’ business objectives as ATSR focuses on the growth of Iress and value to shareholders, 
regardless of the broader market and other companies’ movements. Awards to executives will not vest unless 
substantial shareholder value has been created over the measurement period.

•  ATSR is simple and transparent to both executives and shareholders. It also enables the consideration of a range 

of benchmarks for performance.

•  In setting the three-year ATSR target for each Performance Rights grant, the Board determines a range that reflects 
business strategy but is informed by benchmarks such as recent performance of the All Ordinaries Accumulation 
index, Iress’ cost of equity, market practice for companies with ATSR targets, and the historical performance of Iress 
and its peers.

Board discretion:

The Board retains ultimate discretion to adjust the award, or vesting quantum, of Performance Rights, subject 
to their assessment of individual and company performance. In applying any discretion, the Board takes into 
consideration performance against a set of non-financial measures across the following areas:

•  Clients & users.

•  Product & technology.

•  Company & people.

Vesting

With consideration to internal and external benchmarks, the following vesting schedule applies.

Iress’ annualised ATSR over the three-year 
measurement period

% of Performance Rights that will vest

Below 6.5%

6.5%

Between 6.5% and 10%

0%

50%

Pro-rata portion will vest on a straight-line 
basis between 50% (at 6.5%) and 100% (at 10%)

10% or higher

100%

The number of Performance Rights that will vest will depend on Iress’ ATSR performance over the measurement 
period, measured using a twenty-trading-day VWAP at the start and end of the measurement period.

No retesting applies to Performance Right awards from 2019 onwards. 

Termination of 
employment

If employment ceases due to resignation, termination for cause, or gross misconduct, unvested Performance Rights 
lapse. If employment ceases for other reasons, Performance Rights continue to be held subject to original terms on 
a pro rata basis (subject to Board discretion).

Change of control

Board discretion also applies on a change in control. The Board will consider time elapsed and performance 
achieved when exercising this discretion.

Malus

Significant underperformance or misconduct can lead to reduced vesting at the Board's discretion. In addition, the 
Board may decline to make future grants in such cases.

35

Annual Report 2021Minimum shareholding requirement

•  Executives have a Minimum Shareholding Requirement to be met by December 2023, or within five years of commencing in their executive 

role. The requirement for the CEO and executives is as follows:

> CEO: 400% of base salary.

> Executives: 225% of base salary.

•  Unvested Equity Rights will count towards meeting the requirement. Unvested Performance Rights will not.

•  The value of each holding will be calculated as the maximum of:

> share price at the time of the measurement, or

> share price at the time when equity is acquired (ie, when Equity Rights are granted, when Performance Rights vest, and/or when fully-paid 

shares are purchased).

•  Executive KMP progress towards the Minimum Shareholding Requirement is shown in Section 6.2.

Under the framework, remuneration for 2021 is delivered over a four-year timeframe as shown below:

2021

2022

2023

2024

2025

2026

Base salary

Equity Rights*

Performance Rights*

Cash

Vesting period (Rights)

Holding lock period

Measurement period^

Vesting period^

Performance 
Rights
(Absolute TSR)

Minimum shareholding requirement

Minimum shareholding requirement to be met within five years (ongoing requirement)

*   The Executive grants were awarded on 26 February 2021 with the measurement period for Performance Rights starting from 1 January 2021. The CEO grants 

were awarded post shareholder approval at the AGM on 6 May 2021.

^   Subject to performance, vesting occurs after the vesting period has ended (28 February 2024).

36

Remuneration ReportFor the year ended 31 December 2021Iress Limited1.3  Approach to determining remuneration opportunities

Iress offers executives a Total Remuneration package. Each remuneration component (Base Salary, Equity Rights and Performance 
Rights) is calculated as a proportion of Total Remuneration, using the remuneration mix on grant as shown in the diagram below:

2021 Remuneration mix

CEO

Executive

Base Salary

Equity Rights

Performance Rights

32%

32%

Cash

Equity

33%

50%

50%

25%

35%

68%

25%

50%

In determining Total Remuneration, Iress considers the skills, experience, performance, and value to Iress of the individual and market 
pay levels of comparable roles. Total Remuneration is reviewed annually and approved by the Board for the CEO and by the PPC for 
other executives. Any decision to increase Total Remuneration is considered in the context of the resulting change to Base Salary, 
Equity Rights, and Performance Rights.

Iress serves multiple sophisticated client segments internationally, faces a range of competitors, and is exposed to global technology 
and regulatory influences. As a result, Iress competes for the best people globally.

The challenges and opportunities faced by Iress reflect the international nature of its business, its size, and the industries in which it 
operates. Recognising this, Iress generally considers two main comparator groups when assessing executive remuneration: ASX-listed 
technology companies with complex multinational operations of a similar size (assessed by market capitalisation); and, periodically, 
overseas-listed technology companies operating in a closely comparable industry segment with comparable scale.

The Board routinely assesses the remuneration approach against the market of such peers, and this has been an important input to 
the changes to the 2022 executive remuneration approach.

The benchmarking performed in 2021 indicates that the Iress Base Salary and Equity Rights (which from 2022 will be considered 
part of Fixed Remuneration) for the executive leadership team is appropriately positioned against peers’ fixed remuneration. However, 
the Total Remuneration opportunity, which includes Performance Rights, is below that of our peers.

The 2021 remuneration outcomes for each member of the Executive KMP are shown in Section 2.5.

37

Annual Report 2021SECTION 2 PERFORMANCE AND REMUNERATION OUTCOMES IN 2021

2.1  Mechanisms that link remuneration to performance

Pay for Performance

Our remuneration approach is supported by the following mechanisms that link reward outcomes to key measures  
of business performance and success.

Group & individual performance impacts executives’ remuneration in four ways:

Impact 1:

Impact 2:

Impact 3:

Impact 4:

Non-financial performance 

•  Individual and Group 
performance against 
the annual non-financial 
objectives set by the Board 
is a key consideration when 
the Board determines the 
Base Salary and Total 
Remuneration package 
of an executive.

Equity-based awards to align 
actual remuneration with 
long-term business success

•  Share price movements and 
dividends impact the value 
of equity over the three to 
five-year holding period 
and aligns reward with 
shareholder outcomes.

•  Failure to deliver strong share 
price and dividend outcomes 
has a significant impact 
on individual remuneration 
outcomes.

Performance Right vesting 
subject to ATSR

Ultimate discretion from the Board 
to adjust remuneration in light of 
performance

•  Performance Right vesting is 
subject to a three-year ATSR 
measure that aligns reward 
with shareholder outcomes.

•  The significant proportion 
of Total Remuneration 
delivered via Performance 
Rights only vests subject 
to performance against 
challenging ATSR targets.

•  The Board has discretion to 

reduce, cancel or clawback equity 
remuneration if group or individual 
performance is significantly below 
expectations, or in the event of 
individual misconduct. The discretion 
can be applied at grant, vesting, or 
during the equity holding period.

•  Remuneration can be adjusted prior 
to grant, during vesting, and after 
vesting as a result of performance.

Board discretion
The Board has overarching responsibility to ensure performance is managed appropriately, to maintain a focus on strong performance, 
and long-term link of performance-to-remuneration outcomes.

Each year, the Board approves the Group financial and non-financial objectives consistent with the Group’s risk appetite and specific 
targets for the Group to achieve its strategy. The Group’s financial and non-financial objectives cascade down to individual objectives 
for each executive that are specific to each executive’s role.

At all points throughout the remuneration and performance cycle (ie, before grants are made, during vesting and holding periods, and 
following vesting) the Board and PPC review performance at a Group and individual level and retain discretion to reduce the value of 
awards in line with performance to maintain the alignment between performance and pay.

38

Remuneration ReportFor the year ended 31 December 2021Iress Limited2.2  Group performance against objectives

The table below provides summary information on the Group’s performance for the five years to 31 December 2021:

Measure

2021

2020

2019

2018

2017

Net Profit After Tax ($’000s)

Operating revenue ($’000s)

Basic Earnings per share (cents)

Return on Invested Capital

Annual ATSR (a)

Annualised 3-year ATSR (a)

73,798

595,945

38.8

10.5%

26.5 (b)

8.9%

59,213

542,630

32.4

9.2%

(18.0%)

1.3%

65,128

508,943

37.9

11.4%

23.5%

9.3%

64,096

464,624

37.6

11.5%

2.7%

8.7%

59,755

429,952

35.4

11.0%

2.8%

7.8%

(a)  All share prices and the TSR calculation are based on the twenty-trading-day volume weighted average share price on the relevant dates.

(b)  Iress’ share price (twenty-trading-day volume weighted average share price) was $10.39 at 31 December 2020 and $12.68 at 31 December 2021.

On a reported basis, Iress’ operating revenue grew 10% to $595.9m and Net Profit After Tax (NPAT) increased 25% to $73.8m. We have 
continued to meet product and platform delivery milestones and the pipeline of new business into 2022 is building.

The Board recognises the 2021 market volatility and business uncertainty for current and prospective Iress clients created by the 
continued impact of COVID-19. The pandemic has created impacts on timely decision making, and has placed significant pressure on 
both individuals, and projects, across Iress people and clients.

The Board and management have reset the business with a more highly focussed 2025 strategy which has been built on existing 
foundations already in place, and will accelerate the investment in the future technology platform and capitalise on the market 
opportunities we see in front of us.

Reflecting on 2021, the Board is satisfied that management remains on track to achieve the 2025 strategy. The Board considers 
overall performance to be aligned with expectations, and reflects management’s focus on our people and clients—plus the achievement 
of Iress’ overall financial performance maintaining a lens on the medium and long term.

39

Annual Report 20212.3  Remuneration awarded in the current year

Following the year-end assessment of performance, the Board determined it was fair and appropriate that the 2021 equity grants 
proceed in line with the remuneration mix disclosed in Section 1.3.

The remuneration awarded to Executive KMP in 2021 (and 2020) is shown below.

In the table below, Equity Rights, Transition Equity Rights and Performance Rights are shown at face value (reflecting share price at 
grant multiplied by the number of instruments granted). This differs from the portion of the grant date fair value expensed in 2021, 
which has been used to calculate remuneration in Section 2.4 Executive KMP statutory remuneration.

Executive KMP

A Walsh

M Blomfield (b,h)

J Das

P Ferguson

K Fisk (d)

J Harris

A Knowles (c)

C Lil (b,g)

J McNeill (c)

S New (c)

A Todd

Total Executive KMP

Base 
Salary
$

Equity Rights (a)

$

Additional 
Equity Rights (e)

$

1,000,000
1,000,000

1,008,891
1,008,901

70,477
–

488,095
123,077

550,000
162,885

390,000
390,000

63,194

620,000
620,000

386,795

325,397
133,333

425,926
410,714

611,111
589,286

630,000
630,000

300,010
–

275,008
–

195,005
195,006

–

310,007
310,012

313,738

200,003
–

204,846
218,665

293,910
313,738

315,005
315,006

5,103,723

4,446,090

3,102,685

2,675,066

–
–

–
–

14,475
–

–

21,406
–

–

10,908
–

15,450
–

21,065
–

23,940
–

177,721

–

Additional
 Transition
 Equity Rights (f)

$

–
–

–
–

–
–

8,685
–

–

12,848
–

–

6,541
–

9,270
–

12,643
–

14,368
–

64,355

–

Performance

 Rights (a)

$

Total
 remuneration
$

1,068,891
1,068,900

300,010
–

275,008
–

195,005
195,006

–

310,007
310,012

313,738

200,003
–

204,846
218,665

293,910
313,738

315,005
315,006

3,162,685

2,735,065

3,148,259
3,077,801

1,088,115
123,077

1,100,016
162,885

803,170
780,012

63,194

1,274,268
1,240,024

1,014,271

742,852
133,333

860,338
848,044

1,232,639
1,216,762

1,298,318
1,260,012

11,611,169

9,856,221

Year

2021
2020

2021
2020

2021
2020

2021
2020

2021

2021
2020

2020

2021
2020

2021
2020

2021
2020

2021
2020

2021

2020

(a)  The number of rights granted to each Executive KMP in 2021 and 2020 was based on the twenty-trading-day volume weighted average share price up to and 
including 31 December 2020 and 31 December 2019 respectively. Where not applicable (n/a) is stated, the individual became KMP after the eligibility date for 
this award.

(b)  C Lill and M Blomfield ceased to be KMPs on 25 October 2021. Amounts shown reflect the part of the year the individuals were KMPs as per the introduction to 

this Remuneration Report.

(c)   Salary of A Knowles, J McNeill and S New is denominated fully in British pounds and is subject to foreign exchange movements. The Australian dollar amounts 

shown in the table were converted at an average foreign exchange rate of 0.54 (2020: 0.56).

(d)  K Fisk appointed as KMP from 25 October 2021, base salary includes an allowance for acting in a role of Chief Communications and Marketing Officer prior to 

permanent appointment to that role.

(e)   Amount reflects the additional grant of Equity Rights equivalent to the dividend KMPs would have received if they had held Shares during the 2019 Equity 

Rights Measurement Period. The value of additional Equity Rights is based on the twenty-trading-day volume weighted average share price up to and including 
the grant date.

(f)   Additional Transition Equity Rights was a one-off grant of additional Equity Rights to recognise the cashflow impact of the transition to the new framework. 

Reported amount reflects the additional grant of Transition Equity Rights equivalent to the dividend KMPs would have received if they had held Shares during 
the 2019 Transition Equity Rights Measurement Period. The value of additional Transition Equity Rights is based on the twenty-trading-day volume weighted 
average share price up to and including the grant date.

(g)  C Lill's 2021 Equity Rights and Performance Rights lapsed on resignation effective 17 December 2021.

(h)  M Blomfield retained his 2021 Equity Rights on resignation for health reasons effective 27 October 2021. His 2021 Performance Rights were partially lapsed.

40

Remuneration ReportFor the year ended 31 December 2021Iress Limited2.4  Executive KMP statutory remuneration

The table below presents details of Executive KMP remuneration prepared in accordance with statutory requirements and accounting 
standards. Under AASB 2 Share-based Payment, equity is expensed based on the grant date fair value over the vesting period.

Short-term benefits
$

Post-
employment 
benefits
$

Executive KMP

Year

Salary and

 fees (a)

Non-
monetary
 benefits (b)

Super-
annuation

A Walsh

M Blomfield (e)

J Das

P Ferguson

K Fisk (g,i)

J Harris

A Knowles (f)

C Lill (e)

J McNeill (f)

S New (f)

A Todd

Total

2021
2020

2021
2020

2021
2020

2021
2020

2021

2021
2020

2020

2021
2020

2021
2020

2021
2020

2021
2020

2021

2020

1,000,000
1,000,000

–
17,104

488,095
123,077

550,000
162,885

390,000
390,000

63,194

620,000
620,000

386,795

325,397
133,333

440,926
425,179

611,111
589,286

630,000
630,000

–
–

–
–

2,580
2,369

380

2,580
2,369

2,235

–
–

11,391
8,683

4,598
4,798

–
–

27,500
25,000

32,117
11,692

37,026
15,474

25,975
25,198

6,319

27,500
25,000

6,519

19,411
12,667

38,333
36,830

30,556
29,464

27,500
25,000

5,118,723

4,460,555

21,529

37,558

272,237

212,844

Long-term benefits
$

Share-based
payments
Deferred Share
 Rights (c)/
Equity Rights
 and Transition
 Equity Rights(d,h)

Share-
based 
payments
Performance
 Rights

Long-
service 
leave 
(LSL) (j)

Total
 remuneration
$

Performance
 related
 remuneration

1,153,023
1,366,056

594,550
687,411

(7,166)
32,101

2,767,907
3,127,672

100,463
–

92,091
–

234,148
329,161

–

363,488
495,435

281,009

48,403
88,474

258,166
349,631

358,356
470,477

383,221
545,716

5,685
–

19,022
–

71,302
79,124

–

109,218
119,715

69,573

15,479
19,450

76,920
82,342

105,542
107,050

115,979
114,538

2,991,359

1,113,697

–
–

2,284
–

1,987
9,273

4,311

626,360
134,769

700,423
178,359

725,992
835,125

74,204

12,599
16,300

1,135,385
1,278,819

–

(9,248)
2,274

–
–

–
–

15,409
9,010

20,176

746,131

399,442
256,198

825,736
902,665

1,110,163
1,201,075

1,172,109
1,324,264

9,537,721

3,925,959

1,279,203

68,958

9,985,077

63%
66%

17%
0%

16%
0%

42%
49%

0%

42%
48%

47%

16%
42%

41%
48%

42%
48%

43%
50%

43%

52%

(a)  Salary and fees includes allowances and short-term compensated absences paid during the 2020 and 2021 years.  

(b)  Non-monetary benefits include health and life insurance subsidies.

(c)   Deferred Share Rights were granted under the previous remuneration framework in 2019 in relation to performance in the 2018 financial year. Vesting for the Deferred 

Share Rights award is conditional on three-years’ continued service and achievement of a satisfactory level of individual performance during these three years.

(d)  Equity Rights comprise standard Equity Rights and Transition Equity Rights. Transition Equity Rights was a one-off additional grant in 2019 to executives 

(excluding the CEO) to offset the negative cash flow impact resulting from the introduction of the new executive remuneration framework in 2019. Transition 
Equity Rights have the same vesting conditions and holding restrictions as the annual Equity Rights allocations. 

(e)   C Lill and M Blomfield ceased to be KMPs on 25 October 2021. 

(f)   Remuneration of A Knowles, J McNeill, and S New is denominated fully in British pounds and is subject to foreign exchange movements. The Australian dollar 
amounts shown in the table were converted at an average foreign exchange rate of 0.54 (2020: 0.56). The amounts included under Superannuation refer 
to Pension for these individuals. A Knowles ceased to be KMP on 31 August 2020.

(g)  K Fisk appointed as KMP from 25 October 2021, base salary includes an allowance for acting in a role of Chief Communications and Marketing Officer prior 

to permanent appointment to that role.

(h)  Share based payments for J McNeil and S New include the payment of cash dividend replacement for their vested but unexercised 2019 Equity Rights and 

2019 Transition Equity Rights. Cash dividend replacement is only applicable to KMPs in the UK.

(i)   Long Service Leave movement for K Fisk is between October 2021 and December 2021.

(j)   The movements in LSL for some KMPs are negative. The movement in LSL is largely impacted by government driven discount rates used to calculate 
the provision, however this impact is offset by increases in pay as well as employees progressing towards the date at which their LSL can be taken.

41

Annual Report 20212.5  Remuneration realised from equity granted in previous years

Performance Rights granted prior to 2019
Performance Rights granted prior to 2019 had similar terms to the Performance Rights grants from 2019 onwards. The main difference 
was that vesting was based on RTSR performance over the measurement period. Iress’ TSR was measured against a comparator 
group consisting of companies listed in the S&P/ASX 200 index, excluding mining and resource companies, and listed property trusts. 
The comparator group companies were determined as at 1 January of the year of grant.

For all Performance Rights granted prior to 2019, 0% of the rights vest for RTSR performance below the 50th percentile, 50% vest at 
the 50th percentile and 100% of the rights vest for RTSR performance of 75th percentile with pro-rata vesting on a straight-line basis 
in between. Iress allowed for one re-test, six months after the initial test date, for any portions of awards that did not vest on the initial 
test date.

Equity vested
In May 2021, based on Iress’ RTSR performance in the preceding three and four year periods up to 31 December 2020, there was no 
vesting. Upon retesting for performance as at 30 June 2021, there was partial vesting of Performance Rights granted to the CEO in 
2017 and Performance Rights granted to other executives in 2018.

At end of retesting period (a,b)

Award

Initial measurement period (a)

RTSR percentile

Final vesting

CEO 2017 four-year

1 Jan 2017 to 31 Dec 2020

CEO 2017 three-year deferred start

1 Jan 2018 to 31 Dec 2020

Executive 2018 three-year

1 Jan 2018 to 31 Dec 2020

52.0nd

60.0th

60.0th

54.0%

69.8%

69.8%

(a)  Performance Rights granted prior to 2019 had one re-test six months after the initial measurement period. The final outcomes above are thus based on 

maximum performance as measured on 31 Dec 2020 and 30 June 2021.

(b)  TSR amounts are calculated as per the terms of each Performance Rights offer, which provide for a twenty-trading-day volume weighted average share 

price at the start and end.

The Board also determined there were no individual performance or conduct issues and the full value of Performance Rights as 
determined by RTSR performance would vest.

The value of equity vested to Executive KMP in 2021 (and 2020) is shown below. In addition to the 2017 Performance Rights for the CEO 
and 2018 Performance Rights for the other executives, it includes deferred equity granted in 2018 under the previous remuneration 
framework. Executive KMP had an increase in their realised remuneration in 2021 as compared to 2020, which was primarily driven by 
a higher number of shares vesting, and a higher share price on vesting for Performance Rights.

42

Remuneration ReportFor the year ended 31 December 2021Iress LimitedActual realised remuneration

Financial
 Year

Base 
Salary
$

Deferred
 Equity
 vested (a)

Performance
 Rights 
vested (a)

 $

$

Equity 
Rights
 vested (g)

$

2021
2020

2021
2020

2021
2020

2021
2020

2021

2021
2020

2020

2021
2020

2021
2020

2021
2020

2021
2020

2021

1,000,000
1,000,000

515,845
498,262

1,006,321
917,722

780,019
–

488,095
123,077

550,000
162,885

390,000
390,000

63,194

620,000
620,000

386,795

325,397
133,333

425,926
410,714

611,111
589,286

630,000
630,000

–
–

–
–

127,417
112,356

–

186,218
170,975

170,975

98,017
–

137,756
74,506

172,198
74,506

215,628
161,203

–
–

–
–

132,368
64,084

–

198,538
98,001

98,001

99,269
–

141,828
44,720

165,453
51,101

207,997
–

–
–

–
–

160,156
–

–

236,930
–

–

120,668
–

170,928
–

233,080
–

264,974
–

5,103,723

1,453,079

1,951,774

1,966,755

2020

4,446,090

1,262,783

1,273,629

–

Executive KMP

A Walsh

M Blomfield (b)

J Das

P Ferguson

K Fisk (d)

J Harris

A Knowles (c)

C Lill (b)

J McNeill (c)

S New (c)

A Todd

Total Executive 
KMP

Transition
 Equity 
Rights
 vested (g)

$

–
–

–
–

–
–

96,094
–

–

142,162
–

–

72,397
–

102,557
–

139,852
–

158,986
–

712,048

–

Additional
 Equity 
Rights
 vested (e)

$

70,477
–

–
–

–
–

14,475
–

–

21,406
–

–

10,908
–

15,450
–

21,065
–

23,940
–

177,721

–

Additional
 Transition
 Equity 
Rights
 vested (f)

$

–
–

–
–

–
–

8,685
–

Total
 remuneration
$

3,372,662
2,415,984

488,095
123,077

550,000
162,885

929,195
566,440

–

63,194

12,848
–

1,418,102
888,976

–

6,541
–

9,270
–

12,643
–

14,368
–

655,771

733,197
133,333

1,003,715
529,940

1,355,402
714,893

1,515,893
791,203

64,355

11,429,455

–

6,982,502

(a)  The value of equity that vested is based on the twenty-trading-day volume weighted average share price up to and including the vesting date. A dash indicates 
that the executive started with the Group after the eligibility date for this award or was not eligible for the award . This differs from fair value expensed in 2021, 
which has been used to calculate remuneration in Section 2.4.

(b)  C Lill and M Blomfield ceased to be KMPs on 25 October 2021. Amounts shown reflect the part of the year the individuals were KMPs as per the introduction to 

this Remuneration Report. 

(c)   Salary of A Knowles, J McNeill and S New is denominated fully in British pounds and is subject to foreign exchange movements. The Australian dollar amounts 

shown in the table were converted at an average foreign exchange rate of 0.54 (2020: 0.56).

(d)  K Fisk appointed as KMP from 25 October 2021, base salary includes an allowance for acting in a role of Chief Communications and Marketing Officer prior to 

permanent appointment to that role.

(e)   Amount reflects the additional vesting of 2019 Equity Rights equivalent to the dividend KMPs would have received if they had held Shares during the 

Measurement Period (calculated on an accumulating basis, i.e. assuming the dividends are reinvested). 2019 additional Equity Rights vested in 2021, however, 
are under restriction until February/August 2023. The value of equity vested is based on the twenty-trading-day volume weighted average share price up to 
and including the vesting date.

(f)   Transition Equity Rights was an one-off grant of additional Equity Rights to recognise the cashflow impact of the transition to the new framework. Reported 
amount reflects the additional vesting of Transition Equity Rights equivalent to the dividend KMPs would have received if they had held Shares during the 
Measurement Period (calculated on an accumulating basis, i.e. assuming the dividends are reinvested). 2019 additional Transition Equity Rights have vested in 
2021, however, are under restriction until February/August 2023. The value of equity that vested is based on the twenty-trading-day volume weighted average 
share price up to and including the vesting date.

(g)  Equity Rights and Transition Equity Rights were granted on 28 February 2019 and vested in February 2021. However, both awards are under restriction until 

February/August 2023.

43

Annual Report 20212.6  Change in value of equity held

Iress’ remuneration framework directly links shareholder and executive outcomes. Executives hold a number of different equity 
types, which are affected by share price movements, as well as equity-based Performance Right awards that vest subject to 
TSR performance.

Executive KMP saw an increase in the value of their Equity Rights in 2021 due to an increase in the share price. This increase is aligned 
with shareholder experience in 2021. Previously accumulated shares retained by Executive KMP are also exposed to share price 
changes during the year.

In addition, while measured by ATSR, the 2021 Performance Rights awards are currently tracking to vest due to an annualised ATSR of 
8.22%. The 2020 Performance Rights awards are not currently tracking to vest due to an annualised ATSR of -0.11%.

In its 2021 half-year and full-year assessments, the Board did not identify any individual or company performance or conduct factors 
that would warrant clawback of currently unvested equity at future vesting dates. The Board will continue to monitor such factors until 
the relevant vesting date for each grant of equity.

44

Remuneration ReportFor the year ended 31 December 2021Iress LimitedSECTION 3  CHANGES TO EXECUTIVE REMUNERATION IN 2022

In light of Iress’ strategy to accelerate growth and returns by 2025, in 2021 the Board reviewed the executive remuneration framework 
to enhance alignment to the new business strategy. As part of that review, the Board also considered feedback from investors on the 
2020 Remuneration Report. The changes agreed by the Board will be effective 1 January 2022.

The Board remains confident that the current framework elements (Base Salary, Equity Rights and Performance Rights) remain 
appropriate for our business. However, the Company’s 2021 strategy review made it clear to us that the way we allocate incentives 
needed to change in order to drive the business towards its more focussed 2025 goals. As originally intended when implemented in 
2019, the Equity Rights and Performance Rights continue to provide significant share price exposure and long-term performance 
focus. In addition, the framework supports the attraction and retention of talent within the highly competitive global technology sector 
where we compete with both start-ups and established businesses for talent.

Principles for the executive remuneration framework
The guiding principles that the Board used for its review of the framework were that the new executive remuneration framework should:

•  maintain alignment of executive remuneration outcomes with shareholders’ interests

•  enhance alignment with Iress’ overall strategy for medium to long-term value creation

•  provide performance metrics which directly reflect the achievement of the company goals

•  support Iress to attract and retain the leadership talent needed to succeed on an international basis

•  be simple to understand and be transparent for all stakeholders.

Overview of changes to the executive remuneration framework
The diagrams below set out the 2021 and 2022 executive remuneration framework and timelines. In 2022, Performance Rights vest 
over three and four years (versus three years in 2021), and have an additional one-year holding lock post-vesting. Note that under the 
new remuneration framework, there will be two grants of Performance Rights made in 2022, and none made in 2023.

In the 2021 framework, remuneration was delivered over a four-year timeframe as shown below:

2021

2022

2023

2024

2025

Base salary

Cash

Equity Rights

Equity Rights vesting period

Holding lock period

Performance Rights

Performance Rights measurement period

Minimum shareholding requirement

Minimum shareholding requirement to be met within five years (ongoing requirement)

In the new 2022 framework, remuneration is delivered over a five-year timeframe as shown below:

Base salary

Equity Rights

Performance Rights

2022

2023

2024

2025

2026

Cash

Equity Rights vesting period

Holding lock period

Release of 2020 Equity 
Rights and Performance 
Rights grants is directly 
aligned to Iress' 2025 
strategic timeline

Grant 1: Performance Rights measurement period

Holding lock
period

Grant 2: Performance Rights measurement period

Holding lock period

Minimum shareholding requirement

Minimum shareholding requirement to be met within five years (ongoing requirement)

Release of 2022 Equity Rights and Performance Rights grants
is directly aligned to Iress’ 2025 strategic timeline

45

Annual Report 2021The following details the changes to the executive remuneration framework that will apply for 2022:

Changes to executive remuneration

Alignment with business strategy

Framework

•  Fixed Remuneration comprised of cash and equity: Base 

•  Emphasises focus on overall Iress performance.

Salary plus superannuation plus Equity Rights.

•  Cognisant of competitor remuneration structures in the 

•  No change to quantum of Base Salary or Equity Rights 

technology industry. 

opportunity relating to the change in framework.

Performance 
Rights: grants 
and vesting

•  Two grants of Performance Rights to be made in 2022.

•  Grant 1: three-year performance and vesting period.

•  Grant 2: four-year performance and vesting period.

•  The 2022 grants will be made using a twenty-trading-day 
VWAP commencing on the day following the results being 
announced for the year ending 31 December 2021.

•  A one-year holding lock will apply to Performance Rights 

post-vesting.

•  No grants of Performance Rights to be made in 2023.

•  Increases exposure to absolute shareholder returns 
over the long-term by adding an additional one-year 
holding lock.

•  Directly aligns rewards with the 2025 strategic timeline by 

“bringing forward” the 2023 LTI grant to 2022.

•  Replacement of the current ATSR performance 

•  The performance required for full vesting (i.e. maximum 

performance) is directly in line with the strategic intent to 
double EPS and ROIC from 2020 by 2025.

  The platform measure is the fundamental measure 

underpinning the strategy acceleration, with scale and 
financial outcomes, which are critical to providing returns 
to our shareholders. 

•  The ATSR gateway of 10% per annum—set at the 2021 

maximum hurdle—must be met. Vesting is then dependent 
on performance against Iress’ key business strategy 
objectives: EPS growth, ROIC improvement, and platform.

•  The ATSR VWAP start and end periods, allows for 

market consideration and response to the EPS, ROIC 
and platform delivery results achieved at the end of the 
performance periods. 

measure with:

> an ATSR gateway of 10% per annum measured over the 
period commencing when results are announced; and

> three additional measures, with maximum 

performance and vesting directly aligned to the 2025 
strategy. The three measures align to three tranches, 
each weighted one-third:

– Tranche 1: Threshold EPS of 46.3 cents by 2024, 

51.9 cents by 2025. Maximum EPS of 56.6 cents by 
2024, 66.8 cents by 2025. 

– Tranche 2: Threshold ROIC of 11.9% by 2024, 13.3% by 
2025. Maximum ROIC of 15.3% by 2024, 17.8% by 2025.

– Tranche 3: The platform measure focuses on enabling 
services on the new single prod-tech platform such 
that for threshold vesting, 30%–50% of new services 
are enabled on the platform by 2024, and 30%–50% of 
existing services & every new service is enabled on the 
platform by 2025. For maximum vesting, >50% of new 
services are enabled on the platform by 2024, and the 
majority (>=50%) of existing and every new service is 
enabled on the platform by 2025. 

•  Once the gateway is met, the level of Performance Rights 
vesting will be determined by performance against the 
three performance measures (one measure per tranche). 

For 2022:

•  The 2022 Performance Rights opportunity:

•  The 2023 Performance Rights grant will be brought forward 

> recognises the significant value that will be created for 

to 2022. No Performance Rights will be granted in 2023.

shareholders if 2025 targets are achieved.

•  Executives’ 2022 Performance Rights grants will be 

> focuses on multi-year performance through to the end 

approximately 2.8x (CEO) – 4x (other executives) larger than 
the prior combined 2022/2023 grant quantum would have 
been under the prior plan.

of 2025

> Rewards Executives for the delivery of both ATSR and 

strategy for shareholders.

•  Executives would earn less over the 2022-2025 period, 

versus the 2021 approach, if ATSR is not at least 10% per 
annum and there is not at least threshold vesting on the 
EPS, ROIC and platform tranches.

•  The grant of Performance Rights to the CEO is subject to 

shareholder approval. 

Performance 
Rights: 
performance 
measures

2022 
Performance 
Rights grant 
quantum 
(face value)

46

Remuneration ReportFor the year ended 31 December 2021Iress LimitedThe 2022 approach means executives will be rewarded with Performance Rights vesting where significant additional value is delivered 
for shareholders. 

The upside potential for executives is designed to reward for the delivery of upside value for shareholders. Achievement of maximum 
performance under the 2022 plan, would result in Executive KMP receiving approximately 2% of the total shareholder value created. 
Over the four year life of the scheme, the additional accounting cost of this grant of Performance Rights to executives is on average 
approximately $1.1m per annum.

Iress offers executives a Total Remuneration package. Each remuneration component (Base Salary, Equity Rights and Performance 
Rights) will be calculated as a proportion of Total Remuneration, using the remuneration mix on grant as shown in the diagram below:

2022 Remuneration mix

CEO

Executive

10%

10%

10%

15%

15%

8%

80%

90%

77%

85%

Base Salary

Equity Rights

Performance Rights

Cash

Equity

The Board considers these changes to reflect the right alignment between the strategy and remuneration, and balance between 
shareholder and executive outcomes. The changes for the 2022 structure provide executives with the incentive to outperform against 
a challenging program of work over the next four years.

47

Annual Report 2021SECTION 4  REMUNERATION GOVERNANCE

The People & Performance Committee (PPC) works closely with the Board to apply the Group’s remuneration philosophy and ensure the 
Company’s remuneration strategy supports the creation of sustainable shareholder value. One of the main roles of the PPC is to assist 
and advise the Board to fulfil its responsibilities on remuneration matters. The PPC takes into account a wide variety of information 
including business strategy and culture, stakeholder interests, market practice, and corporate governance principles. Input from other 
stakeholders is provided as required.

The following table summarises the role and responsibility of the PPC as it pertains to remuneration governance and interaction with 
other key bodies.

Board

•  Consultation between PPC on matters relating to remuneration.

•  PPC and Board responsible for diversity and inclusion matters.

•  Approves performance and remuneration arrangements for CEO.

•  Approves NED fee arrangements.

People & Performance Committee (PPC)

Consists of members appointed by the Board after due consideration 
of the composition and skill requirements of the Committee.

The PPC aims to meet three times a year.

Audit & Risk Committee (ARC)

Management

External Advisors

•  Refers risk or other related 

matters relevant to the business 
of the PPC for PPC examination 
and action, as required.

•  Provides recommendations to 
the PPC on matters relating to 
remuneration for PPC review, 
approval, or endorsement.

•  Provision of independent advice 

and engagement with the PPC on 
PPC related matters. 

•  Delegation may be provided 

by the PPC to management on 
certain issues, while maintaining 
independence protocols.

•  No remuneration 

recommendations (as defined 
by the Corporations Act 2001) 
were provided to the Board by 
independent advisors during the 
reporting period.

48

Remuneration ReportFor the year ended 31 December 2021Iress LimitedThe PPC is responsible for:

•  making recommendations to the Board in relation to company-wide remuneration strategies

•  reviewing the remuneration packages for new and current executives (other than the CEO, for which remuneration decisions are 

undertaken at the Board level), and approving the base salary and incentives proposed by the CEO under these packages

•  following the recommendation of the CEO, approving individual key performance indicators for executives

•  reviewing the performance evaluations prepared by the CEO for executives, and reporting on these evaluation criteria and their 

application to the Board

•  developing and regularly reviewing succession plans prepared by the CEO for executives

•  monitoring key appointments and departures as well as trends relating to recruitment, retention, termination, leave and diversity 

statistics, any key work health and safety issues and human resource projects

•  thorough oversight of remuneration strategies for the executives with consideration of alignment to the success of the Company 

without rewarding conduct that is contrary to the Company’s values, policies and risk appetite

•  approving the remuneration and incentive policies of all other employees

•  approving awards under employee equity plans, the terms on which the equity awards are offered, vesting outcomes and amending, 

suspending and cancelling plans

•  reviewing the superannuation and pension arrangements for staff on the recommendation of the CEO.

More information about the Board’s role in remuneration governance can be found at  
https://www.iress.com/trust/corporate-governance/governance-documents/board-charter/.

4.2  Executive KMP service agreements

All Executive KMP have a formal service agreement. Agreements are of an ongoing nature and have no set term of service.

The key terms of the service agreements for the CEO and Executive KMP are summarised below. Termination entitlements are limited 
to twelve months’ base salary unless shareholder approval is received.

Criterion

Term of contract

Resignation

Arrangements

Ongoing.

The Executive KMP may resign by providing six months’ written notice.

Termination on notice 
by Iress

Iress may terminate the employment agreement of Executive KMP by providing six months’ 
written notice, or payment in lieu of the notice period.

Redundancy

Termination for serious 
misconduct

Non-compete

If Iress terminates employment for reasons of bona fide redundancy, a severance payment 
will be made. The quantum of the payment will be determined subject to the Board's discretion, 
considering matters such as statutory requirements, the executive's contribution, position and 
length of service.

Iress may terminate the employment agreement at any time without notice.

A non-compete arrangement exists for a period of six months following employment 
with the Group (a).

(a)  The non-compete period is up to twelve months for other Executive KMP.

The intention is to harmonise the service agreements for all Executive KMP, along with the key terms where possible, in 2022.

49

Annual Report 2021SECTION 5  NON‑EXECUTIVE DIRECTOR FEES

5.1  Fee policy

Non-executive Directors (NED) receive fees for their services plus the reimbursement of reasonable expenses. To ensure objective and 
independent oversight of the Group, NED does not participate in performance-based incentives or receive post-employment benefits.

The fee levels that applied during 2021 were:

Role

Board

Additional fees for serving on the committees
Audit & Risk Committee

PPC

Board Chair
Member

Chair
Member

Chair

Member

Fee ($)

240,000 (a)
130,000

24,000
Nil

24,000

Nil

(a)  The Chairman is entitled to the Board Chair fee only (no additional Committee fees).

NED fees are reviewed at appropriate intervals and are determined by the Board in consideration of fees paid in comparable companies.

There were no changes to NED fees in 2021 and no changes are anticipated for 2022.

NED have a Minimum Shareholding Requirement to be met either by 31 December 2022, or within three years of their appointment if 
past this date. NED are required to accrue and hold Iress equity equivalent to 100% of the base fee for being a Member of the Board, 
unless otherwise determined by the Board.

5.2  Maximum aggregate NED fee pool

The maximum aggregate pool available for NED fees is approved by the shareholders at the Annual General Meeting in accordance 
with the Group’s Constitution. The maximum pool is set around the median of comparable companies, to provide the ability for Iress to 
attract and retain appropriately qualified and experienced directors.

The maximum aggregate fee pool of $1,500,000 per annum was approved at the Annual General Meeting in May 2019. The total 
amount of remuneration paid to NED in 2021 was $1,068,182 (2020: $1,234,691).

50

Remuneration ReportFor the year ended 31 December 2021Iress Limited5.3  2021 Non‑executive Director remuneration

The total remuneration for NED during 2021 and 2020 is set out in the table below. This table is prepared in accordance with statutory 
requirements and accounting standards.

Non-Executive Director

A D’Aloisio (c)

R Sharp (b)

N Beattie

J Cameron

M Dwyer

J Fahey

J Hayes (c)

J Seabrook (d)

G Tomlinson (c)

T Vonhoff (e)

Total Non-Executive Director fees

Short-term 
benefits

Post-
employment 
entitlements

Fees 
($)

Superannuation
 ($)

Total (a)
 ($)

76,431
219,178

167,058

129,705
130,000

118,452
118,721

118,452
108,828

140,320
140,639

49,043
140,639

44,894

45,333
127,180

136,177
108,828

980,971

1,138,907

7,261
20,822

16,416

12,645
12,350

11,548
11,279

11,548
10,339

13,680
13,361

4,659
13,361

1,113

–
2,820

9,454
10,339

87,211

95,784

83,692
240,000

183,474

142,350
142,350

130,000
130,000

130,000
119,167

154,000
154,000

53,702
154,000

46,007

45,333
130,000

145,631
119,167

1,068,182

1,234,691

Year

2021
2020

2021

2021
2020

2021
2020

2021
2020

2021
2020

2021
2020

2020

2021
2020

2021
2020

2021

2020

(a)  NED fees are paid inclusive of superannuation for all NED except for N Beattie, who is paid superannuation on top of fees based on the percentage of total fees 

relating to work performed in Australia. 

(b)  R Sharp was appointed to the Board as NED on 18 February 2021, and appointed Non-executive Chairman on 7 May 2021.

(c)  J Hayes and G Tomlinson ceased to be Non-executive Directors of the Board, and A D’Aloisio ceased to be Non-executive Chairman on 6 May 2021.

(d)  J Seabrook is included for the period she was NED only (1 January to 7 May 2020).

(e)  T Vonhoff was covered by a superannuation guarantee exemption certificate for three months from 1 July 2021 to 30 September 2021.

51

Annual Report 2021SECTION 6  ADDITIONAL REQUIRED DISCLOSURES

6.1  Unvested equity

The table below presents the Equity Rights, Deferred Share Rights and Performance Rights held during the financial year by each 
Executive KMP. No rights are granted to NED or related parties. Any rights that vest will be automatically exercised on or around the time 
Iress notifies the participant that their rights have vested. Equity Rights, Deferred Share Rights, and Performance Rights are granted 
for no consideration, and upon vesting, can be exercised at no cost.

Executive 
KMP

Type of equity

Grant
 date

Number
 granted

Fair value
 at grant
 date

Vesting
 date

Expiry
 date

Number 

vested(a,b)

% 
vested

Number 
lapsed

% 
lapsed

Number
Unvested

A Walsh

Equity Rights

7-May-21

97,089

9.01 28-Feb-23 28-Feb-23

–

0.00%

1-March-21

7,230

9.15

1-Mar-21

1-Mar-21

7,230

100%%

7-May-21

102,863

3.19 28-Feb-24 28-Feb-24

Equity Rights

8-May-20

76,374

11.86 28-Feb-22 28-Feb-22

Performance 
Rights

8-May-20

80,916

2.61 28-Feb-23 28-Feb-23

Equity Rights

10-May-19

80,020

14.22 26-Feb-21 28-Feb-21

80,020 100.00%

–

–

–

0.00%

0.00%

0.00%

10-May-19

80,020

8.6 28-Feb-22 28-Feb-22

10-May-19

42,736

12.73 10-May-22 10-May-22

10-May-18

45,605

5.75 10-May-22 10-May-22

10-May-18

45,605

5.78 10-May-22 10-May-22

–

–

–

–

0.00%

0.00%

0.00%

0.00%

10-May-18

51,707

9.58 10-May-21 10-May-21

51,707

100.00%

Additional  
Equity Rights

Performance 
Rights

Performance 
Rights

Deferred  
Share Rights

Performance 
Rights

Performance 
Rights

Deferred  
Share Rights

Performance 
Rights

Performance 
Rights

11-May-17

54,739

6.64 11-May-21

11-May-23

29,560

54.00%

25,179

46.00%

11-May-17

54,739

7.05 11-May-21

11-May-23

38,208

69.80%

16,531

30.20%

–

–

–

–

–

–

–

–

–

–

–

0.00%

0.00%

97,089

–

0.00%

102,863

0.00%

76,374

0.00%

80,916

0.00%

–

0.00%

80,020

0.00%

42,736

0.00%

45,605

0.00%

45,605

0.00%

–

–

–

216,199

355,009

Total of Equity Rights and Deferred Share Rights

Total of Performance Rights

M Blomfield 
(e,g)

Equity Rights

26-Feb-21

28,871

8.27 28-Feb-23 28-Feb-23

Performance 
Rights

26-Feb-21

28,871

2.56 28-Feb-24 28-Feb-24

Total of Equity Rights and Deferred Share Rights

Total of Performance Rights

J Das

Equity Rights

26-Feb-21

26,465

8.27 28-Feb-23 28-Feb-23

Performance 
Rights

26-Feb-21

26,465

2.56 28-Feb-24 28-Feb-24

Total of Equity Rights and Deferred Share Rights

Total of Performance Rights

52

–

–

–

–

0.00%

–

0.00%

28,871

0.00%

20,961

72.60%

7,910

28,871

7,910

0.00%

0.00%

–

–

0.00%

26,465

0.00%

26,465

26,465

26,465

Remuneration ReportFor the year ended 31 December 2021Iress LimitedExecutive 
KMP

Type of equity

Grant
 date

Number
 granted

Fair value
 at grant
 date

Vesting
 date

Expiry
 date

Number 

vested(a,b)

% 
vested

Number 
lapsed

% 
lapsed

Number
Unvested

P Ferguson Equity Rights

26-Feb-21

18,766

8.27 28-Feb-23 28-Feb-23

–

0.00%

1-Mar-21

2,376

9.15

1-Mar-21

1-Mar-21

2,376 100.00%

–

–

–

–

–

–

–

–

–

0.00%

18,766

0.00%

–

0.00%

18,766

0.00%

0.00%

14,762

14,762

0.00%

–

0.00%

16,430

0.00%

–

0.00%

9,966

26-Feb-21

18,766

2.56 28-Feb-24 28-Feb-24

–

–

–

0.00%

0.00%

0.00%

Equity Rights

28-Feb-20

14,762

11.86 28-Feb-22 28-Feb-22

Performance 
Rights

28-Feb-20

14,762

3.81 28-Feb-23 28-Feb-23

Equity Rights

28-Feb-19

16,430

12 26-Feb-21 28-Feb-21

16,430 100.00%

28-Feb-19

16,430

5.54 28-Feb-22 28-Feb-22

–

0.00%

28-Feb-19

9,858

12 26-Feb-21 28-Feb-21

9,858 100.00%

10-May-19

9,966

12.73 10-May-22 10-May-22

–

0.00%

Additional 
Equity Rights 
and Transition 
Equity Rights

Performance 
Rights

Performance 
Rights

Transition  
Equity Rights

Deferred Share 
Rights

Performance 
Rights

Deferred Share 
Rights

10-May-18

12,770

5.79 10-May-21 10-May-21

8,914

69.80%

3,856

30.20%

10-May-18

12,772

9.58 10-May-21 10-May-21

12,772 100.00%

–

0.00%

Total of Equity Rights and Deferred Share Rights

Total of Performance Rights

K Fisk (c)

Deferred Shares 26-Feb-21

1,639

9.19 28-Feb-24 28-Feb-24

Deferred Shares 26-Feb-21

Deferred Shares 26-Feb-21

1,637

1,637

9.19 28-Feb-23 28-Feb-23

9.19 26-Feb-22 26-Feb-22

Deferred Shares 28-Feb-20

1,066

11.86 28-Feb-23 28-Feb-23

Deferred Shares 28-Feb-20

Deferred Shares 28-Feb-20

Deferred Shares 28-Feb-19

Deferred Shares 28-Feb-19

1,064

1,064

746

742

11.86 28-Feb-22 28-Feb-22

11.86 26-Feb-21 26-Feb-21

1,064 100.00%

12.00 28-Feb-22 28-Feb-22

–

0.00%

12.00 28-Feb-21 28-Feb-21

742 100.00%

Deferred Shares 10-May-18

1,004

10.86 10-May-21 10-May-21

1,004 100.00%

Total of Deferred Shares

–

–

–

–

–

0.00%

0.00%

0.00%

0.00%

0.00%

–

–

–

–

–

–

–

–

–

0.00%

0.00%

0.00%

0.00%

0.00%

0.00%

0.00%

0.00%

0.00%

–

–

43,494

49,958

1,639

1,637

1,637

1,066

1,064

–

746

–

–

7,789

53

Annual Report 2021Executive 
KMP

Type of equity

Grant
 date

Number
 granted

Fair value
 at grant
 date

Vesting
 date

Expiry
 date

Number 

vested(a,b)

% 
vested

Number 
lapsed

% 
lapsed

Number
Unvested

J Harris

Equity Rights

26-Feb-21

29,833

8.27 28-Feb-23 28-Feb-23

–

0.00%

1-Mar-21

3,514

9.15

1-Mar-21

1-Mar-21

3,514 100.00%

26-Feb-21

29,833

2.56 28-Feb-24 28-Feb-24

–

–

–

0.00%

0.00%

0.00%

Equity Rights

28-Feb-20

23,468

11.86 28-Feb-22 28-Feb-22

Performance 
Rights

28-Feb-20

23,468

3.81 28-Feb-23 28-Feb-23

Equity Rights

28-Feb-19

24,306

12 26-Feb-21 28-Feb-21

24,306 100.00%

28-Feb-19

24,306

5.54 28-Feb-22 28-Feb-22

–

0.00%

28-Feb-19

14,584

12 26-Feb-21 28-Feb-21

14,584 100.00%

10-May-19

14,861

12.73 10-May-22 10-May-22

–

0.00%

10-May-18

19,154

5.79 10-May-21 10-May-21

13,370

69.80%

5,784

30.20%

10-May-18

18,666

9.58 10-May-21 10-May-21

18,666 100.00%

–

0.00%

Total of Equity Rights and Deferred Share Rights

Total of Performance Rights

C Lill (e,f)

Equity Rights

26-Feb-21

19,247

8.27 28-Feb-23 28-Feb-23

–

0.00%

19,247 100.00%

1-Mar-21

1,790

9.15

1-Mar-21

1-Mar-21

1,790 100.00%

–

0.00%

26-Feb-21

19,247

2.56 28-Feb-24 28-Feb-24

0.00%

19,247 100.00%

Equity Rights

28-Feb-20

13,059

11.86 28-Feb-22 28-Feb-22

Performance 
Rights

28-Feb-20

13,059

3.81 28-Feb-23 28-Feb-23

0.00%

–

0.00%

13,059

0.00%

13,059 100.00%

Equity Rights

28-Feb-19

12,379

12 26-Feb-21 28-Feb-21

12,379 100.00%

0.00%

28-Feb-19

12,379

5.54 28-Feb-22 28-Feb-22

–

0.00%

28-Feb-19

7,427

12 26-Feb-21 28-Feb-21

7,427 100.00%

–

–

–

0.00%

12,379

0.00%

–

–

–

10-May-19

8,392

12.73 10-May-22 10-May-22

–

0.00%

8,392 100.00%

10-May-18

9,577

5.79 10-May-21 10-May-21

6,685

69.80%

2,892

30.20%

10-May-18

9,825

9.58 10-May-21 10-May-21

9,825 100.00%

–

0.00%

–

–

–

–

–

–

–

–

–

0.00%

29,833

0.00%

–

0.00%

29,833

0.00%

23,468

0.00%

23,468

0.00%

–

0.00%

24,306

0.00%

–

0.00%

14,861

–

–

68,162

77,607

–

–

–

–

–

–

–

–

–

13,059

12,379

Additional 
Equity Rights 
and Transition 
Equity Rights

Performance 
Rights

Performance 
Rights

Transition  
Equity Rights

Deferred Share 
Rights

Performance 
Rights

Deferred Share 
Rights

Additional 
Equity Rights 
and Transition 
Equity Rights

Performance 
Rights

Performance 
Rights

Transition  
Equity Rights

Deferred Share 
Rights

Performance 
Rights

Deferred Share 
Rights

Total of Equity Rights and Deferred Share Rights

Total of Performance Rights

54

Remuneration ReportFor the year ended 31 December 2021Iress LimitedExecutive 
KMP

Type of equity

Grant
 date

Number
 granted

Fair value
 at grant
 date

Vesting
 date

Expiry
 date

Number 

vested(a,b)

% 
vested

Number 
lapsed

% 
lapsed

Number
Unvested

J McNeill (d) Equity Rights

26-Feb-21

1-Mar-21

19,713

2,536

8.27 28-Feb-23 28-Feb-25

–

0.00%

9.15

1-Mar-21 28-Feb-23

2,536 100.00%

Additional 
Equity Rights 
and Transition 
Equity Rights

Performance 
Rights

Performance 
Rights

Transition  
Equity Rights

Deferred Share 
Rights

Performance 
Rights

Deferred Share 
Rights

Additional 
Equity Rights 
and Transition 
Equity Rights

Performance 
Rights

Performance 
Rights

Transition  
Equity Rights

Deferred Share 
Rights

Performance 
Rights

Deferred Share 
Rights

26-Feb-21

19,713

2.56 28-Feb-24 28-Feb-24

Equity Rights

28-Feb-20

16,553

11.86 28-Feb-22 28-Feb-24

Performance 
Rights

28-Feb-20

16,553

3.81 28-Feb-23 28-Feb-23

Equity Rights

28-Feb-19

28-Feb-19

17,535

17,535

12 26-Feb-21 28-Feb-23

17,535 100.00%

5.54 28-Feb-22 28-Feb-22

–

0.00%

–

–

–

0.00%

0.00%

0.00%

28-Feb-19

10,521

12 26-Feb-21 28-Feb-23

10,521

100.00%

10-May-19

10,567

12.73 10-May-22 10-May-22

–

0.00%

10-May-18

13,682

5.79 10-May-21 10-May-21

9,551

69.81%

4,131

30.19%

10-May-18

13,731

9.58 10-May-21 10-May-21

13,731

100.00%

–

0.00%

Total of Equity Rights and Deferred Share Rights

Total of Performance Rights

S New (d)

Equity Rights

26-Feb-21

28,284

8.27 28-Feb-23 28-Feb-25

–

0.00%

1-Mar-21

3,458

9.15

1-Mar-21

1-Mar-21

3,458 100.00%

26-Feb-21

28,284

2.56 28-Feb-24 28-Feb-24

Equity Rights

28-Feb-20

23,750

11.86 28-Feb-22 28-Feb-24

Performance 
Rights

28-Feb-20

23,750

3.81 28-Feb-23 28-Feb-23

Equity Rights

28-Feb-19

28-Feb-19

23,911

23,911

12 26-Feb-21 28-Feb-23

23,911

100.00%

5.54 28-Feb-22 28-Feb-22

–

0.00%

–

–

–

0.00%

0.00%

0.00%

28-Feb-19

14,347

12 26-Feb-21 28-Feb-21

14,347 100.00%

10-May-19

13,520

12.73 10-May-22 10-May-22

–

0.00%

10-May-18

15,962

5.79 10-May-21 10-May-21

11,142

69.80%

4,820

30.20%

10-May-18

17,164

9.58 10-May-21 10-May-21

17,164 100.00%

–

0.00%

Total of Equity Rights and Deferred Share Rights

Total of Performance Rights

–

–

–

–

–

–

–

–

–

0.00%

19,713

100.00%

–

0.00%

19,713

0.00%

16,553

0.00%

16,553

0.00%

0.00%

–

17,535

0.00%

–

0.00%

10,567

–

–

46,833

53,801

–

–

–

–

–

–

–

–

–

0.00%

28,284

0.00%

–

0.00%

28,284

0.00%

23,750

0.00%

23,750

0.00%

0.00%

–

23,911

0.00%

–

0.00%

13,520

–

–

65,554

75,945

55

Annual Report 2021Executive 
KMP

Type of equity

Grant
 date

Number
 granted

Fair value
 at grant
 date

Vesting
 date

Expiry
 date

Number 

vested(a,b)

% 
vested

Number 
lapsed

% 
lapsed

Number
Unvested

A Todd

Equity Rights

26-Feb-21

30,314

8.27 28-Feb-23 28-Feb-23

–

0.00%

1-Mar-21

3,930

9.15

1-Mar-21

1-Mar-21

3,930 100.00%

–

–

–

–

–

–

–

–

–

0.00%

30,314

0.00%

–

0.00%

30,314

0.00%

23,846

0.00%

23,846

0.00%

0.00%

–

27,183

0.00%

–

0.00%

16,784

–

–

70,944

81,343

26-Feb-21

30,314

2.56 28-Feb-24 28-Feb-24

Equity Rights

28-Feb-20

23,846

11.86 28-Feb-22 28-Feb-22

Performance 
Rights

28-Feb-20

23,846

3.81 28-Feb-23 28-Feb-23

Equity Rights

28-Feb-19

28-Feb-19

27,183

27,183

12 26-Feb-21 28-Feb-21

27,183 100.00%

5.54 28-Feb-22 28-Feb-22

–

0.00%

–

–

–

0.00%

0.00%

0.00%

28-Feb-19

16,310

12 26-Feb-21 28-Feb-21

16,310 100.00%

10-May-19

16,784

12.73 10-May-22 10-May-22

–

0.00%

Additional 
Equity Rights 
and Transition 
Equity Rights

Performance 
Rights

Performance 
Rights

Transition  
Equity Rights

Deferred Share 
Rights

Performance 
Rights

Deferred Share 
Rights

10-May-18

20,067

5.79 10-May-21 10-May-21

14,007

69.80%

6,060

30.20%

10-May-18

21,614

9.58 10-May-21 10-May-21

21,614 100.00%

–

0.00%

Total of Equity Rights and Deferred Share Rights

Total of Performance Rights

(a)  This includes equity instruments held by the individual and in a nominated trust. 

(b)  All Equity Rights, Deferred Share Rights, and Performance Rights that vested during the year were exercisable, except for participants in the UK.

(c)  K Fisk was awarded Deferred Shares (DS) prior to being appointed KMP on 25 October 2021.

(d)  Equity Rights vested for UK participants during the year are not exercisable until the end of the exercise restriction period.

(e)  C Lill and M Blomfield ceased to be KMPs on 25 October 2021.

(f)  C Lill’s 2021 Performance Rights and Equity Rights, 2020 Performance Rights and 2019 executive Deferred Share Rights lapsed on termination of his 

employment on 17 December 2021. 2019 Performance Rights and 2020 Equity Rights remained on foot until the original vesting date. 

(g)  M Blomfield’s 2021 Equity Rights remain on foot. 2021 Performance Rights partially lapsed on termination of employment on 27 October 2021.

The maximum value of the grants yet to vest has been determined as the fair value of awards at the grant date. The minimum value is 
zero as no rights vest if the conditions are not satisfied. The fair value of awards differs from the face value at grant date. The current 
market value of the grants is based on the current share price, which reflects executive exposure to the same risks and rewards 
as shareholders.

6.2  Shareholdings

The number of ordinary shares held in Iress Limited during the financial year by each KMP is set out below. Included for each individual 
are shares held on their behalf by the trustee of the Iress Limited Equity Plans Trust and their personally related parties.

NED
NED have a Minimum Shareholding Requirement to be met either by 31 December 2022, or within three years of their appointment if 
past this date. NED are required to accrue and hold Iress equity equivalent to 100% of the base fee for being a Member of the Board, 
unless otherwise determined by the Board.

56

Remuneration ReportFor the year ended 31 December 2021Iress LimitedNED

A D’Aloisio (b)
R Sharp (a)
N Beattie
J Cameron
M Dwyer
J Fahey
J Hayes (b)
G Tomlinson (b)
T Vonhoff

Total

Balance as at 
1 Jan 2021

52,281
–
11,185
42,426
–
2,584
15,226
8,000
13,879

145,581

Shares 
acquired
 during 
the year

–
10,000
–
–
–
85
–
–
5,300

15,385

Other 
changes

Balance as at 
31 Dec 2021

(52,281)
–
–
–
–
–
(15,226)
(8,000)
–

(75,507)

–
10,000
11,185
42,426
–
2,669
–
–
19,179

85,459

Value of 
holdings 
as a % of 
base fees

n/a
98%
109%
414%
0%
22%
n/a
n/a
157%

(a)  R Sharp was appointed to the Board as NED on 18 February 2021, and as Non-executive Chairman on 7 May 2021. 

(b)  A D’Aloisio, J Hayes and G Tomlinson balances as at 6 May 2021 when they ceased to be NED.

Executives
Executives have a Minimum Shareholding Requirement to be met either by December 2023, or within five years of commencing if past 
this date. The CEO is required to accrue and hold Iress equity equivalent to 400% of base salary. Other executives are required to hold 
225% of their base salary. This requirement only applies to equity granted from 2019 onwards. Unvested Equity Rights and Transition 
Equity Rights count towards the requirement but unvested Performance Rights do not.

Prior remuneration framework awards
(pre 2019) and directly acquired shares

New remuneration framework awards
(2019 and after)

Balance 
as at 1 Jan
 2021

Shares
 acquired
 during
the year (a)

546,521
–
–
34,741
6,582
24,418
–
8,849
13,846
16,242

119,475
–
–
21,686
4,981
32,036
16,510
23,282
29,306
35,627

Other
 changes

(140,000)
–
–
(30,864)
(3,552)
–
(16,510)
(12,710)
(15,453)
(35,000)

Executive KMP

A Walsh
M Blomfield (e)
J Das
P Ferguson
K Fisk (f)
J Harris
C Lill (e,h)
J McNeill
S New (j)
A Todd (i)

Balance 
as at 
31 Dec
 2021 (b)

Balance 
as at 1 Jan
 2021

Equity 
Rights
 granted
 during the

 year (g)

Equity 
Rights 
Lapsed
 during the
 year

Balance
 as at 
31 Dec
 2021 (b)

Value of
 Holding as
 % of base

Value 
of Total 
Holdings as
 % of base

 salary (c)

 salary (d)

525,996
–
–
25,563
8,011
56,454
–
19,421
27,699
16,869

156,394
–
–
41,050
–
62,358
32,865
44,609
62,008
67,339

104,319
28,871
26,465
21,142
–
33,347
21,037
22,249
31,742
34,244

–
–
–
–
–
–
(19,247)
–
–
–

260,713
28,871
26,465
62,192
–
95,705
34,655
66,858
93,750
101,583

335%
n/a
61%
204%
0%
198%
n/a
201%
197%
206%

1001%
n/a
61%
287%
29%
313%
n/a
259%
254%
240%

Total

651,199

282,903 (254,089)

680,013

466,623

323,416

(19,247)

770,792

(a)  Shares acquired by executive KMP during the year were acquired on the exercise of Deferred Share Rights and Performance Rights or directly acquired. 

K Fisk's opening balance and shares acquired during the year are shares awarded under the non-executive share plans. 

(b)  This includes equity instruments held individually and in trusts.

(c)  The value of Equity Rights for the purpose of the Minimum Shareholding Requirement calculation is the higher of the grant price and the share price at 

31 December 2021, in both cases using the twenty-trading-day volume weighted average share price. 

(d)  For equity awarded under pre 2019 remuneration frameworks and directly acquired shares, the share price at 31 December 2021 (twenty-trading-day 

volume-weighted average share price up to and including 31 December 2021) was used to calculate the value.

(e)  C Lill and M Blomfield ceased to be KMPs on 25 October 2021.

(f)  K Fisk was appointed as KMP from 25 October 2021. The opening balance reported above reflects the balance that she had prior to her appointment as KMP.

(g)  This includes 2021 Equity Rights, 2019 Additional Equity Rights and 2019 Additional Transition Equity Rights granted this year.

(h)  C Lill’s 2021 Equity Rights lapsed on termination of employment on 17 December 2021.

(i)  The pre-2019 framework opening balance for A Todd does not match the closing balance in the 2020 Remuneration Report as an additional 16,073 shares are 

reported as a result of an error in the 2020 closing balance.

(j)  The pre-2019 framework opening balance for S New does not match the closing balance in the 2020 Remuneration Report as an additional 3,000 shares are 

reported as a result of an error in the 2020 closing balance.

57

Annual Report 20216.3  Transactions with KMP

No transactions (excluding share-based payment compensation) occurred between KMP and the Group during 2021.

6.4  Loans to KMP or related parties

No loans to KMP or related parties were provided during 2021.

6.5  Employee share plans

The global employee share plans offered to employees globally continued in 2021. Under the 2021 OneIress Equity award, permanent 
employees were invited to acquire Iress shares either by:

•  salary sacrificing up to specified limits with Iress supplementing this with shares up to a value of $300, or

•  receiving free Iress shares or share rights worth $300 with the tax obligations being borne by the participant.

Equity is granted in the form of shares or share rights. In 2021, 973 employees (45% of eligible employees) participated in the plan, 
subscribing to 83,013 shares and 273 share rights.

This Directors’ Report has been verified by Management and reviewed by the Company’s Board of Directors and its Audit and 
Risk Committee. 

Signed in accordance with a resolution of the Directors made pursuant to s.298(2) of the Corporations Act 2001 (Cth).

Roger Sharp 
Chair  

Andrew Walsh 
Managing Director & Chief Executive Officer

Melbourne 
16 February 2022 

58

Remuneration ReportFor the year ended 31 December 2021Iress Limited 
 
 
 
 
 
 
Auditor’s Independence Declaration

Deloitte Touche Tohmatsu 
ABN 74 490 121 060 
477 Collins Street 
Melbourne, VIC, 3000 
Australia 

Phone: +61 3 9671 7000  
www.deloitte.com.au 

16 February 2022 

The Board of Directors 
Iress Limited 
Level 16, 385 Bourke Street 
MELBOURNE  VIC   
3000 

Dear Board Members 

AAuuddiittoorr’’ss  IInnddeeppeennddeennccee  DDeeccllaarraattiioonn  ttoo  IIrreessss  LLiimmiitteedd  

In  accordance  with  section  307C  of  the  Corporations  Act  2001,  I  am  pleased  to  provide  the  following 
declaration of independence to the directors of IRESS Limited. 

As lead audit partner for the audit of the financial statements of Iress Limited for the financial year ended 31 
December 2021, I declare that to the best of my knowledge and belief, there have been no contraventions of: 

(i) 

the auditor independence requirements of the  Corporations Act 2001 in relation to the audit; 
and 

(ii)  any applicable code of professional conduct in relation to the audit.   

Yours faithfully 

DELOITTE TOUCHE TOHMATSU 

Tom Imbesi 
Partner  
Chartered Accountants 

Liability limited by a scheme approved under Professional Standards Legislation. 
Member of Deloitte Asia Pacific Limited and the Deloitte organisation. 

59

Annual Report 2021 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Financial Statements

For the year ended 31 December 2021

This is the financial report for Iress Limited (the ‘Company’) and its controlled entities (collectively referred to as the ‘Group’ or ‘Iress’) for 
the year ended 31 December 2021.

Contents

Consolidated Statement of Profit or Loss and Other Comprehensive Income

Consolidated Statement of Financial Position

Consolidated Statement of Changes in Equity

Consolidated Statement of Cash Flows

Notes to the Consolidated Financial Statements

Section 1. Financial results

1.1 Segment information

1.2 Earnings per share and dividends per share

1.3 Revenue from contracts with customers

1.4 Employee benefit expenses

1.5 Share-based payments

1.6 Other expenses

1.7 Depreciation and amortisation

1.8 Notes to the Consolidated Statement of Cash Flows

Section 2. Core assets and working capital

2.1 Intangible assets

2.2 Plant and equipment

2.3 Leases

2.4 Receivables and other assets

2.5 Payables and other liabilities

2.6 Provisions

2.7 Commitments and contingencies

Section 3. Debt and equity

3.1 Debt facilities and derivatives

3.2 Issued capital

3.3 Managing financial risks

Section 4. Other disclosures

4.1 Taxation

4.2 Businesses & investments acquired & divested

4.3 Change in accounting policy

4.4 Iress Limited – parent entity financial information

4.5 Subsidiaries

4.6 Deed of cross guarantee

4.7 Basis of preparation

4.8 The impact of the COVID-19 pandemic on these financial statements

4.9 Transactions with related parties

4.10 Events subsequent to the Statement of Financial Position date

60

61

62

63

64

65

65

65

67

68

71

72

75

76

76

77

77

80

81

85

88

88

89

90

90

92

93

94

94

97

98

99

100

101

103

106

106

106

Iress LimitedConsolidated Statement of Profit or Loss and 
Other Comprehensive Income

For the year ended 31 December 2021

Revenue from contracts with customers
Customer data fees
Communication and other technology expenses
Employee benefit expenses
Net other expenses

Profit before depreciation, amortisation, interest and income tax expense
Depreciation and amortisation expense (1)

Profit before interest and income tax expense
Interest income
Interest expense

Net interest and financing costs

Profit before income tax expense
Income tax expense (1)

Profit after income tax expense

Other comprehensive income
Items that may be reclassified to profit or loss:
Exchange differences on translation of foreign operations
Tax-related to exchange differences recognised directly in foreign currency translation reserve (2)

Total other comprehensive income/(loss) for the period

Total comprehensive income for the period

Earnings per share
Basic earnings per share

Diluted earnings per share

Notes

1.3(a)

1.4
1.6

1.7

3.1(e)

4.1

2021
$’000

595,945
(52,975)
(65,094)
(302,915)
(26,075)

148,886
(46,978)

101,908
193
(9,235)

(9,042)

92,866
(19,068)

73,798

12,467
(51)

12,416

86,214

2020 (1)
$’000

542,630
(48,024)
(54,654)
(285,250)
(29,213)

125,489
(39,146)

86,343
438
(8,422)

(7,984)

78,359
(19,146)

59,213

(19,150)
(76)

(19,226)

39,987

Cents per 
share

Cents per 
share

1.2(a)

1.2(a)

38.8

38.5

32.4

32.1

The Consolidated Statement of Profit or Loss and Other Comprehensive Income should be read in conjunction with the 
accompanying notes.

(1)  Prior year restatement due to changes in accounting policy following recent IFRIC agenda decisions. Refer to Note 4.3.

(2)  Relates to the tax effect on the exchange differences arising from intercompany monetary items that are treated as part of a net investment in a 

foreign operation. Under AASB121 – The Effects of Changes in Foreign Exchange Rates, the foreign exchange gains or losses on these monetary items are 
recognised directly in other comprehensive income rather than the profit or loss.

61

Annual Report 2021Consolidated Statement of Financial Position

As at 31 December 2021

ASSETS
Current assets
Cash and cash equivalents
Receivables and other assets
Current taxation receivables
Derivative assets

Total current assets

Non-current assets
Intangible assets (1)
Plant and equipment
Right-of-use assets
Deferred tax assets

Total non-current assets

Total assets

LIABILITIES
Current liabilities
Payables and other liabilities
Lease liabilities
Provisions
Current taxation payables

Total current liabilities

Non-current liabilities
Lease liabilities
Provisions
Borrowings
Deferred tax liabilities (1)

Total non-current liabilities

Total liabilities

Net assets

EQUITY
Issued capital
Share-based payments reserve
Foreign currency translation reserve
Retained earnings/(accumulated losses) (1)

Total equity

Notes

2021
$’000

2020 (1)
$’000

1.8(a)
2.4(a)

3.1(c)

2.1(a)
2.2(a)
2.3(c)
4.1(c)

2.5
2.3(d)
2.6(a)

2.3(d)
2.6(a)
3.1(a)
4.1(c)

3.2

64,393
74,401
9,831
–

63,141
66,113
2,845
1,739

148,625

133,838

742,615
32,068
77,737
31,580

884,000

730,232
32,740
75,307
34,335

872,614

1,032,625

1,006,452

77,508
15,384
15,346
605

83,943
13,383
5,914
544

108,843

103,784

77,470
2,950
296,530
9,919

386,869

495,712

536,913

493,883
26,178
7,323
9,529

536,913

71,125
43,517
188,433
12,795

315,870

419,654

586,798

558,416
35,020
(5,093)
(1,545)

586,798

The Consolidated Statement of Financial Position should be read in conjunction with the accompanying notes.

(1)  Prior year restatement due to changes in accounting policy following recent IFRIC agenda decisions and update of Onevue’s provisional acquisition 

accounting. Refer to Note 4.2 and Note 4.3.

62

Iress LimitedConsolidated Statement of Changes in Equity

For the year ended 31 December 2021

Balance at 1 January 2020
Impact of change in accounting policy (2)

Adjusted balance at 1 January 2020

Profit for the year
Other comprehensive loss

Total comprehensive (loss)/income

Transactions with owners in their capacity as owners:
Shares issued during the year (3)(6)
Share issue costs, net of tax (7)
Dividends declared (4)
Share-based payment expense, net of tax (8)
Transfer of share-based payments reserve (5)

Balance at 31 December 2020

Issued
Capital (1)
$’000

Share-based
Payments
 Reserve
$’000

Foreign
 Currency
 Translation
 Reserve
$’000

(Retained
 Earnings/
(Accumulated
 Losses)
$’000

383,083
–

383,083

–
–

–

175,604
(2,933)
2,662
–
–

175,333

558,416

30,990
–

30,990

–
–

–

–
–
–
21,177
(17,147)

4,030

14,133
–

14,133

–
(19,226)

(19,226)

–
–
–
–
–

–

35,020

(5,093)

6,700
(1,211)

5,489

59,213
–

59,213

–
–
(83,394)
–
17,147

(66,247)

(1,545)

Issued
Capital (1)
$’000

Share-based
Payments
 Reserve
$’000

Foreign
 Currency
 Translation
 Reserve
$’000

(Retained
 Earnings/
(Accumulated
 Losses)
$’000

Balance at 1 January 2021
Profit for the year
Other comprehensive income

Total comprehensive income

Transactions with owners in their capacity as owners:
Shares issued during the year (3)
Purchase of shares for employee share schemes (7)
On-market buy-back of shares (7)
Dividends declared (4)
Share-based payment expense, net of tax (8)
Transfer of share-based payments reserve (5)

Balance at 31 December 2021

558,416
–
–

–

445
(20,387)
(47,781)
3,190
–
–

(64,533)

493,883

35,020
–
–

–

–
–
–
–
17,420
(26,262)

(8,842)

26,178

(5,093)
–
12,416

12,416

–
–
–
–
–
–

–

(1,545)
73,798
–

73,798

–
–
–
(88,986)
–
26,262

Total
Equity
$’000

434,906
(1,211)

433,695

59,213
(19,226)

39,987

175,604
(2,933)
(80,732)
21,177
–

113,116

586,798

Total
Equity
$’000

586,798
73,798
12,416

86,214

445
(20,387)
(47,781)
(85,796)
17,420
–

(62,724)

(136,099)

7,323

9,529

536,913

The Consolidated Statement of Changes in Equity should be read in conjunction with the accompanying notes.

(1)  For details of shares issued during the period please refer to Note 3.2.

(2)  Prior year restatement due to changes in accounting policy following recent IFRIC agenda decisions. Refer to Note 4.3.

(3)  Shares issued to satisfy Employee Share Plan obligations. Refer to Note 3.2.

(4)  Shares issued under the Dividend Reinvestment Plan. Refer to Note 3.2. For dividends declared refer to Note 1.2(c).

(5)  The movement from share-based payment reserves to retained earnings represents the grant date fair value of share-based payments that have vested 

or lapsed during the year. The amount had previously been recognised as a share-based payment expense over the vesting period. Details of share-based 
payment arrangements are provided in Note 1.5.

(6)  Shares issued during 2020 from a share placement and share purchase plan. Refer to Note 3.2.

(7)  Shares purchased on market during the year including capitalised share issue costs incurred during the year. Refer to Note 3.2 for more details.

(8)  The share-based payment expense on the vesting of employee share-based payments had no tax impact (2020: $0.157 million).

63

Annual Report 2021Consolidated Statement of Cash Flows

For the year ended 31 December 2021

Cash flows from operating activities
Cash generated from operating activities
Interest received
Interest and borrowing costs paid
Interest on lease liabilities
Income tax paid (1)

Net cash inflow generated from operating activities

Cash flows from investing activities
Payments for development of intangible assets
Payments for purchase of plant and equipment
Proceeds from sale of plant and equipment
Payment for deferred consideration (2)
Payments for acquisition of subsidiaries & businesses, net of cash acquired

Net cash outflow utilised by investing activities

Cash flows from financing activities
Proceed from issue of share capital
Purchase of shares for employee share schemes
On-market buy-back of shares, net of tax
Share purchase/issue costs paid
Proceeds from employee share plan repayments
Payment of lease liabilities (3)
Repayment of borrowings within acquired entities
Dividends paid
Proceeds from borrowings
Repayment of borrowings

Net cash (outflow utilised by)/inflow generated from financing activities

Net increase in cash and cash equivalents

Cash and cash equivalents at the beginning of the financial year
Effects of exchange rate changes on cash and cash equivalents

Cash and cash equivalents at end of the year

Notes

1.8(b)

2.3(a)

2.1(a)
2.2(a)

2.6(b)

3.2
3.2
3.2
3.2
2.3(d)

3.1(b)
3.1(b)

2021
$’000

2020
$’000

135,807
253
(6,349)
(2,461)
(26,040)

101,210

(13,476)
(10,654)
6
(10,432)
–

165,565
438
(7,314)
(2,227)
(31,588)

124,874

(6,465)
(17,046)
43
(1,620)
(114,208)

(34,556)

(139,296)

–
(20,336)
(47,805)
(51)
445
(14,437)
–
(85,717)
349,739
(246,226)

(64,388)

2,266

63,141
(1,014)

64,393

175,000
–
–
(4,108)
604
(10,334)
(6,482)
(80,722)
142,039
(172,239)

43,758

29,336

33,386
419

63,141

The Consolidated Statement of Cash Flows should be read in conjunction with the accompanying notes.

(1)  The decrease in income tax paid during the current period compared to the corresponding prior period is as a result of changes in the timing of income tax 

instalment payments primarily in the UK and Australia.

(2)  Deferred consideration paid in the current and previous year are in relation to the 2019 acquisition of QuantHouse. Refer to Note 2.6 for more details.

(3)  Increase in the payment of lease liabilities during the current period principally relates to leases acquired through the acquisition of OneVue in November 2020.

64

Iress LimitedNotes to the Consolidated Financial Statements

For the year ended 31 December 2021

Section 1. Financial results

1.1  Segment information
Iress has a global presence. The Managing Director and Chief Executive Officer (Iress’ Chief Operating Decision Maker) receives internal 
reporting split by the segments listed below.

Any transactions directly between segments are charged on an arm’s length basis.

Iress segments comprise:

(a)  Client segments
Client segment financial performance is measured in terms of revenue and direct contribution (defined as revenue less the direct costs 
of the customer-facing teams that oversee this revenue generation). The Group’s client segments are:

APAC
Consists of:

•  the Trading & Market Data business which provides market data, trading, compliance, order management, portfolio systems and 

related tools to financial markets participants in Australia, New Zealand and Asia

•  the Financial Advice & Superannuation business which provides financial planning systems and related tools to wealth management 

professionals located in Australia and New Zealand, and fund administration software to the superannuation and wealth management 
industries

•  the operations of OneVue which provides administration platforms for managed funds, superannuation and investments.

UK & Europe
Incorporates the financial markets business which provides information, trading, compliance, order management, portfolio systems 
and related tools to cash equity participants; and the wealth management business which provides financial planning systems and 
related tools to wealth management professionals located in the United Kingdom. In addition, market data services are provided to 
customers throughout the UK and Europe.

Mortgages
The Mortgages segment operates in the United Kingdom to provide mortgage origination software and associated consulting services 
to banks.

South Africa
Provides information, trading, compliance, order management, portfolio systems and related tools to financial markets participants 
and provides financial planning systems and related tools to wealth management professionals located in South Africa.

North America
Provides information, trading, compliance, order management, portfolio systems and related tools to financial markets and wealth 
management participants in Canada. In addition, market data services are provided to customers in the United States of America.

(b)  Cost segments
Product & Technology
All costs associated with product and technology will be reported under this segment giving a clear view of the quantum of investment 
made by Iress in maintaining and enhancing its products.

Operations
Includes costs to run client-facing and corporate operations activity, including hosting and networks, information security, client help 
desks and property infrastructure.

Corporate
All other corporate functions include legal, finance and administration, human resources, communications and marketing, board of 
directors and Chief Executive Officer.

65

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

1.1  Segment information (continued)
(b) Cost segments (continued)
The revenue, segment profit and reconciliation to the Group results are shown below:

Operating revenue (1)

Direct contribution

Client segments

Cost segments

APAC
UK & Europe
Mortgages
South Africa
North America

Total group

Product & Technology
Operations
Corporate

Total indirect costs

Group results

Group segment profit

Share-based payment expense

Segment profit after share-based payment expense

Other non-operating income and expenses (2)

Profit before depreciation, amortisation, interest 
and income tax expense

Depreciation and amortisation (3)

Profit before interest and income tax expense

Net interest and financing costs
Income tax expense (3)

Net profit after income tax expense

2021
$’000

335,346
156,157
29,477
43,450
31,515

595,945

2020
$’000

289,843
154,590
26,925
42,931
28,341

542,630

2021
$’000

239,049
98,029
21,095
33,793
14,522

406,488

(135,048)
(60,031)
(45,177)

2020(1)
$’000

203,977
94,363
18,102
33,928
11,009

361,379

(128,407)
(42,619)
(37,435)

(240,256)

(208,461)

166,232

(17,419)

148,813

73

148,886

(46,978)

101,908

(9,042)
(19,068)

73,798

152,918

(21,020)

131,898

(6,409)

125,489

(39,146)

86,343

(7,984)
(19,146)

59,213

(1)  Operating revenue is recognised over time in accordance with AASB 15 Revenue from Contracts with Customers.

(2)  Predominately relates to non-operating income, business acquisition and integration expenses, revaluation of financial liabilities relating to deferred 

contingent consideration, lease related impairment and expense provisioning and realised and unrealised foreign exchange gains and losses. Refer to Note 1.6.

(3)  Prior year restatement due to changes in accounting policy following recent IFRIC agenda decisions. Refer to Note 4.3.

The below table outlines operating revenue and non-current assets by geographical area, being Australia & New Zealand, Asia, UK & 
Europe, South Africa and North America:

Australia & New Zealand
Asia

Total APAC

UK & Europe
South Africa
North America

Grand total

Operating revenue

Non-current assets (1)

2021
$’000

323,785
11,561

335,346

185,634
43,450
31,515

595,945

2020
$’000

279,976
9,867

289,843

181,515
42,931
28,341

542,630

2021
$’000

261,567
636

262,203

488,324
14,435
9,721

774,683

2020
$’000

262,259
777

263,036

475,559
15,022
9,355

762,972

(1)  Excludes right-of-use assets, financial instruments and deferred taxes, and predominantly relates to intangible assets. Refer to Note 2.1.

66

Iress Limited1.2  Earnings per share and dividends per share
(a)  Basic and diluted earnings per share, and dividends per share, for the year are:

Earnings per share
Diluted earnings per share
Dividends per share:
Interim dividend franked to 80% (2020: 35%)

Final dividend declared after the Statement of Financial Position date franked to 15% (2020: 40%)

(b)  The weighted average number of shares used to calculate earnings per share is as follows:

Weighted average number of ordinary shares used in basic earnings per share
Effect of potentially dilutive shares

Weighted average number of ordinary shares used in diluted earnings per share

Cents per 
share
2021

Cents per 
share
2020 (1)

38.8
38.5

16.0

30.0

32.4
32.1

16.0

30.0

Number of
 shares
2021
‘000

190,355
1,120

191,475

Number of
 shares
2020
‘000

182,995
1,411

184,406

(c)  Dividends recognised during the year and after the Statement of Financial Position date were as follows:

Dividends paid during the year
Final dividend for 2020 30.0 cents per share franked to 40% (2019: 30.0 cents per share franked to 40%)
Interim dividend for 2021 16.0 cents per share franked to 80% (2020: 16.0 cents per share franked to 35%)

Dividends declared after balance date
Since the end of the year, the Directors declared a final dividend of 30.0 cents per share franked to 15% 
(2020: 30.0 cents per share franked to 40%)
Franking credit balance

2021
$’000

57,998
30,988

88,986

2020
$’000

52,477
30,917

83,394

56,889

57,998

Franking credits available for subsequent reporting periods based on a tax rate of 30% (2020: 30%)

424

7,921

67

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

1.3  Revenue from contracts with customers
Iress designs, develops, and delivers technology solutions for the financial services industry in Australia, Asia, New Zealand, 
UK & Europe, South Africa and North America.

From these activities, Iress generates the following streams of revenue:

•  Software licence revenue.

•  Implementation and consulting revenue.

•  Royalties revenue from the provision of financial market information.

•  Other ancillary fees such as hosting and support service fees.

Each of the above services delivered to customers are considered separate performance obligations, even though for practical 
expedience they may be governed by a single legal contract with the customer.

Revenue recognition for each of the above revenue streams is as follows:

Revenue stream

Performance obligation

Timing of recognition

Software licence revenue Access to software.

Software licence revenue is recognised over time as the customer simultaneously 
receives and consumes the benefit of accessing the software.

Revenue is calculated based on the number of licences used and rate per licence, or as 
a negotiated package for large customers. Changes in these factors over time may 
impact the revenue recognised over the life of the contract.

Software licence revenue is recognised as the amount to which the Group has 
a right to invoice.

Customers are typically invoiced monthly and consideration is payable when 
invoiced, which corresponds directly with the performance completed to date in 
respect of this stream.

Implementation and 
consulting revenue

As defined in the contract.

Revenue is recognised over time as services are delivered.

For implementation 
revenue – typically 
the completion of 
data conversions, 
completion of user 
acceptance testing, 
provision of functional 
environments.

Revenue from providing services is recognised in the accounting period in which 
the services are rendered.

Revenue is calculated based on time and materials used.

For fixed-price contracts, revenue is recognised based on the actual service 
provided to the end of the reporting period.

Recognition is determined based on the actual labour hours spent as a proportion of 
total expected hours. This requires a judgement of the forecast expected hours and 
changes in implementation timing.

If contracts include the installation of hardware, revenue for the hardware is 
recognised at a point in time when the hardware is delivered, the legal title has 
passed, and the customer has accepted the hardware. 

Royalties revenue

Provision of financial 
market information.

Royalties revenue is recognised over time as the customer simultaneously receives 
and consumes the benefit of accessing the information.

Royalties revenue is recognised as the amount to which the Group has the 
right to invoice.

Customers are typically invoiced monthly and consideration is payable when 
invoiced, which corresponds directly with the performance completed to date 
in respect of this stream.

Over time, depending on circumstances.

Other ancillary fees

Provision of hosting 
services, cloud 
services, support and 
maintenance services.

Some contracts include multiple deliverables, such as implementation services and software licences.

Because the implementation services do not include client-specific material software customisation, and could be performed by 
another party, the implementation service and software licences are accounted for as separate performance obligations. In these 
cases, the transaction prices are allocated to each performance obligation based on the stand-alone selling prices. Where these are 
not directly observable, they are estimated based on expected cost plus a margin.

68

Iress LimitedIn fixed-price contracts, the customer pays the fixed amount based on an agreed payment schedule. If the services rendered by 
the Group exceed the payment, a contract asset is recognised. If the payments exceed the services rendered, a contract liability 
is recognised.

If the contract includes an hourly fee, revenue is recognised at the amount to which the Group has the right to invoice (i.e. based 
on hours actually incurred in providing the service to the client). Customers are invoiced monthly and consideration is payable 
when invoiced.

(a)  Revenue by client segment is summarised below:

Revenue stream

For the year ended 31 December 2020
Software licence revenue
Implementation and consulting revenue
Royalties revenue
Other ancillary fees

Revenue
 recognition

APAC
$’000

UK & 
Europe
$’000

Mortgages
$’000

South 
Africa
$’000

North
 America
$’000

Over time
Over time
Over time
Over time

238,552
14,651
25,178
11,462

129,499
2,317
8,439
14,335

11,773
14,568
–
584

39,817
54
1,696
1,364

42,931

23,074
–
3,254
2,013

Total
$’000

442,715
31,590
38,567
29,758

Total revenue

289,843

154,590

26,925

28,341

542,630

Revenue stream

Revenue
 recognition

APAC
$’000

UK & 
Europe
$’000

Mortgages
$’000

South 
Africa
$’000

North 
America
$’000

For the year ended 31 December 2021
Software licence revenue
Implementation and consulting revenue
Royalties revenue
Other ancillary fees

Over time
Over time
Over time
Over time

Total revenue

285,910
9,739
27,749
11,948

335,346

130,209
1,777
9,457
14,714

156,157

17,121
12,224
–
132

29,477

40,133
95
1,745
1,477

43,450

23,898
–
3,969
3,648

31,515

Total
$’000

497,271
23,835
42,920
31,919

595,945

(b)   Receivables, contract assets, and contract liabilities from contracts with customers by client segment are 

summarised below:

UK & 
Europe
$’000

Mortgages
$’000

South 
Africa
$’000

North
 America
$’000

Total
$’000

For the year ended 31 December 2020
Trade receivables
Contract assets

Contract liabilities

For the year ended 31 December 2021
Trade receivables
Contract assets

Contract liabilities

APAC
$’000

18,445
6,789

9,364
5,827

(787)

(11,584)

APAC
$’000

18,152
7,478

(1,319)

UK & 
Europe
$’000

12,232
3,943

(13,192)

557
3,432

(797)

1,597
349

–

758
–

(245)

30,721
16,397

(13,413)

Mortgages
$’000

South 
Africa
$’000

North
 America
$’000

Total
$’000

557
1,862

(1,424)

1,773
404

(35)

837
–

(534)

33,551
13,687

(16,504)

69

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

1.3  Revenue from contracts with customers (continued)
(c)  Revenue recognised in relation to contract assets and liabilities
The following table shows the revenue recognised in the current reporting period in relation to the contract assets and 
contract liabilities:

Balance at the beginning of the year
Transfer from contract assets to receivables
Revenue raised for work performed but not yet billed
Decrease due to revenue recognised from performance obligations satisfied
Increase due to cash received, excluding amount recognised during the year
Foreign currency translation

Balance at the end of the year

Contract assets

Contract liabilities

2021
$’000

16,397
(16,691)
13,595
–
–
386

13,687

2020
$’000

17,223
(17,154)
15,891
–
–
437

2021
$’000

(13,413)
–
–
13,382
(16,471)
(2)

2020
$’000

(12,083)
–
–
12,340
(13,902)
232

16,397

(16,504)

(13,413)

(d)  Transaction price allocated to the remaining performance obligations
The following table includes the revenue on existing contracts expected to be recognised in the future which relates to performance 
obligations that are unsatisfied (or partially satisfied) at the reporting date:

Year in which 
transaction 
price is 
expected to  
be realised

2022

Revenue stream

Revenue
 recognition

Software licence revenue
Implementation and 
consulting revenue
Other ancillary fees

Over time
Over time

Over time

Total revenue

2023

Software licence revenue
Other ancillary fees

Over time
Over time

Total revenue

2024

Software licence revenue

Over time

Total revenue

2025

Software licence revenue

Over time

Total revenue

Total

Software licence revenue

Over time

Over time

Implementation and 
consulting revenue
Other ancillary fees

Total revenue

UK & 
Europe
$’000

Mortgages
$’000

South 
Africa
$’000

North
America
$’000

APAC
$’000

1,098
307

–

1,405

–
–

–

–

–

–

–

1,098

307

2,700
855

–

3,555

2,856
–

2,856

750

750

148

148

6,454

855

1,394
3,766

–

5,160

–
–

–

–

–

–

–

1,394

3,766

34
–

–

34

–
–

–

–

–

–

–

34

–

–

34

–
–

420

420

–
110

110

–

–

–

–

–

–

530

530

Total
$’000

5,226
4,928

420

10,574

2,856
110

2,966

750

750

148

148

8,980

4,928

530

14,438

Over time

–

–

–

1,405

7,309

5,160

The Group applies the practical expedient in the revenue standard and does not disclose information about the remaining performance 
obligation on contracts that have an original expected duration of one year or less or where the Group has the right to consideration 
from a customer in an amount that corresponds directly with the value to the customer of the Group’s performance to date.

The table above, therefore, does not include revenue expected to be recognised in future years on software licences, royalties and 
other ongoing contracts where the Group will recognise revenue in the amount to which the entity has a right to invoice.

70

Iress Limited1.4  Employee benefit expenses
Short-term employee benefits, mainly comprising base salary and annual leave costs are expensed as the employee renders services.

Post-employment benefits which comprise Iress’ contribution to defined contribution retirement plans are expensed as the service is 
received from the employee.

Termination benefits are amounts paid to employees when their employment is terminated. These are expensed when Iress can no 
longer withdraw the offer of the termination benefit.

Short-term and other employee benefits
Post-employment benefits
Termination benefits
Share-based payment expense
Employee administration expense

Notes

1.5(c)

2021
$’000

(259,179)
(21,959)
(925)
(17,419)
(3,433)

2020
$’000

(237,930)
(19,189)
(484)
(21,020)
(6,627)

(302,915)

(285,250)

Key Management Personnel
Executive and Non-Executive Director Key Management Personnel compensation included in total employee benefits for the year is set 
out below:

Short-term and other employee benefits
Long-term employee benefits
Post-employment benefits
Share-based payment expense

2021
$’000

(6,121)
(20)
(359)
(4,105)

2020
$’000

(5,637)
(69)
(309)
(5,205)

(10,605)

(11,220)

Detailed remuneration disclosures are provided in the Audited Remuneration Report including a description of the executive 
remuneration framework.

71

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

1.5  Share-based payments
The grant date fair value of equity settled share-based payment awards granted to employees is recognised as an expense, with a 
corresponding increase in equity, over the vesting period of the awards. The amount recognised as an expense is adjusted to reflect the 
number of awards for which the related service and non-market performance conditions are expected to meet. Therefore, the amount 
ultimately recognised is based on the number of awards that meet the related service and non-market performance conditions at the 
vesting date.

(a)  Details of share plans
To assist in the attraction, retention and motivation of employees, the Group operated the following share-based payment plans up to 
the end of 2021: 

Plan

Key terms

Performance 
condition

Performance/ 
restriction period

Dividends received 
before vesting

If participant leaves 
before end of 
performance period

Executive Equity 
Rights – From 2019

Eligible participants 
receive equity rights at 
no cost.

Executive Transition 
Equity Rights – 
In 2019

Eligible participants 
receive equity rights at 
no cost.

Individual 
performance 
criteria

Individual 
performance 
criteria

2 year vesting 
followed by 2 year 
holding lock

No but dividend 
equivalent “top-up” 
on vesting

Generally forfeited 
(Board discretion 
may apply)

2 year vesting 
followed by 2 year 
holding lock

No but dividend 
equivalent “top-up” 
on vesting

Generally forfeited 
(Board discretion 
may apply)

Executive PR Plan – 
CEO – From 2019

Executive PR Plan 
– From 2019

Executive PR Plan – 
CEO – Prior to 2019

Executive PR Plan – 
Prior to 2019

Employee Deferred 
Share Plan – 
From 2019

Employee Deferred 
Share Plan – 
Prior to 2019

Employee Deferred 
Share Rights Plan – 
From 2019

Employee Deferred 
Share Rights Plan – 
Prior to 2019

OneIress Equity 
award/UK Share 
Incentive Plan

CEO receives 
performance rights at 
no cost.

Eligible participants 
receive performance 
rights at no cost.

CEO receives 
performance rights at 
no cost.

Eligible participants 
receive performance 
rights at no cost.

Eligible participants 
receive deferred shares 
at no cost. 

Eligible participants 
receive deferred shares 
at no cost. 

Eligible participants 
receive deferred rights 
at no cost. 

Eligible participants 
receive deferred rights 
at no cost. 

Eligible participants are 
invited to acquire Iress 
shares, Iress matches 
this participation to a 
set value. 

3 years

Absolute total 
shareholder return 
(ATSR) against 
hurdles

Total shareholder 
return (TSR) 
against peer group

3 years and

4 years

3 years

Individual 
performance 
criteria

3 years (vesting 
in equal portions 
annually)

3 years

3 years (vesting 
in equal portions 
annually)

3 years

Nil

3 years

No

No

No

No

Yes

Yes

Yes

No

Yes

Generally forfeited 
(Board discretion 
may apply)

Generally forfeited 
(Board discretion 
may apply)

Generally forfeited 
(Board discretion 
may apply)

Generally forfeited 
(Board discretion 
may apply)

Matched shares are 
forfeited under the UK 
Share Incentive Plan 
and released under 
the General Employee 
Share Plan and 
Oneiress Equity Plan

The 2021 Remuneration Report provides details of changes to CEO and Executive share-based payment plans from 2022 onwards.

As at 31 December 2021, the total unvested shares in the OneIress Equity award were 107,205 (2020: 106,225) and 281 unvested share 
rights (2020: 29).

72

Iress Limited(b)  Grant date fair value
The grant date fair value of the employee deferred share plans reflects the market price of shares on the grant date given that the 
awards provide dividends to recipients of grants throughout the vesting period.

The grant date fair value of Executive Plans are independently determined using a Monte Carlo simulation option pricing model using 
standard option pricing inputs such as the underlying share price, exercise price, expected dividends, expected risk free rates and 
expected share price volatility. Key inputs include:

Grant date fair value

Key inputs in determining grant date fair value

Model used
Risk free rate
Share price volatility

Dividend yield

Executive
Performance Rights

Monte Carlo
0.27% – 0.34%
25.00%

5.25%

Executive
Equity Rights

Monte Carlo
0.07% – 0.09%
25.00%

0.00%

As the vesting conditions of the Employee Deferred Share Plan grants are not linked to company performance and participants receive 
dividends during the vesting period, the grant date fair value approximates the share price at the date of grant.

(c)  Details of shares or rights on issue during the year and the amount expensed during the year is shown below:

Number of shares

At grant date

Expenses

Type

Grant date

Vesting date

At 
1 Jan
 2021 Granted Forfeited Vested

At 
31 Dec
 2021

Share
 price
$

Executive Plans – CEO
11 May 2017
2017 Grant – 3 year
11 May 2017
2017 Grant – 4 year
10 May 2018
2018 Grant – 3 year
10 May 2018
2018 Grant – 4 year
2018 Grant
10 May 2018
2019 Grant – DSR pre 19 09 May 2019
09 May 2019
2019 Grant – ER
09 May 2019
2019 Grant – PR
08 May 2020
2020 Grant – ER
08 May 2020
2020 Grant – PR
07 May 2021
2021 Grant – ER
07 May 2021
2021 Grant – PR

11 May 2021
11 May 2021
10 May 2022
10 May 2022
10 May 2021
09 May 2022
26 Feb 2021
28 Feb 2022
28 Feb 2022
28 Feb 2023
28 Feb 2023
28 Feb 2024

–
54,739
–
54,739
–
45,605
–
45,605
–
51,707
–
42,736
–
80,020
–
80,020
–
76,374
–
80,916
–
97,089
– 102,863

(25,179)
(16,531)
–
–
–
–
–
–
–
–
–
–

–
(29,560)
–
(38,208)
45,605
–
45,605
–
–
(51,707)
42,736
–
–
(80,020)
80,020
–
76,374
–
80,916
–
–
97,089
– 102,863

12.39
12.39
10.86
10.86
10.86
14.22
14.22
14.22
10.92
10.92
10.01
10.01

Fair
value
$

6.64
7.05
5.75
5.78
9.58
12.73
14.22
8.60
11.86
2.61
9.01
3.19

2021
$’000

(33)
(35)
(66)
(66)
(59)
(181)
(98)
(245)
(500)
(75)
(314)
(76)

612,461

199,952

(41,710) (199,495) 571,208

(1,748)

73

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

1.5  Share-based payments (continued)
(b) Grant date fair value (continued) 

Type

Grant date

Vesting date

Executive Plans – Non-CEO
2018 Grant
10 May 2018
2019 Grant – DSR pre 19 09 May 2019
2019 Grant – ER & TER 28 Feb 2019
28 Feb 2019
2019 Grant – PR
28 Feb 2020
2020 Grant – ER
28 Feb 2020
2020 Grant – PR
26 Feb 2021
2021 Grant – ER
26 Feb 2021
2021 Grant – PR

10 May 2021
09 May 2022
26 Feb 2021
28 Feb 2022
28 Feb 2022
28 Feb 2023
28 Feb 2023
28 Feb 2024

Employee Deferred Share Plan
2018 Grant (1)
2019 Grant – EAG – B
2019 Grant – EAG – C
2020 Grant – EAG – A
2020 Grant – EAG – B
2020 Grant – EAG – C
2021 Grant – EAG – A
2021 Grant – EAG – B
2021 Grant – EAG – C

10 May 2018
28 Feb 2019
28 Feb 2019
28 Feb 2020
28 Feb 2020
28 Feb 2020
26 Feb 2021
26 Feb 2021
26 Feb 2021

Employee Deferred Share Rights Plan
10 May 2018
2018 Grant
28 Feb 2019
2019 Grant – EAG – B
28 Feb 2019
2019 Grant – EAG – C
28 Feb 2020
2020 Grant – EAG – A
28 Feb 2020
2020 Grant – EAG – B
28 Feb 2020
2020 Grant – EAG – C
26 Feb 2021
2021 Grant – EAG – A
26 Feb 2021
2021 Grant – EAG – B
26 Feb 2021
2021 Grant – EAG – C

Total

10 May 2021
26 Feb 2021
28 Feb 2022
26 Feb 2021
28 Feb 2022
28 Feb 2023
28 Feb 2022
28 Feb 2023
28 Feb 2024

10 May 2021
26 Feb 2021
28 Feb 2022
26 Feb 2021
28 Feb 2022
28 Feb 2023
28 Feb 2022
28 Feb 2023
28 Feb 2024

Number of shares

At grant date

Expenses

At 
1 Jan
 2021 Granted Forfeited Vested

At 
31 Dec
 2021

Share
 price
$

170,470
133,502
372,509
240,289
220,643
220,643

–
–
–
(45,431)
–
(39,152)
–
(52,211)
–
– 300,498
(37,589)
– 300,498 (58,550)

–
(51,476) (118,994)
108,637
–
(24,865)
–
– (372,509)
194,858
–
181,491
–
–
168,432
– 262,909
– 241,948

1,358,056 600,996 (309,274) (491,503) 1,158,275

(10,837) (741,884)
(1,515) (268,242)

(122) (350,503)

752,721
269,757
271,062
350,625
350,625
351,455

(31,216)

–
–
–
–
(36,639)
–
(37,785)
–
– 525,290 (53,452)
– 525,290 (53,960)
(54,225)
– 526,323

–
–
(1,492) 238,354
–
(1,561) 312,425
(1,045) 312,625
– 471,838
– 471,330
– 472,098

2,346,245 1,576,903

(279,751) (1,364,727) 2,278,670

202,015
10,814
10,869
12,619
12,619
12,653
–
–
–

–
–
–
–
770
773
20,801
20,801
20,851

– (202,015)
(10,814)
–
–
(559)
(12,619)
–
–
(1,729)
–
(1,733)
–
(2,008)
–
(2,008)
–
(2,016)

–
–
10,310
–
11,660
11,693
18,793
18,793
18,835

261,589

63,996

(10,053)

(225,448)

90,084

4,578,351 2,441,847

(640,788) (2,281,173) 4,098,237

10.86
14.22
12.00
12.00
11.86
11.86
9.19
9.19

10.86
12.00
12.00
11.86
11.86
11.86
9.19
9.19
9.19

10.86
12.00
12.00
11.86
11.86
11.86
9.19
9.19
9.19

Fair
value
$

5.79
12.73
12.00
5.54
11.86
3.81
8.27
2.56

10.86
12.00
12.00
11.86
11.86
11.86
9.19
9.19
9.19

9.58
12.00
12.00
11.86
11.86
11.86
9.19
9.19
9.19

2021
$’000

(117)
(287)
(355)
(172)
(880)
(158)
(915)
(174)

(3,058)

(852)
(235)
(730)
(650)
(1,678)
(1,118)
(3,639)
(1,823)
(1,218)

(11,943)

(227)
(10)
(37)
(23)
(64)
(43)
(145)
(72)
(49)

(670)

(17,419)

(1)  The weighted average remaining contractual life of the above grants is 0.9 years (2020: 1.4 years).

74

Iress Limited1.6  Other expenses
(a)  Included in other operating and other non‑operating expenses are the following items:

Other operating income/(expenses)
Fees to auditors (1)
Irrecoverable trade debtors written off
Credit loss allowances released to the profit and loss
Rental expense relating to short-term or low-value leases
Other operating expenses (2)

Other non-operating income/(expenses)
Realised/unrealised (losses) on foreign balances
Non-operating income
Business acquisition, integration and restructuring expenses
Defence advisory expenses
Remeasurement of deferred acquisition consideration (3)
(Recognition)/release of onerous contracts
(Recognition)/release of severance pay provision
Impairment of right-of-use assets
Other non-operating expenses (4)

Net other expenses

Notes

1.6(b)

2.6(b)

2.6(b)
2.3(c)

2021
$’000

(1,582)
(369)
494
(158)
(24,533)

2020
$’000

(895)
(637)
50
(170)
(21,152)

(26,148)

(22,804)

(138)
889
(9,857)
(4,013)
22,290
(2,108)
(52)
(3,889)
(3,049)

73

(26,075)

(1,041)
1,281
(10,012)
–
5,128
128
23
–
(1,916)

(6,409)

(29,213)

(1)  Increase in audit fees primarily relates to ordinary course of business internal control audits relating to OneVue’s client services. 

(2)  Includes office related expenses, insurance premiums, professional and legal fees and marketing expenses.

(3)  The remeasurement Includes the net release of provisions in relation to QuantHouse deferred acquisition consideration ($14.2 million) and BC Gateways 

deferred acquisition consideration ($8.1 million) after final settlement was agreed for the contractual earnout arrangements. 

(4)  Comprises all other non-operating project related expenses.

(b)  Fees to auditors, Deloitte Touche Tohmatsu and other audit firms, for services rendered are as follows:

Auditors of the parent entity
Audit or review of the financial report
Other assurance services
Other non-audit services(1)

Network firms of the parent entity auditor
Audit or review of the financial report

Other audit firms
Audit or review of subsidiary financial statements

Total fees to auditors

(1)  Other non-audit services comprise tax and consulting services.

2021
$

2020
$

(553,088)
(491,575)
(89,654)

(432,115)
–
(8,000)

(1,134,317)

(440,115)

(355,413)

(355,413)

(363,116)

(363,116)

(92,355)

(92,355)

(91,825)

(91,825)

(1,582,085)

(895,056)

75

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

1.7  Depreciation and amortisation
Depreciation and amortisation is calculated on a straight line basis over the expected useful life of the respective assets.

Depreciation and amortisation expense
Amortisation – intangible assets
Depreciation – plant and equipment
Depreciation – right-of-use assets

Notes

2.1(a)
2.2(a)
2.3(c)

2021
$’000

2020
$’000

(19,445)
(11,515)
(16,018)

(46,978)

(15,862)
(10,807)
(12,477)

(39,146)

1.8  Notes to the Consolidated Statement of Cash Flows
(a)  Cash and cash equivalents comprise cash at bank held in the following currencies, translated to Australian dollars:

Australian Dollar
Euro
British Pound
United States Dollar
South African Rand
Other currencies

Total cash and cash equivalents

2021
$’000

35,536
1,260
10,783
1,898
10,974
3,942

64,393

(b)  Reconciliation of profit attributable to members of the parent entity to cash generated from operating activities:

Profit for the financial year
Adjustment for non-cash and non-operating cash flow items
Depreciation and amortisation
Net credit loss allowances recognised on trade receivables
Net provision recognised on employee benefits
Net provision reversed on deferred contingent payments
Net provision recognised/(reversed) on the onerous contracts
Net provision recognised/(reversed) on other provisions
Share-based payment expense
Foreign exchanges losses
Losses on sale of plant and equipment
Gains on derecognition of right-of-use-assets and lease liabilities
(Gains)/losses on the fair value recognition of the right-of-use-assets and lease liabilities
Impairment on right-of-use assets
Interest income
Interest expense
Income tax expense
Change in working capital, net of effects from acquisition of controlled entities
(Increase)/decrease in receivables and other assets
Decrease in payables and other liabilities

Notes

1.7
2.4(c)
2.6(b)
2.6(b)
2.6(b)
2.6(b)
1.5(c)

2.3(e)
2.3(e)
2.3(e)

2021
$’000

73,798

46,978
(494)
136
(22,290)
2,108
52
17,419
138
230
(137)
(1)
3,889
(193)
9,235
19,068

(5,090)
(9,039)

2020
$’000

32,634
1,735
11,699
3,634
8,565
4,874

63,141

2020
$’000

59,213

39,146
(50)
1,294
(5,128)
(128)
(23)
21,020
1,041
33
(751)
788
–
(438)
8,422
19,146

24,301
(2,321)

Net cash inflow generated from operating activities

135,807

165,565

76

Iress LimitedSection 2. Core assets and working capital

2.1  Intangible assets
Intangible assets for the Group comprise goodwill arising from business combinations, customer relationships, computer software 
and other intangibles (mainly acquired databases and brands). Intangible assets with finite lives are carried at cost, less accumulated 
amortisation, and accumulated impairment losses.

Goodwill recognised arose from business combinations where the fair value of the consideration paid exceeded the fair value of the 
assets acquired. Goodwill is considered to have an indefinite life and is not amortised as it represents the synergistic benefits of 
bringing the businesses together.

Customer relationships, a proportion of computer software and other intangibles were acquired as part of business combinations. 
These intangible assets are initially recognised at their fair value at the acquisition date. The remainder of the computer software 
was separately acquired, and initially recognised at cost. Subsequent to initial recognition, intangible assets other than goodwill are 
amortised over the expected useful lives noted below.

Internally generated assets will be recognised where the cost of actual development can be reliably measured and clearly distinguished 
from research and ongoing operating and maintenance activities. A significant percentage of software development within the Group 
occurs contemporaneously with the research phase and ongoing operating and maintenance activities in supporting core customer 
systems. As a result the separation of the cost of development can be imprecise and difficult to reliably measure. Accordingly, where 
the expenditure related to the development activity cannot be reliably measured, the Group expenses the amounts in the period they 
are incurred.

During the year, $13.5 million (2020: $6.5 million) of internally generated computer software assets have been recognised. The amount 
capitalised (i.e. recognised as an intangible asset) reflects the continuation of product development projects commenced during 2020 
as well as new product projects that commenced development in 2021. These projects represent the development of new discrete 
products or market offerings outside the core customer systems and as a result are able to be reliably measured. 

The increase in the amount recognised during 2021 also reflects a full twelve months of development effort in the OneVue business 
whereas the amount capitalised during 2020 only included two months of OneVue development following the acquisition in 
November 2020. 

(a)  The carrying value of intangible assets is shown below:

As at 31 December 2020
Cost
Accumulated amortisation

Net carrying value

Movement for the year
Balance at 1 January 2020
Change in accounting policy (1)
Acquired through business combinations (2)
Internally generated development costs
Disposal(3)
Amortisation
Foreign currency translation

Balance at 31 December 2020

Expected useful life (years)

Goodwill
$’000

Customer
 Relationships
$’000

Computer
 Software
$’000

Other
 Intangibles
$’000

604,498
–

604,498

528,676
–
101,160
–
–
–
(25,338)

604,498

indefinite

68,067
(34,639)

33,428

26,145
–
12,977
–
–
(5,081)
(613)

33,428

5 to 15

241,806
(151,743)

90,063

61,137
–
33,462
6,465
–
(10,681)
(320)

90,063

2 to 20

6,090
(3,847)

2,243

3,790
(1,730)
300
–
–
(100)
(17)

2,243

3 to 10

Total
$’000

920,461
(190,229)

730,232

619,748
(1,730)
147,899
6,465
–
(15,862)
(26,288)

730,232

(1)  Prior year restatement due to changes in accounting policy following recent IFRIC agenda decisions. Refer to Note 4.3.

(2)  Acquisitions of BC Gateways, O&M Systems and OneVue during 2020.

(3)  $142.9 million of fully-amortised intangible assets were disposed of during the period (2020: 3.5 million).

77

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

2.1  Intangible assets (continued)
(a)  The carrying value of intangible assets is shown below (continued):

As at 31 December 2021
Cost
Accumulated amortisation

Net carrying value

Movement for the year
Balance at 1 January 2021
Internally generated development costs
Disposal(3)
Amortisation
Foreign currency translation

Balance at 31 December 2021

Expected useful life (years)

Goodwill
$’000

Customer 
Relationships
$’000

Computer
 Software
$’000

Other
 Intangibles
$’000

622,481
–

622,481

604,498
–
–
–
17,983

622,481

indefinite

52,158
(23,555)

28,603

33,428
–
–
(5,176)
351

28,603

5 to 15

137,705
(47,897)

89,808

90,063
13,476
–
(13,737)
6

89,808

2 to 20

1,840
(117)

1,723

2,243
–
–
(532)
12

1,723

3 to 10

Total
$’000

814,184
(71,569)

742,615

730,232
13,476
–
(19,445)
18,352

742,615

(1)  Prior year restatement due to changes in accounting policy following recent IFRIC agenda decisions. Refer to Note 4.3.

(2)  Acquisitions of BC Gateways, O&M Systems and OneVue during 2020.

(3)  $142.9 million of fully-amortised intangible assets were disposed of during the period (2020: 3.5 million).

(b)  Impairment testing for goodwill
In accordance with the accounting standard AASB 136 Impairment of Assets, the Group has conducted a review of indicators of 
impairment during the year for each of the cash generating units (CGUs) to which goodwill has been allocated.

Goodwill is annually tested for impairment, or more frequently when indicators of impairment are identified. In testing for impairment, 
the carrying amount of each Cash Generating Unit (CGU) is compared against the recoverable amount.

For each CGU tested, the recoverable amount has been calculated based on the value-in-use, using a discounted cash flow (DCF) 
approach. The DCF uses post-tax cash flow projections based on the most recent five-year financial plan updated for current 
performance and is discounted at an appropriate after-tax discount rate taking into account the Group’s weighted average cost of 
capital adjusted for any risks specific to the CGU.

Terminal growth rates applied in the DCF are based on estimates of long term inflation and nominal GDP growth in the country in 
which the CGU primarily operates.

78

Iress LimitedThe allocation of goodwill to each cash-generating unit and assumptions applied in calculating the recoverable amounts of the goodwill 
in testing for impairment include:

Cash generating unit

APAC Financial Market
ANZ Wealth Management
International Market Data
UK
UK Mortgages
South Africa
Canada

Total goodwill

Allocated Goodwill

Post-Tax
Discount Rates

Long Term Growth Rates

2021
$’000

42,482
130,869
5,249
333,315
82,036
13,539
14,991

622,481

2020
$’000

43,246
130,932
5,384
317,792
78,052
13,939
15,153

604,498

2021
%

9.5
9.5
8.7
9.0
9.0
19.5
10.4

2020
%

7.2
7.2
10.5
8.2
8.2
17.6
8.6

2021
%

2.7
2.7
2.0
2.7
2.7
4.5
2.0

2020
%

2.7
2.7
2.0
2.7
2.7
4.7
2.0

Based on the impairment testing performed, it was concluded that no impairment was required to be booked in the year to 
31 December 2021.

As reported in Note 4.2 the final goodwill arising from the acquisition of OneVue on 6 November 2020 is $82.9 million. The goodwill has 
been allocated to the ANZ Wealth Management CGU given that it is expected that the benefits of the acquisition of OneVue will flow 
to that CGU.

Significant estimates made
The cash flow projections included in the value-in-use models for each CGU assume that any delays in revenue as a result of COVID-19 
are recovered in future periods. This assumption is based on the impact of COVID-19 observed during the 2020 and 2021 financial 
years which has been largely limited to project delays. If COVID-19 does have a longer term material impact on revenue within a CGU, 
then it will result in reduced headroom or impairment of the goodwill allocated to that CGU.

The Group has also considered the impact of climate change on the cash flow projections included in the value-in-use models and 
concluded that there is not a significant impact based on current expectations, facts and circumstances.

The CGUs whose impairment testing headroom is most sensitive to assumptions around future revenue growth and increasing margins 
are the UK, IMD and UK Mortgages CGUs.

For the UK CGU the value-in-use model assumes that the rate of revenue growth will increase from that achieved in 2021 over the 
forecast period. If that higher revenue growth rate is not achieved it is expected that forecast expenses will be reduced. However, 
if revenue forecasts were not achieved and expenses continued at forecast levels, the resulting reduction in margins would reduce 
headroom in relation to the goodwill allocated to the UK CGU.

For the IMD CGU the value-in-use model assumes a continuation of revenue growth with a corresponding increase in margin over the 
forecast period, as the business increases its recurring revenue base and achieves scale. If that revenue growth is not achieved and 
expenses grow at forecast levels it will result in reduced headroom in relation to the goodwill allocated to the IMD CGU.

For the UK Mortgages CGU the value-in-use model assumes an increase in revenue growth from that achieved in 2021 due to new 
client sales across the forecast period with a corresponding increase in margin as the business scales. If the revenue growth across 
the forecast period is not achieved and expenses grow at forecast levels it will result in reduced headroom in relation to the goodwill 
allocated to the UK Mortgages CGU.

79

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

2.2  Plant and equipment
Plant and equipment are carried at cost, less accumulated depreciation, and any impairment losses.

The estimated useful lives, residual values, and depreciation method are reviewed at the end of each annual reporting period.

The depreciation charge for each period is recognised in profit or loss.

(a)  The carrying value of plant and equipment is shown below:

As at 31 December 2020
Cost
Accumulated depreciation

Net carrying value

Movement for the year
Balance at 1 January 2020
Acquired through business combinations (1)
Reclassified between asset categories
Separately acquired
Disposal
Depreciation
Foreign currency translation

Balance at 31 December 2020

Expected useful life (years)

As at 31 December 2021
Cost
Accumulated depreciation

Net carrying value

Movement for the year
Balance at 1 January 2021
Reclassified between asset categories (2)
Separately acquired
Disposal
Depreciation
Foreign currency translation

Balance at 31 December 2021

Expected useful life (years)

Leasehold
 improvement
$’000

Furniture &
 fittings
$’000

Office
 equipment
$’000

Computer
 equipment
$’000

Work in
 progress
$’000

17,445
(6,207)

11,238

7,919
–
535
4,844
–
(1,634)
(426)

11,238

3 to 10

16,492
(8,042)

8,450

7,749
39
52
2,831
(68)
(1,924)
(229)

8,450

3 to 10

2,361
(1,470)

891

1,090
60
95
23
–
(362)
(15)

891

3 to 5

64,551
(52,397)

12,154

10,241
214
1,821
7,172
(8)
(6,887)
(399)

12,154

3 to 5

7
–

7

548
–
(2,503)
2,176
–
–
(214)

7

Leasehold
 improvement
$’000

Furniture &
 fittings
$’000

Office
 equipment
$’000

Computer
 equipment
$’000

Work in
 progress
$’000

18,002
(6,475)

11,527

11,238
2,125
370
(78)
(2,334)
206

11,527

3 to 10

14,963
(8,009)

6,954

8,450
663
137
(91)
(2,323)
118

6,954

3 to 10

1,851
(1,233)

618

891
25
123
(40)
(386)
5

618

3 to 5

48,317
(35,348)

12,969

12,154
–
7,223
(27)
(6,472)
91

12,969

3 to 5

–
–

–

7
(2,813)
2,801
–
–
5

–

Total
$’000

100,856
(68,116)

32,740

27,547
313
–
17,046
(76)
(10,807)
(1,283)

32,740

Total
$’000

83,133
(51,065)

32,068

32,740
–
10,654
(236)
(11,515)
425

32,068

(1)  Acquisitions of O&M Systems and OneVue during 2020.

(2)  Work-in-progress are transferred to plant and equipment asset classes as brought into use.

(b)  Plant and equipment pledged as security
The Group does not have any plant and equipment pledged to secure borrowings of the Group.

80

Iress Limited2.3  Leases
(a)  Summary of leasing amounts recognised in the Statement of Profit or Loss and Statement of Cash Flows:
(i)   The table below discloses the principle amounts recognised in the Statement of Profit or Loss as well as contractual lease payments:

Contractual rental payments
Depreciation expense on right-of-use assets
Impairment of right-of-use assets

Interest expense on lease liabilities

Notes

2.3(a) (ii)
2.3(c)
2.3(c)

2.3(e)

2021
$’000

(16,898)
(16,018)
(3,889)

(2,688)

(ii)  The table below discloses the total cash flow relating to leases recognised in the Statement of Cash Flows:

Settlement of lease liabilities
Interest expense on lease liabilities

Total cash outflows for leases

2021
$’000

(14,437)
(2,461)

(16,898)

2020
$’000

(12,561)
(12,477)
–

(2,227)

2020
$’000

(10,334)
(2,227)

(12,561)

(b)  Iress Group lease portfolio
The Group leases real estate in the ordinary course of its business. The Group’s real estate leases comprise office building leases in 
the countries the Group operates in. Data servers were previously leased in South Africa until May 2021.

The Group’s regional lease portfolio:

Region

Lease characteristic features

Australia

The Group leases office buildings in a number of Australian cities, with the most significant being head office in 
Melbourne and an office in Sydney. The non-cancellable period of the leases range from two to twelve years with 
variable options to extend the lease terms. The lease payments are adjusted every year, based on contractual fixed 
percentage increases, and in certain instances, additionally increased by the prevailing consumer price index (CPI) 
at the lease review date.

The Group is required to make good (rehabilitate) the installed interconnecting stairs as part of its fit-out to connect 
floors at its head office in Melbourne.

South Africa

The Group leases office buildings in South Africa. The non-cancellable period of these leases range from two to seven 
years with options to extend the lease terms up to five years. The lease payments are adjusted every year by a fixed 
percentage increase at the lease review date.

The Group leased data servers until May 2021.

United Kingdom The Group leases office buildings in the UK. The non-cancellable period of these leases range from five to ten years. 

The lease payments are fixed with no increases over the lease terms. 

Other

The Group leases other office buildings in other countries. The non-cancellable period of these leases range from three 
to ten years. The lease payments are fixed with no increases over the lease terms. 

(i) Group as a lessee
Right‑of‑use asset

The Group recognises a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially 
measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the 
commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying asset – or 
to restore the underlying asset or the site on which it is located—less any lease incentives received.

The right-of-use asset is separately disclosed in the Consolidated Statement of Financial Position.

The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to either the earlier 
of the end of the useful life of the right-of-use asset, or the end of the lease term. The estimated useful lives of right-of-use assets are 
determined on the same basis as those of plant and equipment. In addition, the right-of-use asset is periodically reduced by impairment 
losses, if any, and adjusted for certain remeasurements of the lease liability.

81

Annual Report 2021Notes to the Financial Consolidated Statements

For the year ended 31 December 2021

2.3  Leases (continued)
(b)  Iress Group lease portfolio (continued)
(i) Group as a lessee (continued)
Lease liability

The lease liability is initially measured at the present value of the lease payments not paid at the commencement date, discounted 
using the interest rate implicit in the lease, or, if that rate cannot be readily determined, the Group’s incremental borrowing rate. 
Generally, the Group uses its incremental borrowing rate as the discount rate. The Group’s average incremental borrowing rate used 
is 3.07% (2020: 2.83%).

Lease payments included in the measurement of the lease liability include:

•  fixed payments, including in-substance fixed payments less any lease incentives receivable

•  variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date

•  amounts expected to be payable under a residual value guarantee

•  the exercise price under a purchase option that the Group is reasonably certain to exercise, lease payments in an optional renewal 

period if the Group is reasonably certain to exercise an extension option

•  payment of penalties for early termination of a lease unless the Group is reasonably certain not to terminate early.

The lease liability is separately disclosed in the Consolidated Statement of Financial Position. The lease liability is measured at 
amortised cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from 
a change in an index or rate, if there is a change in the Group’s estimate of the expected payable amount under a residual value 
guarantee, or, if the Group changes its assessment of whether it will exercise a purchase, extension, or termination option.

When the lease liability is remeasured in this way, either a corresponding adjustment is made to the carrying amount of the right-of-use 
asset, or, it is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.

Short‑term leases and leases of low‑value assets

The Group has elected not to recognise right-of-use assets and lease liabilities for short-term leases of office and information 
technology equipment with a lease term of 12 months or less, or for leases of low-value assets. The Group recognises the lease 
payments associated with these leases as an expense on a straight-line basis, over the lease term.

(ii) Group as a lessor
When the Group acts as a lessor—generally when it subleases property on which it has entered a head lease as a lessee–it determines 
at the sublease inception whether each sublease is a finance lease or an operating lease.

To classify each lease, the Group makes an overall assessment of whether the lease transfers substantially all of the risks and rewards 
incidental to ownership of the underlying asset. If this is the case, then the lease is a finance lease. If not, then it is accounted for as an 
operating lease. As part of this assessment, the Group considers certain indicators, such as whether the lease is for the major part of 
the economic life of the asset.

When the Group is an intermediate lessor, it accounts for its interests in the headlease and the sublease separately.

The Group assesses the lease classification of a sublease with reference to the right-of-use asset arising from the headlease, not with 
reference to the underlying asset. If a headlease is a short-term lease to which the Group applies the exemption described above, then 
it classifies the sublease as an operating lease.

If an arrangement contains a lease and non-lease component, the Group applies AASB 15 Revenue from Contracts with Customers to 
allocate the consideration in the contract.

The Group recognises lease payments received under operating leases as income on a straight-line basis over the lease term as part 
of non-operating income.

82

Iress Limited(c)  Carrying value of right‑of‑use assets
The Group’s right-of-use assets comprise real estate and data server leases. Right-of-use assets have finite lives and are carried at 
cost less accumulated depreciation.

The carrying value of right-of-use assets is presented below:

Office buildings

Data servers

Total

Cost
Accumulated depreciation

Net carrying value

Movement for the year
Balance at beginning of the year
Acquired through business 
combinations
New leases entered into contract
Expenses capitalised to  
right-of-use assets
Impairment of right-of use assets
Disposal of right-of use assets  
from early termination
Fair value adjustments from 
modified leases
Depreciation
Foreign currency translation

Balance at end of the year

Expected useful life (years)

2021
$’000

125,586
(47,849)

77,737

2020
$’000

107,195
(31,898)

75,297

75,297

51,850

–
21,806

–
(3,889)

5,681
33,881

797
–

(751)

(1,720)

(257)
(16,008)
1,539

77,737

1 to 12

(1,201)
(12,442)
(1,549)

75,297

2 to 12

2021
$’000

–
–

–

10

–
–

–
–

–

–
(10)
–

–

5

2020
$’000

124
(114)

10

2021
$’000

125,586
(47,849)

77,737

2020
$’000

107,319
(32,012)

75,307

51

75,307

51,901

–
–

–
–

–

–
(35)
(6)

10

5

–
21,806

–
(3,889)

5,681
33,881

797
–

(751)

(1,720)

(257)
(16,018)
1,539

77,737

(1,201)
(12,477)
(1,555)

75,307

The Group has recognised an impairment loss of $3.9 million in 2021 (2020: Nil) in relation to property lease right-of-use assets in 
Australia and the UK following decisions to transfer the teams working in these locations to other existing leased office space. The 
impairment loss recognised represents the difference between the previous carrying value of the assets (derived from the net present 
value of the existing contractual lease rental cash flows) and the net present value of the expected cash flows resulting from subletting 
or assigning the lease.

(d)  Lease liabilities
(i)  Lease liabilities included in the Statement of Financial Position at the end of the period:

Current
Non-current

Total

2021
$’000

(15,384)
(77,470)

(92,854)

2020
$’000

(13,383)
(71,125)

(84,508)

The Group’s liquidity risk with regard to its lease liabilities is managed by the inclusion of lease liability cash flows in the cash flow 
forecasts regularly monitored by the Group in line with the Group’s treasury policy.

83

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

2.3  Leases (continued)
(d)  Lease liabilities (continued)
(ii)  Reconciliation of the movement of the lease liabilities:

Opening carrying value
Lease liabilities assumed in business combinations
Lease liabilities raised from the negotiation of new lease contracts
Lease liabilities reversed from early termination of lease contracts
Lease liabilities reversed from changes in subsequent lease payments
Lease liabilities raised due to the timing of interest payment
Settlement of lease liabilities
Foreign currency translation

2021
$’000

(84,508)
–
(22,074)
888
258
(227)
14,437
(1,628)

2020
$’000

(57,535)
(8,100)
(33,881)
2,471
413
–
10,334
1,790

Closing carrying value

(92,854)

(84,508)

(iii)  Maturity analysis – contractual undiscounted cash flows:

Less than one year
More than one year and not more than five years
More than five years

Total undiscounted lease liabilities at the end of the period

(e)  Amounts recognised in the Statement of Profit or Loss and Other Comprehensive Income
The table below shows the amounts recognised in the Statement of Profit or Loss:

Depreciation expense on right-of-use assets
Interest expense on lease liabilities
Expenses relating to short term or low value assets leases
Gain/(Loss) on the fair value recognition of the right-of-use-assets and lease liabilities 
as a result of incremental lease payments
Impairment of right-of-use assets
Gain on the de-recognition of right-of-use assets and lease liabilities

Income from the sub-leasing of right-of-use assets

Notes

1.7
3.1(e)

2.3(c)

2021
$’000

17,126
62,759
19,384

99,269

2021
$’000

(16,018)
(2,688)
(158)

1
(3,889)
137

–

2020
$’000

15,051
53,803
21,551

90,405

2020
$’000

(12,477)
(2,227)
(170)

(788)
–
751

566

(f)  Operating lease arrangements
As at 31 December 2021 the Group had no outstanding sublease arrangements for which the Group was the lessee under a headlease 
arrangement. The one outstanding sublease arrangement was terminated during the year along with the headlease.

84

Iress Limited2.4  Receivables and other assets
Trade receivables arise from revenue billed, but not yet settled by the customer.

Revenue arises from providing access to Iress software, rendering of services, or recharging for access to capital markets data. 
Revenue is measured at the fair value of the consideration received or receivable.

Revenue is recognised over time as the relevant performance obligations identified in a customer contract are satisfied.

Refer to Note 1.3 for further details of revenue recognition.

Where revenue recognised exceeds billings, it results in a contract asset (refer table below), and where cash amounts are received in 
advance of revenue recognition, it results in a contract liability (refer to Note 1.3(b)).

Iress’ credit terms are generally 30 days from the date of invoice. Therefore, the carrying amount of receivables approximates their 
fair value.

(a)  Receivables and other assets as at the end of the year includes

Trade receivables
Credit loss allowance

Contract assets
Prepayments
Deposits
Financial assets at fair value through profit or loss
GST/VAT receivables
Other assets

Notes

2.4(d)
2.4(b)

1.3(b)

2021
$’000

33,551
(1,248)

32,303

13,687
24,750
824
480
1,163
1,194

74,401

2020
$’000

30,721
(1,720)

29,001

16,397
15,642
901
396
447
3,329

66,113

Included within other assets are financial assets categorised at fair value through profit or loss. Iress has assessed its investments held 
at fair value through profit and loss and these investments are held for trading, where they are acquired for the purpose of selling in the 
short term with an intention of making a profit.

These investments primarily comprise holdings in ASX listed equities that are held for operational purposes. Regular purchase and 
sales of investments are recognised on trade date, the date on which Iress commits to purchase or sell the asset. Investments are 
initially recognised at fair value with any transaction costs expensed through the statement of profit and loss and other comprehensive 
income. Subsequent movements in fair value of financial assets are recognised in the statement of profit and loss and other 
comprehensive income. These instruments—categorised as Level 1 in the Fair Value Hierarchy—are valued using the quoted price in 
active markets.

85

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

2.4  Receivables and other assets (continued)
(b)  Credit Loss Allowance
The Group applies the simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all 
trade receivables.

Expected credit losses are measured by grouping trade receivables and contract assets, based on shared credit risk characteristics 
and the days past due. The contract assets relate to unbilled work in progress and have substantially the same risk characteristics 
as the trade receivables for the same types of contracts.

A provision matrix is then determined based on the historic credit loss rate for each group of customers, adjusted for any material 
expected changes to the future credit risk for that customer group.

The credit loss allowance as at 31 December 2020 is determined as follows:

Provision matrix
As at 31 December 2020

1 to 30 days
31 to 60 days
61 to 90 days
Over 90 days

Contract assets

Ageing of receivables
As at 31 December 2020

1 to 30 days
31 to 60 days
61 to 90 days
Over 90 days

Total trade receivables

Contract assets

Allowance based on historic credit losses
Adjustment for expected changes in credit risk (1)

Credit loss allowance

APAC

UK & Europe

South Africa North America

0.2%
0.4%
0.9%
0.9%

0.1%

0.4%
0.6%
1.8%
1.9%

0.2%

0.3%
0.6%
1.2%
1.3%

0.1%

UK & Europe
$’000

South Africa
$’000

North America
$’000

8,483
630
54
754

9,921

9,259

71
603

674

1,362
34
54
147

1,597

349

7
116

123

710
16
12
20

758

–

9
54

63

APAC
$’000

17,525
511
22
387

18,445

6,789

46
814

860

1.1%
1.9%
2.4%
2.4%

0.2%

Group
$’000

28,080
1,191
142
1,308

30,721

16,397

133
1,587

1,720

(1)  Adjustment to reflect the higher credit risk and probability of default relating to customers that have amounts owing including invoices that are over 90 days 

past due.

86

Iress LimitedThe credit loss allowance as at 31 December 2021 is determined as follows:

Provision matrix
As at 31 December 2021

1 to 30 days
31 to 60 days
61 to 90 days
Over 90 days

Contract assets

Ageing of receivables
As at 31 December 2021

1 to 30 days
31 to 60 days
61 to 90 days
Over 90 days

Total trade receivables

Contract assets

Allowance based on historic credit losses
Adjustment for expected changes in credit risk (1)

Credit loss allowance

APAC

UK & Europe

South Africa North America

0.1%
0.1%
0.1%
0.1%

0.0%

0.6%
1.1%
1.8%
1.9%

0.2%

0.3%
0.6%
5.1%
5.4%

0.2%

UK & Europe
$’000

South Africa
$’000

North America
$’000

11,963
581
33
212

12,789

5,805

99
203

302

1,318
417
–
38

1,773

404

9
21

30

823
9
–
5

837

–

3
29

32

APAC
$’000

16,134
948
496
574

18,152

7,478

12
872

884

0.4%
0.7%
1.0%
1.0%

0.1%

Group
$’000

30,238
1,955
529
829

33,551

13,687

123
1,125

1,248

(1)  Adjustment to reflect the higher credit risk and probability of default relating to customers that are over 90 days past due.

Significant estimate made
The adjustment for material expected changes to credit risk for each client group requires judgement about future events 
and, therefore, a significant increase in actual credit losses from that expected would lead to a significant impact on financial 
performance. To date, COVID-19 has not had a material impact on the credit risk profile of Iress’ clients. However, the broader economic 
uncertainty due to COVID-19 could lead to a deterioration in the credit profile within the client base. Iress continues to monitor credit 
exposures closely.

(c)  Movement in credit loss allowance
The movement in the credit loss allowance during the year includes:

Balance at the beginning of the year
Credit loss allowances released/(recognised) during the year
Credit loss allowance utilised during the year against irrecoverable trade debtors
Acquired through business combinations
Foreign currency translation

Balance at the end of the year

Notes

2.4(a)

2021
$’000

(1,720)
125
369
–
(22)

(1,248)

2020
$’000

(1,718)
(587)
637
(242)
190

(1,720)

87

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

2.5  Payables and other liabilities
Payables and other liabilities are initially measured at fair value. Subsequent to initial measurement, these are recognised at 
amortised cost.

Liabilities are classified as current where Iress does not have an unconditional right to defer settlement beyond 12 months.

Employee related liabilities primarily comprise the annual leave liability and other employee related entitlements. The annual leave 
liability is measured as current leave accrued multiplied by current salary plus statutory charges.

Contract liabilities represent amounts received from customers for which revenue has not been earned or recognised.

Finance arrangements relate to the acquisition of software licences.

Due to the short-term nature of current liabilities, the carrying amount approximates their fair value.

Current
Trade payables
General accruals
Audit fee accruals
Taxation fee accruals
Contract liabilities
GST/VAT payable
Employee related liabilities
Dividend payable
Accrued interest
Other liabilities

Notes

2021
$’000

2020
$’000

1.3(b)

(7,951)
(21,485)
(539)
(457)
(16,504)
(5,741)
(21,796)
(164)
(581)
(2,290)

(9,120)
(24,677)
(559)
(290)
(13,413)
(13,606)
(19,174)
(86)
(437)
(2,581)

(77,508)

(83,943)

The Group’s exposure to foreign currency risk arising from translating payables, and other liabilities to the Group’s functional currency, 
is considered insignificant. The exposure is monitored on a net working capital basis, refer to Note 3.3.

Liquidity risk arises from current payables, and other liabilities, payable in less than one year. The Group manages this liquidity risk by 
maintaining sufficient cash and current assets to meet the contractual obligations as they arise.

2.6  Provisions
Provisions are measured at the present value of management’s best estimate of the expenditure required to settle the present 
obligation at the end of the reporting period.

Employee benefits mainly comprise employee long service leave entitlements in Australia. The amount reflected as a current provision 
in 2021 reflects the amount relating to employees who have reached the statutory length of service required to either take the leave or 
for it to be paid out on departure from the Group. Previously the Group reflected only the amount expected to be taken in the following 
twelve months as current.

Deferred consideration represents purchase consideration payable for acquisitions once certain conditions are met as stipulated in 
the contracts. These are measured at the discounted value of the best estimate of the cash payable based on conditions existing at 
the balance date.

The measurement of deferred consideration at fair value at each reporting date requires estimates to be made about expected revenue 
and expenses over the measurement period to which the deferred consideration relates.

The current provision for deferred contingent consideration in relation to the acquisition of BC Gateways Limited in 2020 is $4.4 million 
(2020: Nil) and the non current provision for deferred contingent consideration in relation to the acquisition of BC Gateways is nil 
(2020: $12.5 million). During the year the Group entered into an agreement with the previous owners of BC Gateways to settle the 
deferred contingent consideration for $4.4 million. This amount was subsequently settled in January 2022.

The current provision for deferred contingent consideration in relation to the acquisition of QuantHouse in 2019 is nil (2020: 
$4.2 million) and the non current provision for deferred contingent consideration in relation to the acquisition of QuantHouse is nil 
(2020: $21.1 million). During the year the total amount paid to the former owners of QuantHouse sellers was $10.4 million after the Group 
entered into an agreement to settle the remaining deferred contingent consideration.

Onerous contracts represent the expected losses on non-cancellable property lease commitments no longer utilised by the Group. 
The amount provided for represents the present value of the future expected expenses to be incurred in relation to the leased premises 
over the remaining lease term.

88

Iress Limited(a)  Provisions as at the end of the year include: 

Current provisions
Employee benefits
Deferred consideration
Onerous contracts
Other provisions

Total current provisions

Non-current provisions
Employee benefits
Deferred consideration

Total non-current provisions

Total provisions

(b)  The carrying value of provisions are reconciled as follows:

2021
$’000

(8,715)
(4,400)
(2,171)
(60)

(15,346)

(2,950)
–

(2,950)

(18,296)

As at 31 December 2020

Balance at 1 January 2020
Assumed in business combination
Provision raised during the year
Provision reversed during the year
Provision utilised during the year
Foreign currency translation

Balance at 31 December 2020

As at 31 December 2021

Balance at 1 January 2021
Provision raised during the year
Provision reversed during the year
Provision utilised during the year
Foreign currency translation

Balance at 31 December 2021

Employee
 benefits
$’000

Deferred
consideration
$’000

Onerous loss
 provision
$’000

Other 
provisions
$’000

(8,694)
(1,552)
(1,294)
–
–
4

(28,311)
(16,158)
–
5,128
1,620
(100)

(11,536)

(37,821)

(192)
–
–
128
–
–

(64)

(32)
–
–
23
–
(1)

(10)

Employee
 benefits
$’000

Deferred
consideration
$’000

Onerous loss
 provision
$’000

Other 
provisions
$’000

(11,536)
(136)
–
–
7

(11,665)

(37,821)
–
22,290
10,432
699

(4,400)

(64)
(2,108)
–
–
1

(2,171)

(10)
(52)
–
–
2

(60)

2.7  Commitments and contingencies
(a)  Capital commitments
As at 31 December 2021, no capital expenditure has been contracted or provided for (2020: Nil).

(b)  Contingencies
As at 31 December 2021, no material contingent liabilities have been contracted or provided for (2020: Nil).

2020
$’000

(1,610)
(4,230)
(64)
(10)

(5,914)

(9,926)
(33,591)

(43,517)

(49,431)

Total
$’000

(37,229)
(17,710)
(1,294)
5,279
1,620
(97)

(49,431)

Total
$’000

(49,431)
(2,296)
22,290
10,432
709

(18,296)

89

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

Section 3. Debt and equity

3.1  Debt facilities and derivatives
Borrowings are initially recognised at fair value, net of transaction costs incurred. Borrowings are subsequently measured at amortised 
cost. Any gains or losses are recognised in the Statement of Profit or Loss in the event the borrowings are derecognised.

On 19 November 2021, Iress entered into agreements with its lenders to extend the expiry date on its unsecured bank facilities from 
April 2024 to October 2025. The amount of the unsecured bank facilities was reduced by $5 million to $400 million. The covenant 
requirements remain unchanged.

(a) Details of borrowings held by the Group include:

Non-current
4 year $400 million bank facility to October 2025
 AUD
 GBP
 EUR

Total amount drawn

Borrowing costs capitalised

Total borrowings

2021
$’000

2020
$’000

75,000
174,005
49,138

298,143

(1,613)

48,500
107,123
34,403

190,026

(1,593)

296,530

188,433

The bank facilities allow multi-currency drawdowns and are at variable interest rates based on BBSY, SONIA and EURIBOR benchmark 
rates plus a market margin. Amounts can be repaid at the discretion of the Group. Therefore, the amounts drawn approximate their 
fair value.

Not included in the table above is a $15 million (2020: $10million) revolving capital and contingent instruments facility used for any 
bank guarantees, letters of credit or similar instruments required by the Group. As at 31 December 2021, $6.5 million (2020: $6.5 million) 
was utilised. The borrowings are unsecured, and the Group has complied with the financial covenants of its borrowing facilities during 
the year.

(b) Reconciliation of the movement in borrowings to the financing cash flows include:

2021
$’000

188,433
349,739
(246,226)
(21)
4,605

296,530

2020
$’000

225,914
142,039
(172,239)
(1,008)
(6,273)

188,433

Balance at beginning of the year
Proceeds from borrowings
Repayments of borrowings
Net borrowing costs capitalised
Foreign exchange rate movements

Balance at end of the year 

90

Iress Limited(c) Derivatives
Derivatives are initially recognised at fair value at the date the derivative contract is entered into and are subsequently revalued to fair 
value at the end of each reporting period.

The fair value of the derivatives is determined by first calculating the future cash flows estimated based on forward interest rates 
(from observable yield curves at the end of the reporting period) and contract interest rates, then discounting the future cash flows at 
a rate that reflects the credit risk of various counterparties.

Iress is not a party to any derivative contracts at 31 December 2021.

Current
Derivative assets at fair value
3 year receive AUD/pay GBP to September 2021

Non-current
Liabilities at fair value

3 year receive AUD/pay GBP to September 2021

2021
$’000

2020
$’000

–

–

1,739

–

(d) Contractual maturity analysis
Contractual cash outflow maturity analysis is shown based on undiscounted cash flows. An estimate, based on forward interest rates 
and foreign currency rates, has been applied in determining interest and foreign cash outflows and inflows. The actual contractual 
outflow may vary to the amounts disclosed.

31 December 2020
Outflows/(inflows)

4 year facilities – principal
Interest on borrowings
3 year cross currency swaps – principal exchange (1)

3 year cross currency swaps – interest (1)

31 December 2021
Outflows/(inflows)

4 year facilities – principal

Interest on borrowings

Within 1 year
$’000

1–3 years
$’000

–
3,420
(1,554)

(108)

–
6,841
–

–

Within 1 year
$’000

1–3 years
$’000

Greater than
3 years
$’000

190,026
1,140
–

–

Greater than
3 years
$’000

–

6,384

–

12,768

298,143

5,320

(1)  Represents expected net cash exchange in AUD that occurs at settlement. Under the terms of the cross currency swaps, the settlements are on a gross basis 

where Iress receives AUD and pays GBP.

91

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

3.1  Debt facilities and derivatives (continued)
(e) Interest expense and financing costs
Interest expense are recognised using the effective interest rate method. Interest expense includes exchange differences arising from 
foreign currency borrowings to the extent they are regarded as adjustments to interest costs.

Net interest expense and financing costs for the year include:

Interest income
Interest expense
Other financing costs comprising:
Interest expense of lease liabilities
Amortisation of borrowing costs
Translation gains/(losses) on intra-group financing arrangements
Fair value changes on cross currency swaps
Fair value changes on managed investment

Net interest expense and financing costs

Notes

2.3(e)

2021
$’000

193
(5,685)

(2,688)
(788)
3,587
(3,746)
85

(9,042)

2020
$’000

438
(5,294)

(2,227)
(1,042)
(3,397)
3,508
30

(7,984)

3.2  Issued capital
On 29 July 2021, Iress announced the launch of an on-market buyback of up to $100 million of ordinary fully-paid shares to be funded 
from Iress’ existing cash and committed debt facilities.

As at 31 December 2021, Iress had repurchased 4,048,296 shares at an average price of $11.802 for a total amount of $47.8 million. 
The shares were all cancelled following purchase.

The number of ordinary shares outstanding at the end of the year include:

Balance at the beginning of the year
New shares issued to employees in relation to 
employee share schemes
Purchase of shares issued to employees in relation to 
employee share schemes
On-market buy-back of shares
Shares issued to meet obligations under the 
Dividends Reinvestment Plan
Shares issued under the Equity Placement (1)
Shares issued under the Share Purchase Plan
Shares issued under employee Share Purchase Plan

Less Treasury Shares (2)

Balance at the end of the year

Amount

Number of shares

2021
$’000

2020
$’000

2021
‘000

2020
‘000

558,416

383,083

193,326

174,924

–

(20,387)
(47,781)

3,190
–
–
445

–

–
–

2,662
147,227
24,840
604

–

1,370

–
(4,048)

350
–
–
–

–
–

238
14,395
2,399
–

493,883

558,416

189,628

193,326

–

–

493,883

558,416

(2,447)

187,181

(2,514)

190,812

(1)  Shares issued during the year net of issue cost and tax.

(2)  The change is due to the net movement in shares granted and shares vested under the Employee Share Plans.

92

Iress Limited3.3  Managing financial risks
(a)  Market risks
Interest rate risk
The Group’s exposure to interest rate risk mainly arises from its variable rate borrowings.

An increase in the benchmark interest rates of 50 basis points (0.5%), with all other factors held constant, would result in an increase in 
the annual interest cost of the Group of $1.5 million (2020: $0.9 million).

Foreign currency risk
GBP and EUR borrowings do not give rise to foreign currency risk to the Group as they are ultimately held in entities that have a GBP or 
EUR functional currency respectively.

The Group is exposed to foreign currency transaction risk mainly from intercompany balances denominated in foreign currency. 
Additional foreign currency risk arises from cash balances, receivables and payables held within each subsidiary but denominated in 
a currency different to the functional currency of that subsidiary.

The material exposure to foreign currency movements arising from foreign currency working capital balances held within the 
Group includes:

Working capital denominated in foreign currency
GBP
ZAR

AUD impact on profit or loss of a 1% increase in foreign currency rates
GBP

ZAR

2021
$’000

1,786
32,234

33

28

2020
$’000

(1,222)
44,374

(22)

40

The above excludes the exposure of the Group from translating its foreign operations to the Group presentation currency.

(b)  Capital risk management
The Group manages its capital to ensure it will be able to continue as a going concern while maximising the return to shareholders.

In order to maintain or adjust the capital structure, the Group may adjust the amount of dividends paid to shareholders, return 
capital to shareholders, issue new shares or sell assets to reduce debt. The Group is not subject to any significant regulatory 
capital requirements.

Management reviews the capital structure of the Group on a regular basis. As part of this review, the cost of capital and the risks 
associated with each class of capital is considered as well as the impact on the Group’s available debt facilities (refer to Note 3.1) and 
the leverage ratio.

The Group’s year end leverage ratio:

Net debt (1)
Segment Profit for the last twelve months

Leverage ratio

(1)  Measured as borrowings and net derivatives liabilities/assets less cash and cash equivalents.

Notes

1.1(a)

2021
$’000

233,750
166,232

1.41

2020
$’000

125,146
152,918

0.82

93

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

Section 4. Other disclosures

4.1  Taxation
Total income tax expense comprises current and deferred tax recognised in the Statement of Profit or Loss in the year. Current and 
deferred tax is also recognised directly in equity, and not in the Statement of Profit or Loss, to the extent it is attributable to amounts 
and movements which have also been recognised directly in equity.

Current tax
Current tax comprises expected tax payable/receivable on business taxable income/loss which is recognised in the Statement of Profit 
or Loss in the current year. Any adjustments to tax payable/receivable are recognised in the current year that relate to taxable income/
loss recognised in the Statement of Profit or Loss in prior years.

Current tax is measured using the applicable enacted (or substantively enacted) income tax rates, at the reporting date in the countries 
where the company’s subsidiaries and associates operate.

Deferred tax
Deferred tax represents the movements in deferred tax assets and liabilities which have been recognised during the year and which 
are attributable to amounts recognised in the Statement of Profit or Loss in the current year and the amounts recognised in the 
Statement of Profit or Loss in prior years. Deferred tax assets and liabilities are attributable to temporary timing differences between 
the carrying amount of assets and liabilities recognised for financial reporting purposes, and the tax base of assets and liabilities 
recognised for tax purposes.

Deferred tax assets are recognised for deductible temporary differences, unused tax losses and unused tax credits to the extent it is 
probable that future taxable profits will be available against which they can be realised.

Deferred tax liabilities are recognised for all the assessable temporary differences as required by accounting standards.

Deferred tax is determined using tax rates which are expected to apply when the deferred tax asset/liability is expected to be realised 
based on enacted (or substantively enacted) laws enacted at the reporting date. The measurement of deferred tax also reflects the tax 
consequences flowing from the manner in which the Group expects, at the reporting date, to realise or settle the carrying amount of its 
assets and liabilities.

Tax consolidation
The Company and its wholly-owned Australian resident entities are part of a tax consolidated group under Australian Taxation Law. 
Iress Limited is the head entity of the Australian tax consolidated group. Tax expense, deferred tax assets and deferred tax liabilities 
arising from temporary differences of the members of the tax consolidated group are recognised in the separate financial accounts of 
the members of the Australian tax consolidated group using the stand-alone taxpayer approach. Current and deferred tax assets and 
liabilities arising from unused tax losses, and tax credits of the members of the Australian tax consolidated group, are recognised by the 
Company (as head entity of the tax consolidated group).

Due to the existence of a tax funding arrangement between the entities in the Australian tax consolidated group, amounts are 
recognised as payable to, or receivable by, the Company and each member of the Australian tax consolidated group. This is in relation 
to the tax contribution amounts paid or payable between the parent entity and the other members of the Australian tax consolidated 
group in accordance with the arrangement.

94

Iress Limited(a)  Income tax expense for the year including current and deferred tax:

Income tax expense recognised in Statement of Profit or Loss
Current income tax expense
Current income tax charge
Adjustments in respect of current income tax of the previous year

Deferred income tax expense
Origination and reversal of temporary differences
Adjustments in respect of deferred income tax of the previous year

Total income tax expense recognised in Statement of Profit or Loss

Income tax expense recognised in other comprehensive income
Arising from gains or losses on long term monetary intercompany balances
Income tax expense recognised directly in equity
Current tax credited directly to other reserves
Deferred tax credited directly to other reserves

Total income tax expense recognised in Other Comprehensive Income and Equity

(b)  The reconciliation of income tax expense at the Australian tax rate to total income tax expense is as follows:

Profit from continuing operations before income tax expense
Tax at the Australian tax rate of 30% (2020: 30%)
Income tax expense adjustments:
Effect of different tax rates in foreign jurisdictions
Effect of non-assessable income
Effect of non-deductible expenses
Employee share plan
Adjustments for current and deferred tax of prior years
Unrecognised tax losses

Income tax expense

2021
$’000

92,866
27,860

56
(17,403)
7,448
313
(238)
1,032

19,068

2021
$’000

2020
$’000

20,045
(701)

19,344

(739)
463

(276)

19,068

(51)

(240)
216

(75)

25,592
(521)

25,071

(5,759)
(166)

(5,925)

19,146

(76)

(158)
(819)

(1,053)

2020
$’000

78,359
23,508

(2,761)
(9,976)
8,574
312
(687)
176

19,146

95

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

4.1  Taxation (continued)
(c)  Deferred income tax assets and liabilities recognised in the Statement of Financial Position:

Opening
 balance
$’000

Charged
to income
$’000

Charged to
OCI/equity
$’000

From business
 combinations
$’000

Exchange
 differences
$’000

Closing
 balance
$’000

146
4,436
2,548
1,074
8,999
(530)
2,358
578
1,272
1,164
434

22,479

(990) 
(191)
(9,074)
513
(47)

(9,789)

153
228
28
2,191
(1,101)
1,052
91
(462)
2,250
327
(433)

4,324

990
(202)
1,827
(1,061)
47

1,601

–
–
–
–
–
–
–
819
–
–
–

819

–
–
456
–
–

456

–
(8)
(572)
129
2,117
–
3,677
1,516
–
546
–

7,405

(65)
–
(5,324)
(3)
–

(5,392)

(12)
(259)
–
(16)
(31)
–
(243)
–
(110)
(21)
–

287
4,397
2,004
3,378
9,984
522
5,883
2,451
3,412
2,016
1

(692)

34,335

–
16
313
–
–

329

(65)
(377)
(11,802)
(551)
–

(12,795)

Opening
 balance
$’000

Charged
to income
$’000

Charged to
OCI/equity
$’000

From business
 combinations
$’000

Exchange
 differences
$’000

Closing
 balance
$’000

287
4,397
2,004
3,378
9,984
522
5,883
2,451
3,412
2,016
1

(77)
(842)
26
1,717
(1,663)
(522)
(1,760)
1,137
(1,360)
693
1

34,335

(2,650)

(65)
(377)
(11,802)
(551)

(12,795)

(535)
(25)
2,935
551

2,926

–
–
–
–
–
–
–
(216)
–
–
–

(216)

–
–
–
–

–

–
–
–
–
–
–
–
–
–
–
–

–

–
–
–
–

–

5
81
–
(3)
1
–
(54)
–
87
(6)
–

111

–
(19)
(31)
–

(50)

215
3,636
2,030
5,092
8,322
–
4,069
3,372
2,139
2,703
2

31,580

(600)
(421)
(8,898)
–

(9,919)

For the year ended
31 December 2020

Deferred tax assets
Receivables and other assets
Plant and equipment
Computer software
Payables and other liabilities
Provisions and accruals
Derivative liabilities
Carry forward tax losses
Capital transaction costs
Share-based payments
Leases
Other

Total deferred tax assets

Deferred tax liabilities
Trade and other payables
Computer software
Intangible assets
Other financial assets
Employee share plan

Total deferred tax liabilities

For the year ended
31 December 2021

Deferred tax assets
Receivables and other assets
Plant and equipment
Computer software
Payables and other liabilities
Provisions and accruals
Derivative liabilities
Carry forward tax losses
Capital transaction costs
Share-based payments
Leases
Other

Total deferred tax assets

Deferred tax liabilities
Trade and other payables
Computer software
Intangible assets
Other financial assets

Total deferred tax liabilities

96

Iress Limited(d)  Unused tax losses to carry forward for which no deferred tax asset has been recognised:

Hong Kong (Tax rate 16.5%, 2020: 16.5%)
France (Tax rate 26.5%, 2020: 28.0%)
Australia (Tax rate 30.0%, 2020: 30.0%) (1)

Potential tax benefit

2021
$’000

131
75,719
17,130

25,226

2020
$’000

121
73,214
17,130

25,659

(1)  Australia tax losses transferred from OneVue into the Australian tax consolidated group.

4.2  Businesses & investments acquired & divested
The Group accounts for business combinations using the acquisition method when control is transferred to the Group. The 
consideration transferred in the acquisition is measured at fair value, as are the identifiable net assets acquired. Any goodwill that 
arises is tested annually for impairment. Any gain on a bargain purchase is recognised in profit or loss immediately. Transaction costs 
are expensed as incurred, except if related to the issue of debt or equity securities.

Any deferred contingent consideration is measured at fair value at the date of acquisition. If any obligation to pay contingent 
consideration meets the definition of a financial instrument it is classified as equity, and not remeasured, with settlement accounted for 
within equity. Otherwise, subsequent changes in the fair value of the contingent consideration are recognised in profit or loss.

Acquisition of OneVue
On 6 November 2020 Iress acquired 100% of the outstanding shares of OneVue (OneVue) via a Scheme Implementation Agreement with 
OneVue Holdings (OVH.ASX). OneVue is an ASX listed administration platform for managed funds, superannuation and investments. 
The business operates through two core divisions: Fund Services and Platform Services. OneVue has scale in Fund Services managed 
funds administration as the largest single third-party fund registry in Australia and third in Superannuation Member Administration.

The allocation of the purchase consideration at 31 December 2020 was provisional in relation to the fair valuation of certain intangible 
assets, accruals and tax accounting. During the year the valuation of the intangible assets, accruals and tax accounting was completed.

The following table summarises consideration paid and payable and the fair value of net assets acquired at, and since, the date 
of acquisition:

Consideration
Cash consideration

Total fair value of consideration

Assets acquired
Cash and cash equivalents
Trade and other receivables
Intangible assets
Plant and equipment
Right-of-use assets
Deferred tax assets
Interest-bearing loan
Payables and other liabilities
Current taxation payables
Lease liabilities
Provisions
Deferred tax liabilities

Fair value of assets acquired

Goodwill recorded on acquisition

6 November 2020

As presented
$’000

Change
$’000

Restated
$’000

115,210

115,210

7,122
6,043
41,444
292
5,169
2,939
(6,482)
(14,187)
(42)
(6,988)
(395)
(3,518)

31,397

83,813

–

–

115,210

115,210

–
–
(1,404)
–
–
5,046
–
(1,487)
(58)
–
–
(1,156)

941

(941)

7,122
6,043
40,040
292
5,169
7,985
(6,482)
(15,674)
(100)
(6,988)
(395)
(4,674)

32,338

82,872

The adjustments to deferred tax assets and liabilities relate to the finalisation and recognition of pre-acquisition tax losses and other 
brought forward tax credits assessed as being claimable by the Group in the years after acquisition.

The retrospective impact of finalisation on the comparative balance sheet at 31 December 2020 is presented in Note 4.3.

97

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

4.3  Change in accounting policy
During the period the Group revised its accounting policy in relation to upfront configuration costs incurred in implementing third-party 
Software-as-a-Service (SaaS) arrangements, through which the Group gains access to the underlying software over a contract period 
but does not obtain possession of the underlying software.

The change resulted from the agenda decision issued by the IFRS Interpretation Committee (IFRIC) in April 2021 that clarified its 
interpretation of how current accounting standards apply to these types of arrangements.

As a result of the change in accounting policy, certain costs previously capitalised and amortised over their expected useful lives will 
now be expensed as the service is received.

In accordance with the requirements of AASB 108 Accounting Policies, Changes in Accounting Estimates and Errors, the accounting 
policy change is required to be applied retrospectively. Therefore, historical financial information has been restated to account for the 
impact of the change in accounting policy as follows:

(a)  Increase in the net profit as a result of a decrease in depreciation and amortisation expense:

Statement of Profit or Loss and Other Comprehensive Income
Depreciation and amortisation
Taxation

Net impact on the profit after tax

For the year ended 31 December 2020

As 
presented
$’000

Fair value
 adjustment (1)

$’000

Policy 
change
$’000

Restated
$’000

(39,356)
(19,082)

(58,438)

–
–

–

210
(64)

146

(39,146)
(19,146)

(58,292)

(b)  Restatement of the Statement of Financial Position in respect of prior year adjustments:

1 January 2020

31 December 2020

As 
presented
$’000

Policy 
change
$’000

Restated
$’000

As 
presented
$’000

Fair value
 adjustment (1)

$’000

Policy 
change
$’000

Restated
$’000

619,748

(1,730)

618,018

734,098

(2,346)

(1,520)

730,232

Statement of financial position
Non-current assets
Intangible assets
Net deferred tax assets 
and liabilities
Payables and other liabilities
Current taxation payables

12,691
–
–

519
–
–

13,210

–

17,194
(82,457)
(486)

3,891
(1,486)
(58)

Impact on net assets

632,439

(1,211)

631,228

668,349

Retained earnings
Gross
Taxation

Impact on total equity

6,700
–

6,700

(1,730)
519

(1,211)

4,970
519

5,489

(481)
–

(481)

1

–
–

–

(1)  Adjustment is a result of finalisation of Onevue’s provisional acquisition accounting. Refer to Note 4.2.

98

455
–
–

21,540
(83,943)
(544)

(1,065)

667,285

(1,520)
456

(1,064)

(2,001)
456

(1,545)

Iress Limited4.4  Iress Limited – parent entity financial information
The ultimate controlling entity of the Group is Iress Limited, which is a for-profit entity listed on the Australian Securities Exchange (ASX).

(a)  Summary financial information
The individual financial statements for the parent entity, Iress Limited:

Current assets
Non-current assets

Total assets

Current liabilities
Non-current liabilities

Total liabilities

Net assets

Equity
Issued capital
Reserves
Retained earnings

Total equity

Profit for the year (1)

Total comprehensive income

(1)  Included within profit for the year is dividend income from subsidiaries of $51.0 million (2020: $85.0 million).

(b)  Capital commitments
As at 31 December 2021, no capital expenditure has been contracted or provided for (2020: Nil).

(c)  Contingencies
As at 31 December 2021, no material contingent liabilities have been contracted or provided for (2020: Nil).

2021
$’000

284,869
900,076

2020
$’000

168,790
866,008

1,184,945

1,034,798

263,440
289,060

552,500

632,445

493,883
26,209
112,353

632,445

33,412

33,412

111,111
188,555

299,666

735,132

558,416
35,051
141,665

735,132

54,422

54,422

99

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

4.5  Subsidiaries
Details of the Group’s wholly-owned subsidiaries at the end of the year are as follows:

Australia

BC Gateways Pty Ltd
Diversa Funds Management Pty Ltd
Diversa Pty Ltd (formerly Diversa Ltd)
FUND.eXchange Pty Ltd
Financial Synergy Actuarial Pty Ltd(1)
Financial Synergy Holdings Pty Ltd(1)
Financial Synergy Pty Ltd(1)
Glykoz Pty Ltd
Group Insurance & Superannuation Concepts Pty Ltd
Innergi Pty Ltd
Investment Gateway Pty Ltd
Iress Data Pty Ltd(1)
Iress Euro Holdings Pty Ltd(1)
Iress Information Pty Ltd
Iress International Holding Pty Ltd(1)
Iress South Africa (Australia) Pty Ltd(1)
Iress Spotlight Wealth Management Solutions (RSA) Pty Ltd(1)
Iress Wealth Management Pty Ltd(1)
Lucsan Capital Pty Ltd
Map Funds Management Pty Ltd
No More Practice Education Pty Ltd
No More Practice Holdings Pty Ltd
OneVue Financial Pty Ltd
OneVue Fund Services Pty Ltd
OneVue Holdings Ltd(1) (2)
OneVue Pty Ltd
OneVue Services Pty Ltd
OneVue Super Member Administration Pty Ltd
OneVue Super Services Holdings Pty Ltd
OneVue Super Services Pty Ltd
OneVue UMA Pty Ltd
OneVue Unit Registry Pty Ltd
OneVue Wealth Services Ltd
OneVue Wealth Solutions Pty Ltd
Planning Resources Group Pty Ltd(1)
Top Quartile Management Pty Ltd(1)(7)
Tranzact Consulting Pty Ltd
Tranzact Financial Services Pty Ltd
Tranzact Superannuation Services Pty Ltd

Canada

Iress Canada Holdings Ltd
Iress (LP) Holdings Corp.
Iress Market Technology Canada LP
Iress (Ontario) Ltd
KTG Technologies Corp.

100

South Africa

Advicenet Advisory Services (Pty) Ltd

Iress Hosting (Pty) Ltd

Iress Financial Markets (Pty) Ltd
Iress MD RSA (Pty) Ltd
Iress Wealth MNGT (Pty) Ltd

United Kingdom

Iress FS Group Ltd
Iress FS Ltd
Iress Mortgage Services Ltd
O&M Systems Ltd
O&M Life & Pensions Ltd
Iress Portal Ltd
Iress Solutions Ltd
Iress Technology Ltd
Iress (UK) Ltd
Iress UK Holdings Ltd
Iress Web Ltd
Proquote Ltd
Pulse Software Systems Ltd
Pulse Software Management Ltd
QuantHouse UK Ltd
TrigoldCrystal Ltd

Other countries

BC Gateways Ltd (Hong Kong)
Iress Asia Holdings Ltd (Hong Kong)
Iress Inc (previously known as QuantHouse Inc) (USA)(4)
Iress Malaysia Holdings Sdn Bhd (Malaysia)
Iress Market Technology (Singapore) Pte Ltd (Singapore)
Iress (NZ) Ltd (New Zealand)
Iress SAS (previously known as QuantHouse SAS) (France)(5)
Iress Tunisia Branch Sàrl (previously known as QuantHouse Sàrl) 
(Tunisia)(6)
Peresys Software Ltd (Ireland)(3)
QH HoldCo (Luxembourg)
QuantHouse Singapore Pte Ltd (Singapore)
Waysun Technology Development Ltd (Hong Kong)

(1)  Iress Limited and its Australian subsidiaries entered into an ASIC Class 

Order and Deed of Cross Guarantee with Iress Limited in December 2014.

(2)  Joined the Iress Deed of Cross Guarantee in 2021.

(3)  Entity was deregistered on 19 November 2021.

(4)  Entity change of name on 25 October 2021.

(5)  Entity change of name on 1 November 2021.

(6)  Entity change of name on 21 December 2021.

(7)  A Revocation Deed was lodged with ASIC on 20 December 2021. The entity 
remains a party to the Iress Deed of Cross Guarantee for 6 months after 
the Revocation Deed being lodged.

Iress Limited4.6  Deed of cross guarantee
Iress Limited and a number of Australian wholly-owned subsidiaries (outlined in Note 4.5) are party to a Deed of Cross Guarantee under 
which each company guarantees the debts of the others. By entering into the deed, the relevant, wholly-owned subsidiaries have been 
relieved from the requirement to prepare the financial report and Directors’ Report under ASIC Corporations (Wholly-Owned Companies) 
Instrument 2016/785 issued by the Australian Securities and Investments Commission.

(a)  Consolidated Statement of Profit or Loss and retained earnings:

Profit before tax
Income tax expense

Net profit after tax

Retained earnings at the beginning of the year
Dividends declared
Transfers from SBP reserve

Retained earnings at the end of the year

2021
$’000

105,781
(6,446)

99,335

7,170
(88,986)
26,262

43,781

2020(1)
$’000

103,717
(16,540)

87,177

(13,776)
(83,394)
17,163

7,170

101

Annual Report 2021Notes to the Consolidated Financial Statements 

For the year ended 31 December 2021

4.6  Deed of cross guarantee (continued)
(b) Consolidated Statement of Financial Position

ASSETS
Current assets
Cash and cash equivalents
Receivables and other assets
Receivables from Iress Group companies outside the Deed (1)
Current taxation receivables

Total current assets

Non-current assets
Intangible assets
Plant and equipment
Right-of-use assets
Deferred tax assets
Investment in subsidiaries
Other financial assets

Total non-current assets

Total assets

LIABILITIES
Current liabilities
Payables and other liabilities
Lease liabilities
Provisions

Total current liabilities

Non-current liabilities
Payables and other liabilities
Lease liabilities
Provisions
Payables to Iress Group companies outside the Deed
Borrowings
Deferred tax liabilities

Total non-current liabilities

Total liabilities

Net assets

EQUITY
Issued capital
Share-based payments reserve
Foreign currency translation reserve
Retained earnings

Total equity

(1)  OneVue Holdings Ltd joined the Iress Deed of Cross Guarantee in 2021 resulting in an increase in related party receivables.

102

2021
$’000

2020
$’000

27,926
34,326
195,167
6,900

264,319

121,499
16,441
40,654
21,166
449,502
173,917

823,179

1,087,498

35,357
9,001
13,115

57,473

50,848
37,228
2,644
77,785
296,530
–

465,035

522,508

564,990

493,883
26,178
1,148
43,781

564,990

27,593
28,856
7,975
935

65,359

112,359
15,311
26,913
17,761
548,579
165,465

886,388

951,747

28,285
5,512
4,777

38,574

50,846
25,443
42,833
5,321
188,433
121

312,997

351,571

600,176

558,416
35,020
(430)
7,170

600,176

Iress Limited4.7  Basis of preparation
Iress Limited (the ‘Company’) is a for-profit company domiciled in Australia. The full year financial report is a general purpose 
financial report comprising the Company and its subsidiaries (collectively referred to as the ‘Group’ or ‘Iress’) for the year ended 
31 December 2021. The full year financial statements:

•  have been prepared in accordance with the Corporations Act 2001 (Cth), Australian Accounting Standards and Interpretations, and 

International Financial Reporting Standards (IFRS)

•  were authorised for issue by the Directors on 16 February 2022

•  have been prepared on a historical cost basis, except for derivative financial instruments and investments in financial assets which 

have been measured at fair value

•  have all amounts presented in Australian dollars, unless otherwise stated

•  have amounts rounded off to the nearest thousand dollars, unless otherwise stated, as allowed under ASIC Corporations 

(Rounding in Financial/Directors Reports) Instrument 2016/191 dated 24 March 2016 (ASIC guidance).

(a) Adoption of new standards
In the current period, the Group has adopted all of the new and revised standards and interpretations issued by the Australian 
Accounting Standards Board (AASB) that are relevant to its operations and effective for annual reporting periods commencing on or 
after 1 January 2021 including the following:

•  AASB 2020-8 Amendments to Australian Accounting Standards

•  Interest rate benchmark reform – Phase 2

•  AASB 2021-4 Amendments to Australian Accounting Standards

•  COVID-19 related rent concessions

None of these standards have had a material impact on the Group in the current period and are not expected to have a material impact 
in future reporting periods or on foreseeable future transactions.

(b)  Standards on issue but not yet effective
At the date of authorisation of the financial statements, the following new accounting standards and interpretations have been 
published that are not mandatory for 31 December 2021 reporting periods and have not yet been applied by the Company within this 
financial report:

•  AASB 17 Insurance contracts 

•  Measurement of insurance liabilities (2)

•  AASB 2014-10 Consolidated Financial Statements and 
AASB 128 Investments in Associates (amendments)

•  Sale or contribution of assets between an investor and 

its associate or joint venture (1)

•  AASB 2020-1 Amendments to Australian Accounting Standards

•  Classification of liabilities as current or non-current (2)

•  AASB 2021-2 Amendments to Australian Accounting Standards

•  Disclosure of Accounting Policies and Definition of 

Accounting Estimates (2)

•  AASB 2020-3 Amendments to Australian Accounting Standards

•  Annual Improvements 2018-2020 and Other Amendments  (2)

(1)  Effective for annual periods beginning on or after 1 January 2022, with earlier application permitted.

(2)  Effective for annual periods beginning on or after 1 January 2023.

Iress does not believe these new accounting standards, amendments, and interpretations will have a material impact on the financial 
statements of the Group in future periods.

103

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

4.7  Basis of preparation (continued)
(c)  Summary of general accounting policies
The following significant accounting policies have been adopted 
in the preparation and presentation of the financial report.

(i) Consolidation
The consolidated financial statements include the financial 
statements of the Company, and the information and results of 
each subsidiary from the date on which the Company obtains 
control and until such time as the Company ceases to control 
such entity.

An entity is controlled when Iress is exposed to, or has rights to, 
variable returns from involvement with the entity and has the 
ability to affect those returns through power over the entity.

When necessary, adjustments are made to the financial 
statements of subsidiaries to bring their accounting policies in 
line with the Group’s accounting policies.

In reporting the consolidated financial statements, all 
intercompany balances and transactions, and unrealised profits 
or losses within the Group are eliminated in full.

(ii) Foreign currency translation
Foreign currency transactions

All foreign currency transactions during the financial year are 
brought to account using the exchange rate in effect at the 
date of the transaction. Foreign currency monetary items at 
reporting date are translated at the exchange rate existing at the 
reporting date.

Exchange differences are recognised in profit or loss in the 
period in which they arise except that exchange differences on 
monetary items receivable from or payable to a foreign operation 
for which settlement is neither planned or likely to occur, which 
form part of the net investment in a foreign operation are 
recognised in the foreign currency translation reserve in the 
consolidated financial statements and are recognised in profit or 
loss on disposal of the net investment.

Foreign operations

Assets and liabilities of foreign operations are translated using 
exchange rates prevailing at the end of each reporting period. 
Income and expense items are translated at the average 
exchange rates for the period, unless exchange rates fluctuate 
significantly during that period, in which case the exchange 
rates at the dates of the transactions are used. Any exchange 
differences are recognised in equity. On the disposal of a foreign 
operation, all of the exchange differences accumulated in equity 
in respect of that operation are reclassified to profit or loss.

(iii) Financial instruments
Financial assets and financial liabilities are recognised in the 
Company’s Statement of Financial Position when the Group 
becomes a party to the contractual provisions of the instrument.

Financial assets and financial liabilities are initially measured 
at fair value. Transaction costs directly attributable to the 
acquisition or issue of financial assets and financial liabilities 
(other than financial assets and financial liabilities at fair value 
through profit or loss) are added to or deducted from the fair value 
of the financial assets or financial liabilities, as appropriate, on 
initial recognition. Transaction costs directly attributable to the 
acquisition of financial assets or financial liabilities at fair value 
through profit or loss are recognised immediately in profit or loss.

When the transaction price differs from fair value at initial 
recognition, the Group will account for such difference if:

•  fair value is evidenced by a quoted price in an active market for 
an identical asset or liability or based on a valuation technique 
that uses only data from observable markets, then the 
difference is recognised as a gain or loss on initial recognition 
(ie day 1 profit or loss) 

•  (in all other cases), the fair value will be adjusted to bring it in 
line with the transaction price (ie day-1 profit or loss will be 
deferred by including it in the initial carrying amount of the 
asset or liability).

After initial recognition, the deferred gain or loss will be released 
to profit or loss such that it reaches a value of zero at the time 
when the entire contract can be valued using active market 
quotes or verifiable objective market information.

Depending on the type of financial instrument, the Group can 
adopt one of the following policies for the amortisation of day 1 
gain or loss:

•  Calibrate unobservable inputs to the transaction price and 
recognise the deferred gain or loss as the best estimates 
of those unobservable inputs change based on observable 
information.

•  Release the day-1 gain or loss in a reasonable fashion based 

on the facts and circumstances (ie using either straight-line or 
non-linear amortisation).

Financial assets

The Company’s financial assets include cash and cash 
equivalents, derivatives, listed shares and trade and 
other receivables.

104

Iress LimitedClassification and subsequent measurement of financial assets

Financial assets that meet the following conditions and are 
subsequently measured at amortised cost include:

Share capital represents the nominal value of equity shares 
issued. Share premium represents the excess over nominal value 
of the fair value of the consideration received for equity shares, 
net of direct issue costs.

•  the financial asset is held within a business model whose 

objective is to collect contractual cash flows

Bank borrowings

•  the contractual terms give rise on specified dates to cash 

flows that are solely payments of principal and interest on the 
principal amount outstanding.

All other financial assets are subsequently measured at fair value.

Amortised cost and interest income

Interest income is recognised using the effective interest method 
for financial assets measured subsequently at amortised cost. 
Interest income is calculated by applying the effective interest 
rate to the gross carrying amount of a financial asset, except for 
financial assets that have subsequently become credit impaired.

Impairment of financial assets

The Group performs impairment assessment under the expected 
credit losses model on financial assets (including trade and other 
receivables, receivables from related parties and bank balances) 
which are subject to impairment under AASB 9 Financial 
Instruments. The amount of expected credit losses is updated 
at the end of each reporting period to reflect changes in credit 
risk since initial recognition. Refer to Note 2.4(b) on the Group’s 
approach to the credit loss allowance.

Derecognition of financial assets

The Group derecognises a financial asset only when the 
contractual rights to the cash flows from the asset expire, or, 
when it transfers the financial asset and substantially all the risks 
and rewards of ownership of the asset to another entity.

On derecognition of a financial asset measured at amortised 
cost, the difference between the asset’s carrying amount and the 
sum of the consideration received and receivable is recognised 
in profit or loss.

Cash and cash equivalents

Cash and cash equivalents include cash in hand and on-demand 
deposits, and other short-term highly liquid investments, readily 
convertible into a known amount of cash and are subject to an 
insignificant risk of changes in value.

Financial liabilities and equity

Financial liabilities and equity instruments are classified 
according to the substance of the contractual arrangements 
entered into. An equity instrument is any contract that evidences 
a residual interest in the assets of the Company after deducting 
all of its liabilities. Equity instruments issued by the Company are 
recorded at the proceeds received, net of direct issue costs.

Interest-bearing bank loans and overdrafts are recorded at 
the fair value of proceeds received, net of direct issue costs. 
Finance charges, including premiums payable on settlement 
or redemption and direct issue costs, are accounted for on 
an accruals basis in the statement of comprehensive income 
using the effective interest rate method. They are added to the 
carrying amount of the instrument to the extent that they are 
not settled in the period in which they arise.

Trade payables

Trade payables are initially measured at fair value and are 
subsequently measured at amortised cost, using the effective 
interest rate method.

(d)   Accounting judgement in relation to the presentation 

of the Mortgages business

During 2021, as a result of a strategic review, Iress informed the 
market that it was considering a sale of the Mortgages business.

In accordance with AASB 5 Non-current Assets Held for Sale 
and Discontinued Operations, Iress conducted an assessment 
of whether the Mortgages business should be presented as an 
Asset Held for Sale in the financial statements for the years 
ended 31 December 2021. As a result of that assessment, Iress 
has concluded that the potential sale of the Mortgages was 
not highly probable at 31 December 2021 and, therefore, the 
Mortgages business is not presented as Held for Sale in these 
financial statements.

(e)  Significant sources of estimation uncertainty
The following assets and liabilities recognised in the Consolidated 
Statement of Financial Position as at 31 December 2021 are 
subject to estimates made about future performance and as 
such require significant judgement:

(i) Goodwill
Significant judgement is required in the assumptions used in the 
value-in-use models used in impairment testing. Refer to Note 2.1 
for more detailed information.

(ii) Credit Loss Allowance
Significant judgement is required in the assumptions made in 
calculating the Group’s credit loss allowance included within trade and 
other receivables. Refer to Note 2.4 for more detailed information.

105

Annual Report 2021Notes to the Consolidated Financial Statements

For the year ended 31 December 2021

4.9  Transactions with related parties
There are no shareholders with substantial holdings that 
materially transacted with the Group during the year.

4.10   Events subsequent to the Statement of 

Financial Position date

On 16 February 2022, the Directors declared a final dividend of 
30.0 cents per share franked to 15% totalling $58.0 million.

Other than the declaration of the final dividend, and the items 
noted above, there has been no other matter nor circumstance 
which has arisen since the end of the financial year that has 
significantly affected, or may significantly affect, the operations 
of the Group, the results of those operations, or the state of 
affairs of the Group in subsequent years.

4.8   The impact of the COVID-19 pandemic on 

these financial statements

Since the onset of the global pandemic in March 2020, Iress has 
taken a number of steps in response to managing the impact 
of COVID-19 for the welfare of our people and for business 
continuity. Iress’ key focus during this time has been the health 
and wellbeing of its people, ensuring they have been able to 
work safely and effectively on a remote basis as required, while 
continuing to provide service continuity for clients and users.

Members of the Iress leadership team, including the CEO, 
together with specialists from within the business, continue to 
meet regularly to ensure the right measures are in place. Where 
offices are open again, our teams have been returning on an 
optional basis. In locations where offices are closed, our teams 
are working well remotely.

Employees who return to offices in select locations do so in 
line with government, health & safety, landlord and internal 
guidelines. We are not requiring vaccinations for our people as a 
condition of employment or for entry to our offices (unless there 
are government, landlord or client requirements). However, we 
continue to closely follow the advice of governments and health 
authorities in each of our locations.

Iress has been able to continuously operate and support all 
services. We have not experienced any serious negative impact 
on operations or productivity as a result of this global pandemic. 
We are satisfied that our teams, including business-critical 
teams, can continue to operate remotely for an extended period 
of time if required.

Our data centres are deliberately located in different and 
independent locations consistent with prudent failover strategies. 
Following assessment, we are confident these services are not 
materially at risk at present from coronavirus-related issues. 
We are also not aware of any change to our supply chain that 
has or will have a material impact on our clients and users. 
Regular updates regarding business continuity are published 
on Iress’ website.

Iress operates a software subscription model, with most of its 
revenue recurring in nature. Iress has a history of strong cash 
conversion and low debtor defaults. These features of Iress’ 
commercial model have continued throughout the pandemic.

The majority of client implementation projects have continued 
since the onset of the pandemic, notwithstanding a short period 
of adjustment in 2020.

The Group is exposed to the broader economic uncertainty 
evident in all of Iress’ markets as a result of COVID-19 
and the impact of Government public health responses 
including lockdowns.

At the date of this report, due to the resilience of Iress’ business, 
Iress has not been eligible, nor applied for, significant Government 
COVID-19 related support. The exception being a deferral of 
certain VAT payments offered to all companies in the UK during 
2020 and the deferral of payroll tax in the state of New South 
Wales, Australia during 2020 and 2021. Iress settled the deferred 
2020 payroll tax payments during the second half of 2020, the 
UK VAT liabilities during the first half of 2021 and the deferred 
2021 payroll tax payments in January 2022.

106

Iress LimitedDirectors’ Declaration

31 December 2021

In the Directors’ opinion:

(a)   the financial statements and notes set out on pages 60 to 106 are in accordance with the Corporations Act 2001, including:

(i) 

 complying with the Accounting Standards, the Corporations Regulations 2001 and other mandatory professional 
reporting requirements

(ii) 

 giving a true and fair view of the consolidated entity’s financial position as at 31 December 2021 and of its performance for the 
financial year ended on that date

(b)  there are reasonable grounds to believe that the Company will be able to pay its debts as and when they become due and payable

(c)   at the date of this declaration, there are reasonable grounds to believe that the members of the extended closed group identified 

in Note 4.5 will be able to meet any obligations or liabilities to which they are, or may become subject by virtue of the deed of cross 
guarantees described in Note 4.6.

Note 4.7 confirms that the financial statements also comply with International Financial Reporting Standards as issued by the 
International Accounting Standards Board.

The Directors have been given the declarations by the Chief Executive Officer and Chief Financial Officer required by section 295A 
of the Corporations Act 2001.

This declaration is made in accordance with a resolution of the Directors.

Roger Sharp

Chair

Melbourne

16 February 2022

Andrew Walsh

Managing Director &  
Chief Executive Officer

107

Annual Report 2021 
 
Independent Auditor’s Report

Deloitte Touche Tohmatsu 
ABN 74 490 121 060 
477 Collins Street 
Melbourne, VIC, 3000 
Australia 

Phone: +61 3 9671 7000  
www.deloitte.com.au 

IInnddeeppeennddeenntt  AAuuddiittoorr’’ss  RReeppoorrtt    
ttoo  tthhee  mmeemmbbeerrss  ooff  IIrreessss  LLiimmiitteedd  

RReeppoorrtt  oonn  tthhee  AAuuddiitt  ooff  tthhee  FFiinnaanncciiaall  RReeppoorrtt 

OOppiinniioonn   

We  have  audited  the  financial  report  of  Iress  Limited  (the  “Company”)  and  its  subsidiaries  (the  “Group”),  which 
comprises the consolidated statement of financial position as at 31 December 2021, the consolidated statement of 
profit or loss and other comprehensive income, the consolidated statement of changes in equity and the consolidated 
statement of cash flows for the year then ended, notes to the consolidated financial statements, including a summary 
of significant accounting policies and other explanatory information, and the directors’ declaration. 

In  our opinion,  the  accompanying  financial  report  of the  Group,  is  in  accordance  with  the  Corporations  Act  2001, 
including:  

(i)  

giving  a  true  and  fair  view  of  the  Group’s  financial  position  as  at  31  December  2021  and  of  its  financial 
performance for the year ended on that date; and  

(ii)  

complying with Australian Accounting Standards and the Corporations Regulations 2001. 

BBaassiiss  ffoorr  OOppiinniioonn  

We conducted our audit in accordance with Australian Auditing Standards. Our responsibilities under those standards 
are further described in the Auditor’s Responsibilities for the Audit of the Financial Report section of our report. We 
are independent of the Group in accordance with the auditor independence requirements of the  Corporations Act 
2001 and the ethical requirements of the Accounting Professional and Ethical Standards Board’s APES 110  Code of 
Ethics for Professional Accountants (including Independence Standards) (the Code) that are relevant to our audit of 
the financial report in Australia. We have fulfilled our other ethical responsibilities in accordance with the Code.  

We confirm that the independence declaration required by the Corporations Act 2001, which has been given to the 
directors of the Company, would be in the same terms if given to the directors as at the time of this auditor’s report. 

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. 

KKeeyy  AAuuddiitt  MMaatttteerrss    

Key audit matters are those matters that, in our professional judgement, were of most significance in our audit of the 
financial report for the current period. These matters were addressed in the context of our audit of the financial report 
as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.  

Liability limited by a scheme approved under Professional Standards Legislation. 
Member of Deloitte Asia Pacific Limited and the Deloitte organisation. 

108

Iress Limited 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
KKeeyy  AAuuddiitt  MMaatttteerr  

HHooww  tthhee  ssccooppee  ooff  oouurr  aauuddiitt  rreessppoonnddeedd  ttoo  tthhee  KKeeyy  AAuuddiitt  
MMaatttteerr  

CCaarrrryyiinngg   vvaalluuee   ooff   ggooooddwwiillll   iinn   tthhee   UUKK   MMoorrttggaaggeess  
bbuussiinneessss  

Our procedures included but were not limited to: 

•  Obtaining an understanding of the key controls 

Refer to Note 2.1 - Impairment assessment. 

As  at  31  December  2021,  the  Group’s  goodwill 
totalled  $621.5  million  which  is  allocated  to  the 
relevant Cash Generating Units (CGUs). Goodwill 
is required to be assessed for impairment on an 
annual  basis  or  when  any 
indicators  of 
impairment exist. 

impairment  due  to 

The UK Mortgages CGU was identified as having a 
heightened  risk  of 
its 
dependency  on  securing  new  contracts  in  order 
forecast  revenue  growth  rates. 
to  achieve 
Included  within  the  UK  Mortgages  CGU  at  31 
December 2021 is goodwill of $82.0 million. 

The Group has prepared a value in use model to 
determine  the  recoverable  amount  of  the  UK 
Mortgages CGU. 

During the current year, Iress engaged advisors to 
market the UK Mortgages  business  for  potential 
divestment. As at 31 December 2021, this process 
remained  in  progress,  with  initial  non-binding 
offers received in January 2022.  

associated with the preparation of the value in use 
models and critically evaluating management’s 
methodologies. 

With the assistance of our valuation specialists, we: 

• 

• 

• 

• 

• 

• 

Assessed key assumptions, including forecast growth 
rates by comparing them to economic and industry 
growth rates  
Challenged the forecasted revenue for the UK 
Mortgages CGU with reference to: 

- 

- 

the historical accuracy of forecasting of the 
Group 
evaluation of current pipeline and historical 
pipeline conversion rate 

Evaluated the discount rate used for the UK 
Mortgages CGU against comparable organisations  
Agreed the cash flow forecast to the latest Board 
approved four year financial plan for the UK 
Mortgages CGU 
Tested the mathematical accuracy of the value in use 
models 
Assessed the net present value of the UK Mortgages 
CGU in local currency against its to the carrying value 
in local currency. 

We performed a sensitivity analysis to stress test the key 
assumptions used in the value in use model, including 
revenue growth, terminal growth rates and discount rate 
used.  

Our procedures in relation to the potential divestment of the 
UK Mortgages CGU included: 

•  Obtaining an understanding of the status of the sale 

process as at 31 December 2021, and then 
subsequently to date of the financial report. 
Reviewing non-binding indicative offers received, 
including offer value and the basis on which the 
offers were provided. 
Assessing if the non-binding indicative offers support 
the carrying value of the UK Mortgages CGU. 

• 

• 

We also assessed the appropriateness of the disclosures 
included in Note 2.1 to the financial statements.  

109

Annual Report 2021 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
Independent Auditor’s Report

OOtthheerr  IInnffoorrmmaattiioonn   

The  directors  are  responsible  for  the  other  information.  The  other  information  comprises  the  information  in  the 
Company’s annual report for the year ended 31 December 2021, but does not include the financial report and our 
auditor’s report thereon.  

Our opinion on the financial report does not cover the other information and we do not express any form of assurance 
conclusion thereon.  

In connection with our audit of the financial report, our responsibility is to read the other information and, in doing 
so,  consider  whether  the  other  information  is  materially  inconsistent  with  the  financial  report  or  our  knowledge 
obtained in the audit or otherwise appears to be materially misstated. If, based on the work we have performed, we 
conclude that there is a material misstatement of this other information, we are required to report that fact. We have 
nothing to report in this regard.  

RReessppoonnssiibbiilliittiieess  ooff  tthhee  DDiirreeccttoorrss  ffoorr  tthhee  FFiinnaanncciiaall  RReeppoorrtt    

The directors of the Company are responsible for the preparation of the financial report that gives a true and fair view 
in accordance with Australian Accounting Standards and the  Corporations Act 2001 and for such internal control as 
the directors determine is necessary to enable the preparation of the financial report that gives a true and fair view 
and is free from material misstatement, whether due to fraud or error.  

In preparing the financial report, the directors are responsible for assessing the ability of the Group to continue as a 
going  concern,  disclosing,  as  applicable,  matters  related  to  going  concern  and  using  the  going  concern  basis  of 
accounting  unless  the  directors  either  intend  to  liquidate  the  Group  or  to  cease  operations,  or  has  no  realistic 
alternative but to do so.  

AAuuddiittoorr’’ss  RReessppoonnssiibbiilliittiieess  ffoorr  tthhee  AAuuddiitt  ooff  tthhee  FFiinnaanncciiaall  RReeppoorrtt   

Our objectives are to obtain reasonable assurance about whether the financial report as a whole is free from material 
misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable 
assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with the Australian 
Auditing Standards will always detect a material misstatement when it exists. Misstatements can arise from fraud or 
error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence 
the economic decisions of users taken on the basis of this financial report. 

As part of an audit in accordance with the Australian Auditing Standards, we exercise professional judgement and 
maintain professional scepticism throughout the audit. We also:   

• 

Identify and assess the risks of material misstatement of the financial report, whether due to fraud or error, 
design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient 
and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting 
from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional 
omissions, misrepresentations, or the override of internal control. 

•  Obtain an understanding of internal control relevant to the audit in order to design audit procedures that 
are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness 
of the Group’s internal control.  

• 

Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates 
and related disclosures made by the directors.  

•  Conclude on the appropriateness of the directors’ use of the going concern basis of accounting and, based 
on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that 
may  cast  significant  doubt  on  the  Group’s  ability  to  continue  as  a  going  concern.  If  we  conclude  that  a 
material  uncertainty  exists,  we  are  required  to  draw  attention  in  our  auditor’s  report  to  the  related 

110

Iress Limited 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
disclosures  in  the  financial  report  or,  if  such  disclosures  are  inadequate,  to  modify  our  opinion.  Our 
conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future 
events or conditions may cause the Group to cease to continue as a going concern.  

• 

Evaluate the overall presentation, structure and content of the financial report, including the disclosures, 
and whether the financial report represents the underlying transactions and events in a manner that achieves 
fair presentation.  

•  Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business 
activities within the Group to express an opinion on the financial report. We are responsible for the direction, 
supervision and performance of the Group audit. We remain solely responsible for our audit opinion.  

We communicate with the directors regarding, among other matters, the planned scope and timing of the audit and 
significant audit findings, including any significant deficiencies in internal control that we identify during our audit.  

We also provide the directors with a statement that we have complied with relevant ethical requirements regarding 
independence, and to communicate with them all relationships and other matters that may reasonably be thought to 
bear on our independence, and where applicable, actions taken to eliminate threats or safeguards applied. 

From the matters communicated with the directors, we determine those matters that were of most significance in 
the audit of the financial report of the current period and are therefore the key audit matters. We describe these 
matters  in  our auditor’s  report  unless  law  or regulation precludes  public disclosure about the  matter  or  when,  in 
extremely rare circumstances, we determine that a matter should not be communicated in our report because the 
adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such 
communication. 

RReeppoorrtt  oonn  tthhee  RReemmuunneerraattiioonn  RReeppoorrtt  

Opinion on the Remuneration Report 

We have audited the Remuneration Report included in pages 30 to 58 of the Directors’ Report for the year ended 31 
December 2021. 

In our opinion, the Remuneration Report of Iress Limited, for the year ended 31 December 2021, complies with section 
300A of the Corporations Act 2001.  

Responsibilities 

The directors of the Company are responsible for the preparation and presentation of the Remuneration Report in 
accordance  with  section  300A  of  the  Corporations  Act  2001.  Our  responsibility  is  to  express  an  opinion  on  the 
Remuneration Report, based on our audit conducted in accordance with Australian Auditing Standards.  

DELOITTE TOUCHE TOHMATSU 

Tom Imbesi 
Partner 
Chartered Accountants 
Melbourne 16 February 2022 

111

Annual Report 2021 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Shareholder Information

The below shareholder information was applicable as at 31 December 2021.

(a)  Distribution of members and their holdings:

1 to 1,000
1,001 to 5,000
5,001 to 10,000
10,001 to 100,000
100,001 and over

Total

(b)  Substantial shareholders:

MITSUBISHI UFJ FINANCIAL GROUP
GREENCAPE CAPITAL PTY LTD
DALTON NICOL REID PORTFOLIO MANAGERS

Total substantial shareholders

Balance of register

Total

(c)  20 largest shareholders of quoted equity securities

Rank

Name

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

GREENCAPE CAPITAL (MELBOURNE)
FIRST SENTIER INVESTORS – AUSTRALIAN SMALL COMPANIES (SYDNEY)
DNR CAPITAL (BRISBANE)
SELECTOR FUNDS MGT (SYDNEY)
AUSTRALIAN FOUNDATION INVESTMENT CO (MELBOURNE)
STATE STREET GLOBAL ADVISORS (SYDNEY)
VANGUARD GROUP (PHILADELPHIA)
BLACKROCK INVESTMENT MGT – INDEX (SAN FRANCISCO)
IRE EQUITY PLANS TRUST (MELBOURNE)
SCHRODER INVESTMENT MGT (SYDNEY)
HYPERION ASSET MGT (BRISBANE)
DIMENSIONAL FUND ADVISORS (SYDNEY)
SPHERIA ASSET MGT (SYDNEY)
ELLERSTON CAPITAL (SYDNEY)
VANGUARD INVESTMENTS AUSTRALIA (MELBOURNE)
NORGES BANK INVESTMENT MGT (OSLO)
CELESTE FUNDS MGT (SYDNEY)
NAMU HOLDINGS (SINGAPORE)
ELEY GRIFFITHS GROUP (SYDNEY)
BLACKROCK INVESTMENT MGT (AUSTRALIA) – INDEX (SYDNEY)

Total top-20 shareholders

Balance of register

Total

112

Number of
shareholders

Number of
shares

% of issued
capital

5,970
3,485
632
404
50

2,320,771
8,213,741
4,550,498
8,777,690
165,765,656

1.22
4.33
2.40
4.63
87.42

10,541

189,628,356

100.00

Number held

13,549,386
13,109,447
9,634,257

36,293,090

153,335,266

189,628,356

%

7.15
6.91
5.08

19.14

80.86

100.00

Number
held

% of issued
shares

13,109,447
10,620,168
9,634,257
9,049,430
8,211,205
6,045,829
6,016,246
5,970,507
5,515,900
4,966,406
3,929,996
3,835,889
3,469,315
3,431,310
3,346,563
2,999,607
2,849,232
2,766,420
2,506,564
2,397,481

6.91
5.60
5.08
4.77
4.33
3.19
3.17
3.15
2.91
2.62
2.07
2.02
1.83
1.81
1.76
1.58
1.50
1.46
1.32
1.26

110,671,772

78,956,584

189,628,356

58.36

41.64

100.00

Iress LimitedCorporate Directory

Directors

A D’Aloisio (2)

R Sharp (1)

A Walsh

N Beattie

J Cameron

M Dwyer

J Fahey

J Hayes (2)

G Tomlinson (2)

T Vonhoff

Chair since August 2014, Independent Non-Executive 
Director since June 2012 and final term as Chair and 
Director ended at the AGM in May 2021

Chair since May 2021 and Independent Non-Executive 
Director since February 2021

Managing Director and Chief Executive Officer since 
October 2009

Independent Non-Executive Director since 
February 2015

Independent Non-Executive Director since March 2010

Independent Non-Executive Director since 
February 2020

Independent Non-Executive Director since 
October 2017 and Chair of the People & Performance 
Committee since February 2020

Independent Non-Executive Director since 
June 2011 and final term as Director ended at the 
AGM in May 2021

Independent Non-Executive Director since 
February 2015 and final term as Director ended at the 
AGM in May 2021

Independent Non-Executive Director since 
February 2020 and Chair of the Audit & Risk 
Committee since May 2021

Company Secretary

Registered Office

Share Registry

Stock Exchange Listing

P Ferguson

Level 16, 385 Bourke Street
Melbourne VIC 3000
Phone: +61 3 9018 5800
Fax: +61 3 9018 5844

Computershare Investor Services Pty Ltd
452 Johnston Street
Abbotsford VIC 3067
www.computershare.com

Iress Limited shares are quoted on the 
Australian Securities Exchange under 
the code: IRE

Auditor

Deloitte Touche Tohmatsu

(1)  Appointed as Independent Non-Executive Director on 18 February 2021 and Chair on 6 May 2021.

(2)  Retired on 6 May 2021.

113

Annual Report 2021Technology to perform  
better every day.

iress.com